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Abstract
The synthesis and characterisation of ruthenium (II) 
bis-(1 ,10-phenanthroline) and bis-(2 ,2 1-bipyridyl) complexes 
containing amino and isothiocyanate phenanthroline and 
pyridine ligands are described. These complexes were 
characterised using HPLC, UV/vis spectroscopy, 
electrochemistry, NMR, IR, and emission spectroscopy. HPLC 
was used to determine the purity of the various complexes.
Electronic spectra and electrochemical 
measurements indicate that most likely, the 2 ,2 '-bipyridyl 
and 1 ,10-phenanthroline ligands are the emitting ligands and 
the amino and isothiocyanate phenanthroline and pyridine 
ligands act as the spectator ligands.
These complexes were subsequently conjugated to 
biological materials, including albumins, immunoglobulins and 
poly-L-lysine. The complexes were bound at different sites 
on the biomolecules, via the lysine residues, the 
carbohydrate moieties and via the tyrosine residues.
The effect of conjugation on the spectroscopic 
properties of the complexes was examined. The absorption 
spectra were found to exhibit changes in the MLCT band with 
the absorption wavelength maximum experiencing slight red 
shifts together with general band broadening effects. The 
emission decay behaviour was also investigated. The unbound 
complexes were found to exhibit single exponential decay 
behaviour and the bound complexes exhibited essentially 
double exponential behaviour. From the double exponential 
decay fits, the first short-lived species was suggested to be 
a quenched bound species whilst the second species probably 
arises from a bound species which is considerably protected 
from the effects of quenching molecules.
The synthesis and characterisation of a number of 
bis-(1,10-phenanthroline) (phen), and bis-(4,4'-dimethyl- 
2, 2'-bipyridyl) (dmbpy), ruthenium (II) complexes containing 
a series of pyridyltriazole ligands are described. The 
ruthenium ion may bind via the Nl'/ N 2 ' or n4' of the
triazole ring. The most favourable coordination mode being 
dependent on the position of a substituent on the triazole 
ring. Coordination isomers were obtained and separated by 
semi-preparative HPLC methods. The electrochemical results 
suggest that the phen and dmbpy ligands are the emitting 
ligands and that the pyridyltriazole ligands are the 
spectator ligands.
The acid-base chemistry of those pyridyltriazole 
complexes which can undergo protonation / deprotonation 
reactions was investigated and the results substantiated the 
coordination modes proposed using NMR data for the 
complexes. The ground state pKa values show that there is 
a strong a-donating effect from the triazole ring to the 
ruthenium ion. Also, the excited state pKa* values are 
lower than the ground state pKa values which indicates that 
the pyridyltriazole ligands do not participate in the 
emission process. This study completes investigations which 
were initially conducted on the 2 ,2 '-bipyridyl analogues.
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CHAPTER 1
INTRODUCTION
1.1 Introduction.
The primary concern of this thesis is the application of 
ruthenium polypyridyl compounds as fluorescent labels in 
biological systems. The second part involves a study of the 
synthesis and characterisation of bis-(1 ,1 0 1-phenanthroline) 
and bis-(4,4'-dimethyl-2,2 1-bipyridyl) ruthenium compounds 
containing various pyridyltriazole ligands and is a 
continuation of studies carried out on the analogous bis- 
(2 ,2 '-bipyridyl compounds). [1 ,2]
The common factor in both these projects is the 
use of ruthenium polypyridyl compounds, therefore, it is 
appropriate to commence with a review of the properties of 
ruthenium polypyridyl compounds relevant to this thesis.
This chapter will also survey the literature in relation to 
the use of fluorescent labels in biological systems with 
emphasis on the application of ruthenium compounds in this 
manner. The literature will also be summarised in regard to 
the study of the ruthenium coordinated pyridyltriazole 
complexes.
Hundreds of papers have been published about 
various aspects of ruthenium polypyridyl spectroscopy, 
photophysics, photochemistry and electrochemistry, in
24-particular [Rulbpy)^] where bpy = 2 ,2'-bipyridyl, has 
received extensive attention. [3,4,5,6,7]
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1.2 The structure and physical properties of
ruthenium polypyridyl complexes.
9+ £Ru is a d system and the polypyridyl ligands are
usually colourless molecules possessing (7-donor orbitals
localised on the nitrogen atoms and Jt-dcnor and 
★
71 -acceptor orbitals more or less delocalised on aromatic
2 +rings. The compound [Ru(bpy)3J and other 
2 +[Ru(L-L)^] compounds where L-L = bidentate polypyridyl
*ligand, exhibit symmetry and the 71 and 71 orbitals
of the ligands may be symmetrical ( X  ) or anti-symmetrical
( )  with respect to rotation around the C^ axis retained
by each Ru(bpy) unit. [3] The X-ray crystal structure for 
2 +[Ru(bpy)^] shows that the metal to ligand (Ru-N) bond
lengths are short, indicating significant back-bonding
★between Ru(II) and the K  orbitals of bpy. [3]
For most Ru(II) polypyridyl complexes, the lowest 
excited state is a ^MLCT (metal to ligand charge transfer) 
transition, [8,9,10] which undergoes slow radiationless decay 
and thus exhibits long lifetime luminescence emission. [4]
An important advantage of MLCT excited states is the presence 
of two distinct redox sites, i.e. an oxidising site on the 
metal and a reductive site on the ligands. [3] The energy 
position of the MLCT state depends on the redox properties of 
the metal and ligands, in particular on the <7 -donor or 
31 -acceptor properties of the ligands. [11]
Compounds containing strong q  -donor ligands
2
donate much electron density into the metal d orbitals, 
causing lower oxidation potentials and more negative 
reduction potentials. Strong ji -acceptor ligands stabilise 
the filled metal orbitals giving rise to high oxidation 
potentials and low reduction potentials. The Q-donor 
strength of the ligands modulates the metal d orbital 
energies. Weaker o-donor ability to a central metal ion 
results in a higher formal charge on the metal and 
consequently, the stabilisation of the metal d orbital.
The C7-donor ability of the ligand is related to the pK of3.
the free ligand. The difference in energy between the filled 
d orbitals and the lowest unoccupied ligand-based orbital is 
related to the absorption and emission energy of the 
complexes. By a judicious choice of ligands in a series of 
complexes of the same metal ion, the orbital nature of the 
lowest excited state and, hence, its energy, emission 
lifetime, emission quantum yield, redox properties, chemical 
stability and oxidation and reduction potentials can be 
controlled. [3 ]
As a consequence of the unique combination of
photochemistry, electrochemistry and chemical stability of
Ru(II) polypyridyl type compounds, they find application as
a) photoluminescent compounds; b) excited state reactants in
electron and energy transfer processes and c) excited state
products in electron transfer chemiluminescence and
electrochemiluminescence. [12]
2 +[Ru(bpy)3 ] has been recognised as a 
potential catalyst for the decomposition of water into its
3
elements by irradiation with solar light. [13] However, a
2 +major disadvantage is that [Ru(bpy)^] is not
photochemically inert towards ligand substitution. Ligand
photosubstitution may be avoided by increasing the energy gap 
3 3between the MLCT and MC state. This may be achieved by 
the choice of other ligands such that the ground and excited 
state properties of the compounds may be improved. [3] Also, 
this drawback may be remedied by the use of caged ruthenium 
polypyridyl complexes which have much better chemical 
stability and longer excited state lifetimes. [14,15,16]
Other problems associated with water splitting systems 
include problems with the platinum catalyst, inefficient 
electron transfer processes, the separation of the evolving 
dihydrogen and dioxygen gases and back reactions. [13]
1.2.1 Absorption spectroscopy.
2 +The absorption spectrum of [RuCbpy)^] is shown in
Figure 1.1. The intense transitions observed in the visible
region are due to the metal to ligand charge transfer
transition between the metal centred ground state and
★ligand JZ states. [3,8,9,10] The intense bands in the
ultraviolet region have been assigned to intraligand Jl - 
*
Jl transitions by comparison with the spectrum of the 
protonated bipyridine.
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2 +Figure 1.1 Absorption spectrum of [RuCbpy)^] in
aqueous solution, with the assignments for the
various bands.
Exact assignment of the multiplicity of levels
involved in the MLCT excited state is not possible because of
the heavy atom effect where spin-orbit coupling mixes the two
spin states. However, it has been established that the
2 +electronic transitions of [RuCbpy)^] may be assigned as
either singlet or triplet states. In particular, a singlet
character of about 10% has been estimated for the lower lying
2 +excited states of [Ru(bpy)^] . Excitation leads to a 
state, which is best defined as ^MLCT from which 
intersystem crossing occurs with unit efficiency to a lower 
lying MLCT considered triplet in character and from which 
emission occurs. [17,18]
5
The weaker absorption observed to the blue of the visible
* .band has been assigned to a metal centred d-d transition 
while the tail at longer wavelengths has been assigned to a 
weak spin-forbidden MLCT transition. [4,8] It is now 
believed that the excited electron is delocalised among the 
ligands in the ^"MLCT excited state but that as interaction
between the ligands is low, it localises on only one ligand
3when intersystem crossing to the MLCT excited state takes 
place, Figure 1.2.
6
Figure 1.2 Representation of the excited state properties of 
[Ru(bpy)3 32+*
7
1.2.2 Emission spectroscopy.
The exact nature of emission in ruthenium polypyridyl
compounds is surrounded by controversy and uncertainty. The
points of contention are the nature and multiplicity of the
levels involved and whether charge transfer results in the
electron being localised on one ligand or delocalised over
all the ligand orbitals.
The electronic structural model proposed by Kober
and Meyer, [8,9,10] seems best to describe the photophysical
2 +events in [Ru(bpy)^] and related compounds. This model
assumes very little interaction occurs between ligands so
that the excited electron is localised on one orbital for the
lifetime of the excited state. While including spin-orbit
coupling this model finds that the ^MLCT and ^MLCT states
are predominantly singlet and triplet in character,
respectively.
A second model proposed by Crosby et al .
[19,20,21], has also been used to explain the nature of the
MLCT states involved in emission. This electron ion-pairing
model assumes that the terms singlet and triplet become
meaningless because of strong spin-orbit coupling. The model
also assumes ligand interaction such that the excited
electron is delocalised among them. The symmetry of the
3excited state remains and the MLCT state, which is
split into three levels, is populated according to the 
Boltzmann distribution. All the states have mixed
8
multiplicities and the emission can be considered as 
essentially spin-forbidden from a manifold of states.
A general model of the photophysical processes of
2 +[RuCbpy)^] has already been presented in Figure 1.2.
The electron is excited to a ligand centred ^MLCT manifold
which is singlet in character. Fast intersystem crossing
occurs with unit efficiency from the singlet state to the
triplet manifold of three closely spaced ^MLCT states,
(shown through detailed studies on the temperature dependence
of the emission lifetime and quantum yield in the temperature
range 2-70 K), with a fourth state occurring several hundred
cm"^ to higher energy. The presence of the fourth MLCT
state in Ru(II) polypyridyl complexes is usually masked by
the deactivating ^MC state. The three lowest lying levels
are fairly close together ( A e  is about 100cm ^ ) and have
predominantly triplet character. Calculations on the fourth
higher state have shown that this state has more singlet
character than the other three lower lying states. [8,9,10]
At higher temperatures all of these states are
populated and contribute to the excited state decay so that
the excited state manifold may be considered as an average
state and on emission, results in a broad band. At low and
ambient temperatures the contributions of the upper states
(unless they are extremely short lived) are thought to be
negligible. At low temperatures, the emission spectrum
exhibits a fine structure which has been attributed to a
perturbed skeletal vibration of the aromatic ring due to
*removal of the Jt electron. The maximum wavelength of
9
emission occurs at higher wavelength (lower energy) at room 
temperature compared to that at low temperature. This red 
shift of the emission X  max. in comparison to the 
emission A. max. at low temperature, is called the 
rigidochromic effect and has been attributed to relaxation of 
the rigid matrix perturbation.
Emission from the triplet state to the ground state 
(K^) or radiationless decay (Knj.) to the ground state can 
take place. The ^MC state is responsible for a further 
deactivating pathway giving rise to either radiationless 
deactivation or photodecomposition of the complex.
Emission intensities are stronger at lower
temperature. This may be explained by the energy difference
between the emitting ^MLCT state and the deactivating ^MC
state. [10,22,23,24,25] At room temperature, thermal
population of this deactivating state is possible [4,11,26],
and hence Kr will decrease i.e. the emission intensity
decreases. At low temperatures, thermal population of the 
3MC state is not possible and Kr increases resulting in a
3more intense emission. The MC dd state lies about 
4000cm-  ^ above the ^CT manifold, and has a high rate of 
radiationless decay. In addition to being responsible for 
thermal deactivation, this  ^MC state is accountable for 
photochemical reactions such as racemisation and 
photosubstitution. [27,28,29] Non-radiative decay occurs but 
less efficiently from the ^CT manifold which is important 
at low temperatures and is dependent on vibrational activity 
and on the solvent. [30] For most complexes there is a
10
radiationless deactivation path which is to some extent
"frozen" when the solvent matrix is rigid at low temperature
and becomes important only as the solvent matrix becomes
"fluid" at room temperature. [31]
Studies indicate that there is some CTTS (charge
transfer to the solvent) character in the MLCT states and
while this has little effect on the radiative decay of the
excited state, it does effect the radiationless decay through
3thermally accessed MC states and has an important role in 
the photochemistry of the ruthenium polypyridyl compounds. 
[4,6,7,27,30,32]
1.2.3 Emission lifetime and temperature dependence.
Temperature dependence studies of the luminescence behaviour
can yield information concerning energy, electronic nature,
and deactivation rate of the luminescent and reactive states.
The essential features of the temperature dependence
2+(Figure 1.3) of the luminescence decay of [Rufbpy)^] are 
(a) an Arrhenius type behaviour of the luminescence decay in 
the rigid glass region (84-100 K); (b) a discontinuity in the 
glass-fluid transition region (about 100-150 K); (c) an 
Arrhenius type behaviour in the 150-250 K temperature range 
with essentially the same parameters as in the rigid glass and 
(d) another steeper Arrhenius type region for T > 250 K. This 
complex behaviour has been accounted for by the equation given
11
below, where K o ' is a temperature-independent term;
1/T - K0 , + Bi + a ^ - ^ / R T  + A2e - AE 2 / R T
1 + exp [G (1/T-l/T, ]
D
The second term takes care empirically of the
behaviour in the glass-fluid transition and the two
exponential terms account for the Arrhenius behaviour at low
and high temperature. The temperature behaviour of 
2 +[Rufbpy)^] has been accounted for as follows: emission 
originates from a cluster of closely spaced ( A e  about 100 
cm-^) MLCT levels having similar but not identical decay 
properties. When the matrix melts, large amplitude (low 
frequency) vibrational modes come into play, which enhance 
the rate of radiationless deactivation processes, with a 
consequent decrease in lifetime and intensity. Once the 
glass is completely melted, the slightly activated Arrhenius 
behaviour continues because the emission always originates 
from the same cluster of MLCT excited states. As already 
mentioned, at higher temperatures, a ^MC excited state 
which lies about 4000 cm~^ above the emitting levels becomes 
accessible. Since this level is strongly distorted compared 
with the ground state geometry, it undergoes very fast 
radiationless decay which includes ligand substitution and 
raceraisation reactions. The fourth MLCT excited state
12
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Figure 1.3 Temperature dependence behaviour of
2+[Ru(bpy).j] in nitrile solution.
at several hundred cm-1 higher with the largely singlet 
character does not play a role in the temperature dependence 
behaviour because it is "masked" by the surface crossing to 
3MC. [3,33]
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1.2.4 2+Electrochemical properties of [Ru(bpy)3 ]
Four successive reversible one electron cyclic voltammetric
2 +responses are observed for [Ru(bpy)3 J , see Figure 1.4.
One couple at positive potential corresponds to a metal based 
oxidation and three couples at negative potentials correspond 
to successive bpy reductions.
V vs SCE
Figure 1.4 Cyclic voltammagram of the oxidation and
2+reduction processes of [Rufbpy)^] in 
CH3CN/0.1 M NEt4C104 (TEAP).
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2 +Oxidation of [Ru(bpy)3 ] involves a metal centred 
orbital with formation of a low spin 4d^ system which is 
inert to ligand substitution:
[Ru(bpy)3]2+ [Ru(bpy)3 ]3+ + e
2 +The oxidation potential of [Ru(bpy)^] occurs at
1.26 V. By substituting one or more of the bpy ligands, the
oxidation potential can be changed dramatically. For
instance, the substitution of one bpy ligand in
2 +  —[Ru(bpy)3 ] with two Cl ions to give
[Ru(bpy)2CI2 ] lowers the oxidation potential to about
0.35 V vs SCE (saturated calomel electrode), whereas
★substitution with two strong jz - acceptor CO molecules
increases the oxidation potential above 1.9 V in
2 +[Ru(bpy)2 (CO)^] • [3] This shows that the oxidation
potential of the ruthenium complexes is strongly dependent on
the c t-donor or jt-acceptor properties of the ligands. [3]
2+Reduction of [Ru(bpy)3 J involves a ligand 
*centred X  orbital, which is the commonly observed 
behaviour for Ru(II) polypyridyl compounds where the ligand 
field is sufficently strong and/or the ligands may be easily 
reduced.
[Ru((bpy)3]2+ + e~ s —  [Ru(bpy)2(bpy“ )]+
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The added electron appears to be localised on a single
ligand. Several reduction steps may be observed and up to 6
electrons can be pumped into the complex at low temperature,
yielding [R u (bpy2-)^ ]4 • [3]
The localisation of the acceptor orbitals in the
reduction processes is often very clear in mixed ligand
compounds involving polypyridyl ligands with different 
*
71 orbital energies. Strong jt-accepting ligands have 
*low lying 71 orbitals and compounds containing such
★ligands are easily reduced. Compounds containing weak 71- 
accepting orbitals have a much more negative reduction 
potential. In mixed ligand complexes the first reduction 
potential usually involves the ligand with the lowest lying
•k
n orbital. [3]
1.2.5 Chemistry and quenching reactions of the
2+[RuCbpy)^] excited state.
The first step in any photochemical and photophysical process 
is the absorption of a photon by a molecule. The excited 
state that is formed in this way is a high energy unstable 
species which must undergo some type of deactivation 
process. Excited state deactivation can occur in a number of 
ways, as shown in Figure 1.5.
Deactivation may occur via (i) disappearance of the original 
molecule which undergoes some photochemical reaction; (ii) 
emission of light (luminescence); (iii) degradation of the
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excess energy into heat (radiationless deactivation) and (iv) 
some type of interaction with other species present in the 
solution (quenching processes). [3]
photochemical
reaction
pro d u cts
A +  h v  luminescence
A +  hv
A +  heat radiationless 
+  g  deactivation
A a n d /o r  products 
quenching processes
Figure 1.5 Schematic representation of excited state 
deactivation processes.
Processes involving radiationless deactivation, quenching or 
photochemical reactions compete with the luminescent decay 
process of the excited state. The presence of the thermally 
accessible ^MC state may result in deactivation through 
photosubstitution and photoracemisation processes. [28,29,30] 
When the lifetime of the excited state is 
sufficiently long, the excited state may have a chance to 
encounter a molecule of another solute. Interaction may 
occur bimolecularly, leading to quenching of the excited 
state.
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3 2 +The lowest MLCT excited state of [Ru(bpy)3 ] lives long
enough to encounter other solute molecules and possesses
suitable properties to play the role of energy donor, electron
donor or electron acceptor. Figure 1.6 shows the energy
* 2 +available to the excited [Rufbpy)^] and its reduction 
and oxidation potentials.
e *  14600 R u(bp y),
fTIQX  =  452n m  /
/
2*
\
T l / S C  “1 
- T =  0 -6 /is
" 0*86
*Ru(bpy)32'
\hV \  \  ♦ 0 84 
; 0=0 04
^2*12 eV
R u ^ b p y ) ,3 * '£ * *  * *  R u ( b p ^ ) 3 2 “ =?=►  R ^ tb p y ) ;
hv'
!♦
2 +Figure 1.6 Molecular quantities of [Rutbpy)^] relevant 
for energy and electron transfer processes.
** 2+ .[Rutbpy)^] indicates spin-allowed
* 2+excited states and [Ru(bpy),J indicates
the lowest spin-forbidden excited state (^MLCT) 
3[Ru(bpy),]2+.
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The excited state redox potentials estimated from 
corresponding ground state values and the excited state 
energy, indicate that the luminescent excited state is a 
strong reductant as well as a good oxidant. The higher 
energy content of an excited state means that the excited 
state is both a stronger reductant and oxidant than the 
corresponding ground state. [3]
The most important bimolecular processes are energy transfer 
and electron transfer. [3,4,7]
(1) * [Ru ( bpy) 3 ] 2+ + Q -------► [ R u ( b p y ) 3 ]2+ + Q*
(1) Energy transfer
(2) * [Ru( bpy) 3 ] 2+ + Q ------- ►  [R u (bpy) 3 ] 3+ + Q-
(2) Oxidative quenching
(3) *[Ru(bpy)3 ]2+ + Q ------- ► [ R u ( b p y ) 3 ]+ + Q+
(3) Reductive quenching
The excited state acts as (i) an energy donor in process (1); 
(ii) a reductant in process (2) and (iii) an oxidant in 
process (3).
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Energy transfer (process (1)) is a physical process where 
through contact, an excited state molecule transfers its 
energy to another molecule. The second and third processes 
involve electron transfer from/to the excited molecule and 
simultaneous oxidation or reduction of another species in 
solution.
The actual quenching mechanism is determined by
both thermodynamic and kinetic factors and most often
establishment of the actual mechanism is quite difficult.
The ability to undergo energy transfer is related to the
zero-zero spectroscopic energy E 1^  ^ of the donor-acceptor
pair (spectral overlap) and that of electron transfer to the
redox potentials. The kinetic factors are associated with
the activation energy needed to reorganise the inner and
outer shells before electron transfer can occur. [4]
The assignment of quenching processes to "energy
transfer" requires either direct observation of the acceptor
phosphorescence or at least photoreactions arising from the
excitation into the acceptor excited sites. The number of
authenticated cases of energy transfer from 
* 2 +[Rutbpy)^] are very few. [3] A clear example of the
it 2 + 3 —quenching of [Rufbpy)^] by [Cr(CN)g] has been
demonstrated by the observation of sensitised phosphorescence
from the chromium complex. In this case both reductive and 
* 2 +oxidative [Ru(bpy)3 J electron transfer quenchings by
3 _[Cr(CN)g] are thermodynamically forbidden, because it 
is very difficult to oxidize or reduce [Cr(CN)g]^ .
[3,4,34]
20
In contrast, [Cr(bpy)3 ]3+ can be very easily reduced and
with this quencher, oxidative electron transfer prevails over
energy transfer, which has been demonstrated by the
2 +appearance of the [Cr(bpy)3 ] absorption spectrum in 
flash photolysis experiments. [3,4,35] The direct 
observation of redox products in flash photolysis represents 
the strongest evidence to support the occurrence of oxidative 
and reductive quenching mechanisms. [3]
An example of reductive electron transfer quenching is that
2 +involving Eu as the quencher. [36,37]
[RufbpyJ^]2* + Eu2+ (aq) ---►[Ru(bpy)3 ]+ + Eu^+ (aq)
The absorption spectrum obtained after flash photolysis shows
2 +bleaching effects due to depletion of [Rufbpy)^] and
increased absorption due to the formation of [Ru(bpy)3]+ .
The increased absorption due to the [Ru(bpy)3 ]+ occurs at
the same rate of decay of luminescence emission of
* 2 +[Rutbpy)^] and indicates kinetically that reductive 
quenching has taken place.
2 +Quenching of the excited state of [Rutbpy)^] 
has been widely investigated. The excited state has been 
shown to be quenched by a variety of inorganic species. [3,4] 
A useful parameter in considering an excited state 
is its mean lifetime given by;
1//T = Kobs
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where T = lifetime and K , g = decay rate constant.
This is the average lifetime for an excited state, decaying 
by all possible decay mechanisms, each with its own decay 
constant so that;
1/T = K + K + K [Q]' T- r nr q
where K = rate constant for emission, K = rate r nr
constant for internal non-radiative decay and K = rateq
constant for bimolecular quenching with Q, a quencher such as
3triplet oxygen, C^.
From this is derived the Stern-Volmer equation;
l/x - l / T o  + Xq [Q]
where T and T are the observed lifetimes in the presence 
and absence of the quencher respectively, [Q] is the 
concentration (M) of the quencher and is the quenching 
rate constant.
This describes the effect of a quencher in solution 
on the lifetime. [38,39,40] A Stern-Volmer plot of 1 / x vs 
[Q ]  yields (slope).
Compounds containing unpaired electrons can act as 
efficient quenching agents. The most important compound of 
this type is molecular oxygen which is well known as a 
paramagnetic species and is universally present in solution
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in all samples. It is particularly effective in removing the 
energy from triplet state molecules and is, therefore, a 
particular problem in phosphorescence and with molecules 
possessing relatively long fluorescence lifetimes. Oxygen is 
one of the few molecules which effectively quenches
[Ru(bpy)3]2+ (Kg = 3.3 x 109m-1s-'1' ) . Singlet 
oxygen formation by energy transfer and electron transfer
mechanisms has been proposed. The lifetime of
* 2 +[Ru(bpy)^] is reduced by about a third in aerated
aqueous solutions, however, bubbling with nitrogen or argon 
reduces oxygen quenching to less than 1%. [6 ]
Although the Stern-Volmer method for the 
determination of quenching constants is widely used, it is 
difficult to deduce from a single study which of the three 
mechanisms is responsible for quenching. Clarification of 
which process is responsible for Stern-Volmer behaviour may 
be obtained by examination of the dependence of the quenching 
constants (Kg)> for a given quencher, on the excited state 
reduction potential of a series of closely related Ru(II) 
polypyridyl complexes. Dependence of K^ on the excited 
state potential indicates quenching by electron transfer 
processes whilst absence of any dependence suggests quenching 
by energy transfer mechanisms. [7]
Sometimes it is difficult to obtain direct evidence 
for energy transfer quenching (sensitised luminescence or 
absorption spectrum of the excited acceptor), or electron 
transfer quenching (absorption spectrum of redox products).
In such cases, it has been shown that free energy correlation
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of rate constants are useful in elucidating the quenching 
rate mechanism. [3]
1.2.6 Acid-base properties of the ground and excited 
states of ruthenium polypyridyl complexes which 
undergo proton transfer reactions.
One concern of this thesis was the continuation of studies
conducted on various bis-(2 ,2 '-bipyridyl) ruthenium
pyridyltriazole compounds. In this work,bis-(4,41-dimethyl-
2 , 2 '-bipyridyl) and bis-(1 ,10-phenanthroline) ruthenium
pyridyltriazole compounds were investigated. Some of these
pyridyltriazole compounds may undergo proton transfer
reactions. Studies on ruthenium complexes which can undergo
proton transfer reactions are of interest since the acid-base
properties of the ground state and excited state can often be
related to electron density distributions in the compounds
and the nature of the lowest unoccupied molecular orbital
(LUMO) of the ruthenium complexes. The nature of the LUMO
may be revealed by measurement of the ground state pKa and
*the excited state pK , pK . This is especially
a  cl
important in mixed ligand complexes where emission can be 
located on one or other of the ligands.
Usually, upon coordination to ruthenium the pK
of the ligand decreases because of electrostatic effects due 
to the positive charge on the metal ion and because of 
CJ-donation from the ligand to the metal. [41,42,43,44]
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2 +One exception is [ (NH^ ),-Ru ( pyrz ) ] where pyrz = 
pyrazine, which exhibits reverse behaviour and the pK of
cl
the coordinated pyrazine is higher when coordinated to the
ruthenium ion. [45] This has been attributed to the strong
back-donation of electron density from the filled metal based
★
t„ orbitals into the unoccupied 71 anti-bonding2g
orbitals of the pyrz ligand, thus making the second nitrogen
of this ligand more basic when coordinated. [45]
It is generally accepted that the excited state
acidity of a metal complex is related to the nature of its
emitting state. [46] If the acidity of the excited state is
greater than that of the ground state, the ligand is not
expected to be involved in the emission process but acts
merely as a spectator ligand. In this case, after excitation
the metal ion becomes formally 3+ and more charge is donated
from the ligand to the metal ion, less electron density is
present on the ligand and its acidity increases. Examples of
2 +these compounds are [RuCbpy^] complexes with the 
ligands 4,7-dihydroxy-l,10-phenanthroline [43], imidazoles 
[47,48,49,50,51], pyrazoles [51,52,53], and 1,2,4-triazoles 
[54], The excited states of the bis(-2,21bipyridyl) 
ruthenium pyridyltriazole compounds are more acidic than in 
the ground state, which indicates that the pyridyltriazole 
ligands do not participate in the luminescence process.
[1/2] This is also reflected in the lower oxidation 
potentials measured for the deprotonated species.
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The pyridyltriazole ligands have stronger O -donor and
weaker jt-acceptor properties than the bipyridine ligand.
For other complexes, the excited state may be more
basic than in the ground state. Here, after excitation more
electron density is present on the ligand and it becomes
easier to bind a proton. For these complexes, the excited
electron is thought to reside on the ligand which is actively
involved in the emission process. [42,45,46] Examples
2 +include [Ru(bpy)~] complexes with 4, 4-dicarboxylic acid
- 2 ,2 'bipyridine [44,55,56,57,58], bipyrazine [59,60], and
1,4,5,8,-tetraazaphenanthrene . [ 61]
Recently studies of a combination of the two types
of ligand have been conducted using [Ru(bpy)2 complexes
with pyrazyltriazoles.[2] The compounds exhibit rather
unusual behaviour in that the orbital nature changes upon
deprotonation. The combination of the strong JT-accepting
pyrazine ring together with the strong O -donor triazole ring
is accountable for this interesting behaviour. When the
pyrazyltriazole ligand is protonated the LUMO is based on
this ligand and hence this ligand is involved in the emission
process. When protonated, the filled d Jt orbitals as well as 
*the 71 level of the pyrazyltriazole ligand are lowered 
(below the 31 * level of bpy), and a combination of a higher 
oxidation potential with a less negative reduction potential 
is observed.
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Upon deprotonation of the coordinated pyrazyltriazole ligand,
*the LUMO is based on the bpy ligand because its Jl level 
is now lower than that of the pyrazyltriazole ligand, and the 
emission process originates from the bpy ligand.
This change in orbital nature is unique, as 
normally the emission originates from one or other of the 
ligands for both the deprotonated and protonated species.
This is the case for the bis-{2,21-bipyridine) ruthenium 
pyridyltriazole complexes [1,2 ] and indeed for the analogous 
bis-(4,4'-dimethyl-2 ,2-bipyridine) and bis-(1 ,10-phenan­
throline) complexes.
*The excited state pK may be estimated using the Forstera
cycle given in the equation below:
pKa* = pKa+ 0.625 ( V b - V a )
where T = absolute temperature, v a an<  ^ V ^  are the 
energies of the zero-zero transition from the ground state to 
the excited state involved in the deprotonation equilibrium 
for the acid and base forms, respectively. [62]
Another method may also be used to calculate the
*pK and is given m  the equation below: a
PKa = pH i + log( X a / t  b )
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where pHi = inflection point of the luminescence titration 
curve; X a and X b are the excited state state lifetimes of 
the acid and base forms, respectively. [56]
1.3 Ruthenium polypyridyl interactions with DNA.
The interactions of ruthenium polypyridyls with DNA and 
polynucleotides have been the subject of active investigation 
over the past few years. Metal complexes are uniquely suited 
for these studies since their unusual binding properties 
together with their general photoactivity render them as 
suitable candidates for (a) the design of site- or 
conformation-specific probes for recognition of the 
biopolymer structure; (b) the development of selective DNA 
cleaving agents for mapping or footprinting experiments and 
(c) the design of site specific drugs. [63,64,65,66,67,68,69, 
70,71]
Ruthenium polypyridyls possess a number of 
features which are critical to their application as 
DNA/polynucleotide binders and photocleavage reagents. They 
are rigid, planar, chiral and contain a coordinatively 
saturated metal ion at their core. By virtue of their 
chirality, the complexes have been shown to bind 
preferentially to right- or left-handed DNA, making them 
useful probes of DNA helicity. [72]
The complexes display intense MLCT absorptions and 
emit strongly, with room temperature lifetimes in aqueous
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solution in the range 100-600 n s . [3] The strong visible 
absorption band distinct from the absorption due to DNA or 
indeed the biomolecules used in this thesis, together with 
the strong luminescence, provide a spectroscopic tool to 
monitor the binding process. [3,65]
The complexes also possess a redox active site 
which is essential for their ability to act as DNA photo­
cleaving molecules. [72,73] The nature of the heterocyclic 
ligands surrounding the Ru(II) centre directly controls the 
ground and excited state properties of the complexes as well 
as their binding and probing abilities. [74]
DNA is a polyanion with one negative charge for 
each nucleotide or a charge of -2 for each step along the 
a-helix. Thus, the helix is awash with negative charge and 
electrostatic considerations alone account for a high 
association of cationic metal centres with nucleic acids. 
However, further interaction can occur if the aromatic 
ligands attached to the metal provide a sufficently extended 
structure where intercalation may occur in the major groove 
of the DNA helix. [73]. DNA has various sites where a 
molecule may bind and are depicted in Figure 1.7.
DNA binding molecules tend to interact 
non-covalently in the following ways, (a) by full intercala­
tion, where the molecule is inserted between the hydrophobic 
base pairs of the polynucleotide duplex and is stabilised 
through n  stacking; (b) minor groove and major groove binding 
where a mixture of hydrophobic, electrostatic and 
hydrogen-bonding interactions stabilise the DNA duplex;
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(c) externally, by binding on the outside (surface binding) 
of the helix. [63 ] .
Covalent
Binding
External Binding 
with S tacking
Major Groove 
Binding
Minor Groove 
Binding
Intercalation
External
Binding
Partial
In tercalation
Figure 1.7 Schematic representation of the available 
binding sites of DNA.
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Binding to the minor and major groove and externally are
essentially electrostatic, reversible interactions, which
occur between the negatively charged residues on the DNA and
occur rapidly by diffusion and coulombic attraction.
It has been proposed that intercalative binding is
a non-covalent stacking interaction, resulting from the
insertion of a planar heterocyclic aromatic moiety between
the base pairs of the DNA helix. For insertion to occur, the
base pairs must separate and the helix must unwind to
accommodate the planar intercalator.
Covalent binding may also take place. This is an
irreversible type of binding in which the molecules form
covalent bonds with atoms in the DNA residues. The classic
example is the antitumour drug [cis-Pt(NH^)2C12 ^ '
cis-platin. In solution the chlorines are lost and the
platinum forms covalent bonds with the base atoms. [75],
Bis(phenanthroline)dichlororuthenium has also been bound to
DNA and exhibits striking enantiomeric selectivity, different
from that observed upon intercalation. [76] DNA oligomers
and duplexes containing a covalently attached derivative of 
2 +[Ru(bpy)3 ] have also been reported. [77]
Bathophenanthroline ruthenium (II) complexes have 
also been covalently attached to DNA. [78,79,80].
Covalent attachment to biomolecules is of 
particular interest in this thesis because all the binding 
methods used result in a covalent bond between the protein / 
polypeptide molecules and the ruthenium (II) polypyridyl 
complexes. Most of the research reported in the literature
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dealing with the interaction of ruthenium polypyridyl 
complexes with biomolecules concerns electrostatic and 
intercalative binding modes. In comparison, very little is 
is reported on covalent attachment of ruthenium polypyridyls 
to biomolecules. However, it is pertinent to review the 
literature generally with regard to ruthenium polypyridyl 
interactions with DNA and polynucleotides.
Firstly, it is useful to distinguish briefly 
between the various conformational forms of DNA. Much of the 
literature describes the chiral discrimination of ruthenium 
polypyridyls in relation to the "handedness" of DNA i.e. 
whether the ruthenium complexes bind to right-handed DNA or 
left-handed DNA. Right-handed helical structured DNAs are 
the A and B forms, left-handed DNA is the Z-form.
Since Crick and Watson [81], first described the 
double helical structure of DNA in 1953, it has been shown 
that DNA exists in three helical conformations, A-DNA, B-DNA 
and Z-DNA. There are also C-DNA and D-DNA but these are 
considered as modified versions of A-DNA and B-DNA. The 
overall shapes of the helices are quite different even though 
each form involves a helix made up of two anti-parallel 
polymer strands with the bases paired through Watson and 
Crick hydrogen bonding. Both A-DNA and B-DNA are 
right-handed helical structures, whereas Z-DNA spirals in a 
left-handed sense. B-DNA, the predominant form, is a regular 
right-handed helix with base pairs oriented essentially 
perpendicular to the helix axis and distinctive major and 
minor grooves of well defined width and depth. The A-DNA
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helical form is the predominant conformation of DNA-RNA 
hybrids and double-stranded RNA segments, it has a very 
shallow and wide minor groove. Z-DNA is not a left-handed 
version of either A or B helices. The Z-DNA helix zig-zags 
and can best be considered as a long slender helix with a 
wide and shallow, almost convex, major groove and a minor 
groove pinched down into a narrow crevice. Along the DNA 
strands themselves, there are a range of structural 
variations including cruciforms, bends, hairpin loops, kinks 
and left-handed sites. The previous discussion has been 
concerned with double-stranded DNA (dsDNA), but research has 
also been conducted on ruthenium (II) polypyridyl 
interactions with single-stranded DNA (ssDNA), RNA and 
various synthetic "ss" and "ds" polynucleotides of the bases 
adenosine (A), thymine (T), cytosine (C), guanine (G) and 
uracil (U). Ruthenium polypyridyl complexes may bind elect­
rostatically to single or double stranded DNA at low ionic 
strength and also intercalatively in the case of dsDNA. [82] 
Secondly, it is beneficial to distinguish between 
the enantiomeric forms of ruthenium polypyridyl compounds. 
Octahedral complexes with three bidentate ligands such as 
phenanthroline do not contain an inversion centre and 
therefore, two enantiomeric forms are possible.
Ruthenium(II) complexes of phenanthroline and derivatives are 
of interest due to their inertness to racemization. This
allows the enantiomers to be resolved. [65,72] The two
2+enantiomeric configurations of [Rufphen)^] are shown in 
Figure 1.8.
2+Figure 1.8 Enantiomeric forms of [Rutphen)^]
The intercalating phenanthroline ligand is coordinated 
directly to the assymetric metal centre. Due to the 
proximity of this chiral metal centre to the site of 
intercalation, the interaction of ruthenium polypyridyls with 
DNA clearly illustrates stereospecific binding to a similarly 
asymmetric DNA helix and suggests the use of these complexes 
as probes for DNA helicity. [65]
Organic cations bearing an extended heteroaromatic 
system have long been recognised as intercalators of DNA. 
These intercalators consist of various anti-tumour drugs such 
as daunomycin and actinomycin, whose pharmacological activity 
arises from their ability to intercalate into DNA and dyes
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such as ethidium bromide, acridine orange and proflavine which 
serve as DNA stains and probes of nucleic acid structure. [73]
Lippard and co-workers were the first to discover 
that metal complexes could intercalate into DNA and RNA. [83] 
The original studies centered on square planar platinum(II) 
complexes containing aromatic terpyridyl or phenanthroline 
ligands. X-ray diffraction studies of terpyridylplatinum(II) 
complexes stacked with nucleotides showed that the platinum 
complex inserted almost fully between the base pairs.
Generally, charged tetra-coordinated planar platinum complexes 
were found to intercalate into DNA whilst the neutral cis 
dichloroplatinum complexes could bind covalently to DNA 
through coordination to its nitrogen bases. The reagent 
methidiumpropyl-Fe(II )-EDTA, is a well characterised planar 
intercalator and has also been used in DNA cleavage studies. 
[72] Metalloporphyrins represent another family of 
essentially aromatic metal complexes that can intercalate into 
DNA. [72]
Direct intercalation of metal complexes is not 
restricted to those metal centres possessing a square planar 
geometry. Non-planar metal complexes with planar aromatic 
ligands can bind to DNA by intercalation. One such example is 
the tetrahedral zinc complex, ZnCphenjC^. The analogous 
complex of cuprous ion, [Cutphen^]^*, has been shown to 
cause efficient DNA strand cleavage. [63,72]
Octahedral transition metal (Ru,Zn,Co,Rh) 
polypyridyl complexes can interact with DNA and RNA and
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synthetic polynucleotides. The literature describes the use 
of these chiral complexes in designing spectroscopic probes 
and photoactivated DNA cleaving agents for DNA. The 
interactions of transition metal polypyridyl complexes with 
DNA and polynucleotides has been studied by various groups 
using quite a diverse range of homoleptic and heteroleptic 
complexes. The common feature of these complexes is the 
incorporation of planar aromatic ligands which can interact 
non-covalently, intercalatively and electrostatically with 
biomolecules. Covalent linkage to DNA has also been 
described to some degree using ruthenium(II) phenanthroline 
compounds. [76]
DNA ruthenium polypyridyl interactions will be 
reviewed conveniently in the following manner. Firstly, in 
regard to their chirality and their use as probes for DNA 
handedness. Secondly, in terms of the effects of binding on 
the physical properties of DNA and the spectroscopic changes 
which occur to the complexes upon binding to DNA. Thirdly, in 
relation to their use as sensitisers for the photocleavage of 
DNA. There will of course be some overlap between these 
sections but it is hoped that a clear and concise picture of 
the interactions of polypyridylruthenium(II) complexes with 
DNA will be presented.
36
1.3.1 The use of ruthenium polypyridyl complexes as
probes for DNA handedness.
Numerous studies of DNA interactions with chiral tris-chelate
metal complexes have been inspired by the possibility of
discriminating DNA handedness. These complexes are shaped
like three-bladed propellers and have two enantiomeric forms
corresponding to right ( A ) and left ( A ) handed screws.
See Figure 1.8 earlier. [84]
Ruthenium(II) polypyridyl enantiomers may be
resolved by diastereometric recrystallisation procedures,
[63] by virtue of their inertness to racemisation.
Enantiomeric selectivity has been observed in the
ruthenium tris(phenanthroline) complexes with B-DNA. The A
enantiomer, a right-handed propeller-like structure displays
2 +a greater affinity than A  “[Ru(phen)^] for the 
right-handed DNA helix. Figure 1.9 illustrates the basis for 
this selectivity. With one phenanthroline ligand 
intercalated, the two non-intercalated ligands of the 
isomer fit closely along the right handed helical groove.
The non-intercalated ligands of the A isomer are repelled 
sterically by the phosphate backbone of the duplex. The 
disposition of the left-handed isomer is opposed to the 
right-handed helical groove of B-DNA. [65]
Experiments have demonstrated that both 
enantiomeric isomers of the tris (phenanthroline) 
ruthenium(II) complex can bind to DNA, one isomer binds in an 
intercalative manner and the other in a surface bound mode.
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Figure 1.9 Lambda ( A )  and delta ( A )  tris (phenanthroline) 
metal complexes, a schematic illustration of the 
complex intercalated into right-handed DNA.
Intercalative binding through the major groove of B-DNA is 
associated with preferential binding of the A isomer to the 
right-handed helix and surface bound binding with the A  
isomer. It is noteworthy that it is surface groove binding 
that requires a complementary asymmetry in structures, 
left-handed A -[ Ru (phen) ^  ] 2 + binds against a right-handed 
helix, whereas intercalation, inserting into the base pairs
of the helix is best when symmetries are matched, as a result 
2 +A-[Ru(phen)3 ] intercalates selectively into a right- 
handed helix. This stereochemical criterium has been 
observed also with respect to the covalent coordination of
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bis(phen)Ru(II) species to a B-DNA helix. [76]
The enantiomeric selectivity for intercalation 
depends on the size of the helical groove relative to the 
diameter (sterically excluded distance) of the chiral metal 
complex. If the DNA groove is wider than the metal complex, 
there is no enantiomeric discrimination. If the complex is
24-much larger than the groove, as for [RutDIP)^] , the 
binding is stereospecific. [64]. The level of enantiomeric 
discrimination is not high for the ruthenium, tris- 
(phenanthroline) enantiomers since both bind to some degree 
to DNA. In order to amplify the chiral discrimination of the 
complex, phenyl substituents on the 4 and 7 positions of each 
of the phenanthroline ligands were incorporated to give
[R u (DIP)^]2+, [64]. See Figure 1.10.
A -tris (4 ,7 -d iphenyl-1 l 10-ph€nanthroline)Ruthenium(H)
2 +
2+Figure 1.10 Structure of [RufDIP)^]
39
Barton and co-workers have shown that isomers of 
2 +[RuCDIP)^] bind B-DNA enantiospecifically. The
2 +right-handed isomer A  -[Ru(DIP)3 ] binds to B-DNA
2 +whereas A - [ R u ( D I P ) 3 ] , the left-handed isomer does
not. The right-handed isomer is able to bind in the well
defined major groove of B-DNA by intercalation of one of the
diphenylphenanthroline ligands, because in such an
interaction, the two non-intercalated ligands are oriented
along the direction of the groove. In contrast,
intercalation by the left-handed isomer is prevented by
steric clashes between the two non-intercalating ligands and
the phosphate backbone of the B-DNA, the bulky substituents
on the phenanthroline ligands block completely the
intercalation of this isomer into a right-handed helix. This
compound has proven to be a useful spectroscopic probe for
Z-DNA. A left-handed helix favours the left-handed isomer,
but only a slight stereoselectivity in binding A —
2 +[RulDIP)^] to Z-DNA is observed. Z-DNA is not a
left-handed DNA and due to its wide and shallow major groove,
the Z-helix provides a poor template for discrimination
between steric isomers. Thus, both isomers can bind to DNA.
2 +However, the comparative binding by [Ru(DIP)3 ]
enantiomers serves as the probe for helix conformation. If
only the A isomer binds to the polynucleotide, the
conformation is likely to be right-handed and B-like. Since
2 +the A -[Ru(DIP)3 ] isomer does not bind to B-DNA, then 
if the unknown DNA binds this isomer, the helical 
conformation is probably left-handed. If binding occurs
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with both isomers, but to a lesser extent with the 
right-handed isomer, the unknown conformation is likely to be 
Z-DNA.
A probe for the A-DNA conformation has been
reported which targets sites along the strand by shape as
2 +well as by symmetry. [85] The complex [Ru(TMP)^]
(Figure 1.11), associates with the nucleic acid in a surface 
or groove bound mode rather than through intercalation. The 
complex binds against the surface of A-form polynucleo- tides 
but it is too large to bind against the well defined major 
groove of B-DNA. In binding against the right-handed A-DNA 
helix, the complementary symmetry of the left-handed 
isomer provides for a better fit between the metal complex 
and the nucleic acid, thus accounting for the chiral 
discrimination.
C H 3
2 +Figure 1.11 Structure of [RulTMP)^]
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Studies have been conducted on the interaction of mixed
ligands complexes of Ru(II) with right-handed B-DNA.
Equilibrium dialysis experiments showed that after dialysis
of the DNA against the racemic mixture of these mixed ligand
complexes, the optical activity observed in the dialysate
reflected enrichment in the less favoured enantiomer. For
most of the complexes, optical activity was found in the
dialysate. The enantiomeric selectivity was compared to the
24-well studied [Rutphen)^] enantiomers. On the following 
assumptions, an enrichment of the left-handed A isomer in 
the dialysate and the preferential binding of the 
right-handed A isomer to the right-handed DNA, enantiomeric 
selectivity was demonstrated for the complexes 
[Ru(phen)2 (phi)]2+, [R u (phen)2 (DIP)]2 + , [Ru(bpy)2~
(phi)]2+ and [R u (bpy)2 (DIP)]2+. [86]. See Figure 1.12
for a diagram of the ligands used in these systems and those
described subsequently.
Recently, a report was published stating that both
2 +enantiomers of [Rutphen)^] bind to the major groove but 
with different geometries owing to steric interactions. It 
was proposed that the left-handed A enantiomer has a single 
chelate pointing in toward the DNA, lying parallel to the DNA 
base pairs and that the stability and average orientation of 
the ruthenium ion with the DNA molecule are mainly determined 
by interaction of the two remaining wings with phosphates of 
the strands. For the right-handed A complex, an opposite 
geometry was proposed where two chelates sit in the groove 
and determine the orientation by closely fitting the helical
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2,2' -bipyridyl 
(bpy)
2,2'-biquinoline 
( biq)
2,2' -bipyrazine 
(bpz )
H 3 C X H 3
S H 3
4,4'-dimethyl-2,21-bipyridyl 
(dmb)
1,10-phenanthroline 
(phen)
4,7-diphenyl-l,10-phenanthroline 
(DIP)
2 , 2 ' , 2 ' '-terpyridine 
(terpy)
1,4,5,8-tetraazatriphenylene 
(TAP)
4,5-diazafluorene-9-one 
(flone)
Figure 1.12 Structures and abbreviations of the ligands used 
in studies of ruthenium polypyridyl interactions 
with DNA and polynucleotides, continued on the 
following page.
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3,4,7,8-tetramethy1-1,10-phenanthroline 
{TMP)
1 , 4 , 5 ,8 ,9 ,12-hexaazatriphenylene 
(HAT)
9,10-phenanthrenequinonediimine 
(phi)
/  \
n h 2 n h 2
5-nitro-l,10-phenanthroline ethylene diamine
(N02phen) (en)
Figure 1.12 Structures and abbreviations of the ligands 
used in studies of ruthenium polypyridyl 
interactions with DNA and polynucleotides, 
continued from previous page.
stack of base pairs. The results indicated that the binding 
geometry measured through the orientations and chromophoric 
perturbation of the complex is almost the same for a given 
enantiomer irrespective of the kind of DNA. In addition, 
variations in affinity suggested that the enantioselectivity 
is sensitively dependent on DNA sequence. [84].
This report was quickly followed by another paper 
disproving these suggestions stating that not enough 
experimental techniques were used to definitively establish 
whether or not intercalative or surface binding occurred.
[87]
These reports show that the question of whether 
tris chelate metal complexes can discriminate 
enantiomerically between different conformational forms of 
DNA is controversial and details of the DNA / complex 
interaction are far from being well understood.
The complex [R u (phen)2Cl2 ] binds covalently to 
B-DNA, and has been shown to exhibit striking enantiomeric 
selectivity different from that seen on intercalation.
[76,88] The neutral complex contains like cis-platin two 
cis-oriented chloride ions that are good leaving groups. 
Racemic Ru(phen)2Cl2 binds covalently to DNA and optical 
enrichment studies have indicated that enantiomeric 
selectivity accompanies the covalent binding of the complex 
to the helix. Unlike intercalation, where a right-handed 
isomer stacks best with a right-handed helix, it appears that 
the left-handed A isomer is favoured.
Covalent coordination of [R u (phen)2C12 ] to DNA
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seems to resemble the groove bound mode, which favours the 
left-handed A  isomer in binding to a right-handed helix.
Model building has shown that from an initially intercalated 
position the A  left-handed isomer is well oriented for 
covalent binding to the base positions above and below.
Similar alignment for covalent binding of the 
right-handed isomer is not possible because the other 
non-stacked phenanthroline ligand is considerably crowded by 
the right-handed helical column.
2 +For intercalation by [Ru(phen)^] , the 
right-handed isomer which has the same helical screw sense as 
the right-handed B-DNA is preferred, while covalent binding 
seems best to require the left-handed A  ~ [ Ru (phen ) 2^2  ^ 
isomer which is a structure complimentary to the right-handed 
B-DNA helix.
1.3.2 Spectroscopic properties of DNA bound ruthenium
polypyridyl complexes and the effect of binding on 
the physical properties of DNA.
Intercalative binding allows a close approach of the metal 
complex to the helix as one of the ligands is sandwiched 
between the adjacent base pairs. This mode of binding leads 
to a substantial perturbation in the photophysical properties 
of the metal complex such as emission lifetimes and 
intensities as well as steady-state polarisation. In 
addition, intercalation imposes constraints on rotational
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degrees of freedom and can enhance the emission 
polarisation. The stereoselectivity associated with this 
binding mode is sensitive to the chirality of the metal 
complex, matching the symmetry of the metal complex to the 
helix topography and DNA groove size. In contrast, surface 
binding provides stabilisation due to hydrophobic and 
electrostatic interactions. The metal complex is relatively 
free to diffuse along the helix surface. [89] The stereo­
selectivity of this type of binding is also sensitive to the 
helix topography and DNA groove size.
Numerous methods of probing the intercalation of a
DNA molecule with its host in solution are available. The
physical effects and characteristics of intercalation on DNA
structures have been well studied. The techniques available
for studying intercalation are based on some fundamental
features of this type of binding, (a) the double helix is
o
stretched by about 3.4 A per input dye at each binding site;
(b) the double helix is unwound by 18-26° per input dye;
(c) the helix is stabilised by intercalation; (d) the dye is
held coplanar with the DNA base and is therefore oriented;
(e) the spectroscopic properties of the dye are altered by 
intercalation. [87] The techniques used to study binding 
modes are based either on physical changes occurring to the 
DNA or on spectroscopic changes occurring to the dye.
Intercalating compounds have been shown to unwind
and lengthen helical DNA using electrophoretic mobility 
assays. The electronic interaction of the intercalator with 
the helix may be investigated using spectroscopic techniques
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with the observation of hypochromicity and red shifts in the 
MLCT band and increased MLCT excited state lifetimes upon 
binding to DNA. Thermal denaturation of DNA can be used to 
distinguish between those molecules which bind 
intercalatively and those which bind externally.
Intercalation generally results in a considerable 
stabilisation (more so than for electrostatic binding) of the 
DNA helix with a corresponding increase in its T , melting 
temperature. Upon intercalation, there is substantial 
structural overlap between the base pairs and the 
intercalator. The intercalator becomes rigidly held and 
oriented with the planar moiety perpendicular to the helical 
axis. These effects may be monitored using fluorescence 
depolarisation and anisotrophic techniques which indicate, 
only if intercalation occurs, the retention of polarisation 
of emitted light. [87]
It is recommended that as many of the mentioned 
techniques as possible are conducted in order to verify 
whether binding occurs via intercalation or surface binding. 
[87]
Kelly and Tossi have examined the nature of 
binding of a series of ruthenium complexes containing various 
different ligands with calf thymus DNA, poly [(dA-T)] and 
poly [(dG-C)]. [71] They studied, (a) how the ligands affect 
the mode of binding using absorption and emission 
spectroscopy and DNA thermal denaturation techniques, (b) how 
the photophysical properties of the bound ruthenium complexes 
were modified by binding and (c) the use of the complexes as
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photocleavage agents.
The ligands have already been given in Figure 1.12.
DNA thermal denaturation experiments indicated
that three classes of behaviour were observed.
[Ru(phen)^ ] ,  [R u (phen)2 (e n )]2+ and [Ru(bpy)2~
2 +(HAT)] were found to fall into one class with behaviour
very similar to the intercalator ethidium bromide.
2 + 2 +[Ru(bpy)^] and [Ru(terpy)^] fall into a second
2+class with similar behaviour to that of Mg ■ which binds 
electrostatically. The remaining complexes [Ru(bpy)2~ 
(phen)]2+, [R u (bpy)2 (DIP)]2+, [Ru (bpy)2 (biq)]2+,
[Ru(dmb)2 (phen)]2+ and [Ru(TAP)^]2+ exhibit 
intermediate behaviour.
Two complexes, [R u (bpy)2 (C N )„] and 
[Ru(phen)2 (C N )2 ], did not have any effect on DNA melting 
or on the unwinding / lengthening of DNA, nor do they show 
any change in the absorption or emission spectroscopy upon 
addition of DNA. These complexes have been termed as 
non-binders. The fact that these complexes are not affected 
to any degree upon addition of DNA has been taken as evidence 
that electrostatic interactions play an important role in the 
binding of ruthenium(II) polypyridyl complexes to DNA. All 
of the compounds which bind to DNA are charged and their 
binding has been shown to be sensitive to the ionic strength 
of the solution. [71]
2+ 2 +[Ru(bpy)^] and [Rufterpy)^] are
external binders and affect the melting of DNA in a similar
2-fway to that of Mg , and they do not unwind or lengthen
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DNA. These facts suggest that these complexes bind mainly
through ionic interactions on the outside of the DNA helix.
2 +The other complexes, [Rutphen)^] >
[Ru(phen)2 (e n )]2+ and [R u (bpy)2 (HAT)]2+, in the
presence of calf thymus DNA are subject to a hypochromicity
at the band maximum and a slight shift of the band to longer
wavelengths to a greater or lesser degree depending on the
ligand. The largest effects have been observed for
2 +[R u (bpy)2 (HAT)] , the complexes intercalated HAT ligand,
with an additional aromatic ring compared to phenanthroline, 
can be inserted further into the base pairs than 
phenanthroline and this allows a greater Jt electron
24-overlap. [R u (TAP)^ ] shows intermediate behaviour which 
is interesting since the compound is very similar in
24-structure to [Ru(phen)^] , which intercalates into the 
DNA helix. The presence of the two additional nitrogens on 
the ligands must destabilise the intercalative binding of 
this complex to DNA. This may be the result of interactions 
of the lone pair of electrons on the nitrogens with the atoms 
of the DNA backbone and the increased hydrophobicity of the 
TAP ligands compared to the phenanthroline ligands. [71]
The complexes containing the biquinoline ligands 
result in greater stabilisation than for [ R u ( b p y ) ^ ] 2 +  a n ( ^
2 +less than for [R u (bpy)2(HAT)] , which is consistent with
the more extended ring system for the biquinoline ligand than 
for the bipyridine ligand and the inability of the additional 
ligand to obtain as great an overlap as that achieved by the 
HAT ligand. [71]
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Synthetic polynucleotides were used to test for dependence of 
the binding on base content. It was established that 
[Ru(phen)^]2+ and [Ru(bpy)2 (HAT) ] have a marked
24-preference for poly [d(A—T ) ], while [Ru(bpy)^] and 
2 4-[RufTAP)^] bind equally to poly [d(A-T)] and poly
[d(G-C)]. This is interesting, since until recently the view
was held that intercalators preferred to bind in the doublet
pyrimidine (3'-5') purine with an increased preference for
DNA rich in G C .
For all the complexes studied except for 
2 +[Ru(TAP)^] binding to DNA leads to an enhancement of 
luminescence. This is probably due to an increase in the 
average lifetime of the complex upon binding to DNA and to 
protection of the complexes excited state from oxygen. The 
lifetimes measurements of the bound complexes show non­
single exponential decay behaviour, with two decay 
components. One with a lifetime shorter than the unbound 
species and the second with a much longer lifetime than the 
unbound species. The presence of the shorter lived species 
is under investigation but may be due to self-quenching, if 
the complexes can move along the DNA strand as proposed by 
Barton [89,90], or due to triplet-triplet annihilation caused
by the high laser excitation intensities, which has been
2 +suggested to cause quenching of DNA bound [R u (bpy)^]
[91] The longer lived species is probably the composite of 
similar decays from the complexes where binding can occur to 
different base sequences, externally and intercalatively.
Also the possibility of the binding of the different
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enantiomers can not be excluded. [71]
The complex [R u (bpy)^ (HAT)] showed the most
marked enhancement in emission intensity on addition of calf
thymus DNA which is unaffected by oxygen concentration or
changes in temperature.
2 +[RufTAP)^] was the only complex where a 
marked degree of excited state quenching was observed for the 
poly [d(G-C)] and calf thymus DNA and not for poly [d(A-T)]. 
The quenching process has been explained by photoredox 
interaction with guanines. [71]
2 +The rate of oxygen quenching for [Ru(phen)^]
2 +and [RuCbpy)^] when bound to DNA are quite similar and
substantially reduced compared to the unbound compounds.
Intercalation is not essential for the protection from this
2 +type of quenching since [RuCphen)^] is known to
2 +intercalate DNA whilst [Ru(bpy)^] binds
electrostatically to DNA. [71]
Electrostatic interactions of ruthenium
polypyridyls with DNA are known to be dependent on the ionic
strength of the solution, in addition to the solvent nature
and the DNA phosphate/ruthenium(II) ratio. Addition of
alkali or alkaline earth salts at very low concentrations,
stabilises partial intercalation whereas high salt
concentrations leads to a release of the ruthenium complex
from the strand. [92]
Gorner and co-workers have proposed that 
2 +[Rufbpy)^] may partially intercalate into DNA but this 
type of binding is sensitive to the ionic strength of the
2 +
52
solution. Therefore, the proportion and lifetimes of the 
decaying species are probably dependent on the ionic strength 
of the solution under investigation, which may explain the 
varying results obtained by different groups. [92]
Various factors may result in the enhancement of 
the emission intensity in the absence of quenching by 
electron transfer processes. [93] Among which are (a) the 
protection from quenchers in the sheltered environment of the 
DNA; (b) changes in solvent environment; (c) a decrease in 
the vibrational activity of the bound dye as it is held in a 
more rigid environment or (d) an increase in the energy gap 
between the emitting state and the other states involved in 
deactivation.
The binding of [Ru(bpy)^ ]Cl21 
[Ru(phen)^]C12 and [R u (DIP)^ ]Cl2 and of various mixed 
ligands complexes has been investigated by other workers.
[86] The mixed ligand complexes include [Ru(bpy)2~
(DIP)]2+, [Ru(bpy)2 (phen)]2+, [R u (phen)2 (bpy)]2+,
[R u (phen)2(DIP)]2+ , [R u (DIP)2 (phen)]2+,
[Ru(phi)2 (bpy)]2+ and [R u (phen)2 (phi)]2 + . The 
ligands used in these systems have already been shown in 
Figure 1.12. Generally, binding led to hypochromicity in the 
intense MLCT band which was accompanied by a red shift of 
this band, the magnitude of which were found to correlate 
with the strength of the intercalative interaction. [86] The 
complexes containing the phi ligand exhibit the largest red 
shifts (about 10 nm) , followed by those containing DIP 
ligands (about 5 n m), phen ligands (about 3 nm) and bpy
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ligands (no red shift). If the red shift is taken as a 
measure of intercalating ability, then the optimal shape for 
intercalation is phi > DIP > phen > bpy.
This variation in intercalating ability is a 
reflection of the differing capacity of the ligands to stack 
and overlap with the base pairs. The phi ligand is flat, 
large in surface area and has a geometry that permits 
substantial overlap with the base pairs of the DNA helix. 
Hence, the phi ligand is well suited for intercalation and in 
mixed ligand complexes, it would be the phi ligand which 
would be expected to preferentially intercalate. The DIP 
ligand is not expected to be flat with phenyl groups twisted 
out of the plane of the phenanthroline ring which diminishes 
the ligands favourability for intercalation. However, it is 
not established whether its greater affinity over the 
phenanthroline ligand is associated with intercalation or 
additional stabilisation through hydrophobic surface binding. 
[8 6 ]
The complexes examined with the exception of 
2 +[Rutbpy)^] , were found to intercalate and to surface 
bind to DNA. For those that bound appreciably, enantiomeric 
selectivity was observed. The bipyridine ligand provides 
insufficent Jt electron overlap with the DNA base pairs for 
intercalation to be effective. These conclusions were based 
upon effects of hypochromism, increases in emission 
intensities and lifetimes, DNA helical unwinding and excited 
state resonance Raman experiments.
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The effects of ancillary ligands and hydrogen bonding were 
also investigated. It was found that the primary effect of 
the ancillary ligand is in altering the extent of enantio-
selectivity. This has also been demonstrated in comparisons
2 + 2 + of [Ru(phen)3 ] with [Ru (DIP)3 ] . The increased
2 +steric bulk of the ancillary ligands of [Ru(DIP)^]
ensures that the right-handed isomer intercalates with
right-handed DNA, while the left-handed A  isomer can not
intercalate. By investigation of mixed ligand complexes it
is possible to establish how different ancillary ligands add
or detract from the overall binding affinity for DNA.
2 +[Ru(DIP)2(phen)] has a similar binding affinity as
2 +[Ru(phen)2 (DIP)] which suggests that the presence of
one bulky hydrophobic ligand that can intercalate stabilises
the bound complex, but that a second bulky ancillary ligand
does not further stabilise the bound complex. The complex
2 +[R u (phi)2 (bpy)] displays decreased affinity for DNA in
2 +comparison with [R u (bpy)2 (phi)] • Here, steric
interaction may interfere with the insertion of the 
intercalating ligand into the helix. Also, due to the 
increased hydrophobicity of the complexes, self-stacking of 
the complexes may occur which would decrease the binding 
affinity for DNA. [86]
24-In comparison of [R u (bpy)^ (phen)] with 
[Ru(phen)2] and [Ru(bpy)2 (DIP)]2+ with [Ru(phen)2
24--(D I P ) ] , it was noticed that the DNA binding affinity
increased with increasing hydrophobicity of the ancillary 
ligands, with the greater binding affinity being observed
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2 + 2 + for [Ri^phen)^] and [Ru(DIP)2 (phen)] . it was
thought that hydrogen bonding might further stabilise
complexes bound to DNA. To this end, the binding of the
2 +complexes [R u (S-NO^phen)^ ] and [Ru(phen)2
2 +-(flone)] to DNA was investigated. The structures and 
abbreviations of these ligands have been presented in Figure
1.12. These complexes were found to bind poorly to DNA.
2 +Space models of [R u (5-N02phen)^ ] indicated 
that for binding intercalatively or via surface binding, the 
nitro groups on the ancillary ligands would be oriented 
appropriately for hydrogen bonding. However, the major type 
of binding was found to be electrostatic. A similar 
conclusion was drawn for the flone complex. For this ligand, 
the oxygen atom is aligned appropriately for hydrogen 
bonding, in a manner different to that of the nitro ligands, 
but no further stabilisation was observed. It was concluded 
therefore, that the substitution of potential hydrogen 
binding acceptors onto the phenanthroline ligands provides no 
additional source of stabilisation. [86]
Recently, the nature of the interaction of some 
homo and heteroleptic ruthenium(II) polypyridyl complexes 
containing bipyridine, bipyrazine, phenanthroline, DIP, TMP, 
TAP, and HAT has been investigated. [74] The structures and 
abbreviations of these ligands have been presented in Figure
1 . 1 2 .
This study was divided into (a) those complexes 
that bind to and photoinduce redox processes with DNA and (b) 
those complexes that bind to DNA without any photoredox
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processes. The complexes that were capable of photoinducing 
redox processes were those containing at least two HAT / TAP 
ligands coordinated to the ruthenium centre. These chelates 
were [Ru (bpy) (TAP)2 ]2 + , [Ru (bpy) (TAP)(HAT) ]2+,
[Ru(bpy)(HAT)2 )]2+, [Ru (TAP)2 (HAT)]2+, [Ru(TAP)-
2 + 2 +(HAT)2 ] and [R u (HAT)^ ] . These chelates all have
excited state reduction potentials of ^ 1.1 V vs SCE and as
such were shown to oxidise guanine when bound to DNA with
quenching of luminescence and emission lifetimes. At excited
state reduction potentials of > 1.40 V, the chelates can
oxidise guanine free poly[(dA-T)]. Similar oxidising
2 +behaviour has already been described for [Ru(TAP)^] ,
where the excited state potential is 1.35 V (vs SCE). [74]
The quenching process has been shown to be
2 +important for the complexes [Ru(TAP)^] and
2 +[Ru(bpy)2 (TAP)] with regard to their use as sensitisers 
for photocleavage. Some of the other complexes mentioned 
above, may also have potential in this regard.
The complexes studied that bound to DNA without 
redox processes were those possessing excited state reduction 
potentials lower than 0.80 V (vs SCE) so that photo-oxidation 
of DNA guanine is not a spontaneous process. These chelates 
included homoleptic or heteroleptic chelates containing 
solely bpy, phen, DIP or TMP as well as those incorporating 
one HAT or TAP ligand. The complexes under investigation 
were [R u (phen)2 (H A T )]2+, [Ru(bpy)2 (HAT)]2 + ,
[Ru(bpy)2 (TAP)]2+, [R u (bpy)2 (phen)]2+,
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[Ru ( bpy ) 2 ( DIP ) ]2+, [R u (phert)^ ]2+ and 
2 +[Ru^MP)^] . Upon the addition of DNA all the complexes
2 +with the exception of [Ru(TMP)^] exhibit biexponential 
emission decay behaviour. It has been established previously 
that this latter molecule is too large to bind against the 
well-defined groove of B-DNA, thus the single exponential 
decay is that of the unbound species.
In every case, the decay of the unbound complex 
was single exponential, but upon addition of DNA, 
biexponential behaviour decays were observed with a fast 
component and a slower component. For the most oxidising 
complexes i.e. [R u (TAP)(HAT)9 ]2+ and [R u (HAT)^]2+, 
the fast component was not detected and the decay profile 
exhibited single exponential decay behaviour. However, when 
bound to poly [d (A—T )], instead of DNA, the chelates exhibit 
biexponential (possibly multiexponential in the case of the 
two most oxidising complexes) decay behaviour.
Thus, those complexes containing two or more TAP / 
HAT ligands photooxidise the guanine base upon binding to DNA 
but show emission enhancement and increased emission 
lifetimes in the presence of poly [d(A-T)], but even the 
complexes [R u (TAP)(HAT)^ ]2+ and [R u (HAT)^]2+, 
photooxidise the adenosine base, with quenching of emission 
in the presence of adenosine or guanine. [74]
The relative contribution of each decay component
2 +for the series [R u (bpy)2 (L )] was examined and showed 
that the contribution of each component was dependent on the 
structure of L. The effects of the polynucleotide-phosphate
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/ Ru(II) ratio, ionic strength of the solution and solvent 
nature were also examined. It was found that the 
intercalation of the complexes into DNA increases with (a) 
decreasing ionic strength of the medium, (b) increasing DNA / 
Ru(II) and (c) partial replacement of water with glycerol.
The enhancement observed upon partial replacement
of water with glycerol is the usual effect observed for
Ru(II) polypyridyls when water is replaced by alcohols and
other organic solvents. [3] and may be explained by a less
efficient energy transfer to the solvent oscillators which
influences the non-radiative deactivation rate constant of 
3the MLCT excited state.
It was also demonstrated that the use of a mixed 
solvent medium is a useful tool for the elucidation of 
binding patterns of Ru(II) polypyridyls to DNA because 
intercalative, surface bound and free species may be 
differentiated.
2 +The complex [Ru(bpy)^ (dppz)] (Figure 1.13) 
has been found to be a highly sensitive reporter molecule for 
double stranded DNA. The compound does not exhibit any 
luminescence in aqueous solution at ambient temperatures but 
displays intense emission in the presence of DNA to which the 
compound binds avidly. [94]
It has been proposed as a molecular "light switch" 
for DNA. Electrochemical and photophysical measurements in 
the ground and excited states of this molecule show that the 
charge transfer is directed from the metal centre to the
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phenazine ring and the major non-radiative deactivation 
pathway for the compound likely involves the protonation of 
the phenazine nitrogen atoms in the excited state.
24-Figure 1.13 Structure of the complex [Ru(bpy)2 (dppz)]
The compound binds intercalatively to DNA as 
expected from the extended planar structure of the dppz 
ligand. Lifetime decay profiles reveal biexponential decay 
behaviour with a short-lived component and a long-lived 
component. Quenching experiments using [Fe(CN)g]4 as 
quencher showed that the shorter-lived component is 
preferentially quenched indicating that the long-lived 
component may be a less accessible tightly intercalated 
form. The complex when bound to oligonucleotides may find 
application as a sensitive non-radioactive DNA probe in 
heterogenous and homogenous assays.
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1.3.3 Ruthenium polypyridyl complexes as sensitisers
for the photocleavage of DNA.
In conjunction with studies on the enantiomeric selectivity 
and changes in the spectroscopic properties of the complexes 
combined with the effects on the DNA itself upon binding, 
there has been a great deal of effort involved in the 
investigation of many of the Ru(II) polypyridyl complexes 
described as DNA photocleavage agents. Photoactive compounds 
may act either by sensitising the formation of singlet oxygen 
which attacks DNA or by direct reaction with the 
polynucleotide by photoredox processes. [95]
A very simple and effective method of monitoring 
the photosensitised cleavage of DNA is the use of covalently 
closed circular (ccc) plasmid DNA, such as pBR322 which is 
highly supercoiled. This is achieved by monitoring the 
transition from the naturally occurring, ccc form (Form I) to 
the open circular (oc) relaxed form (Form II). This occurs 
when one strand of the ccc plasmid is nicked which may be 
observed using gel electrophoresis of the plasmid followed by 
microdensitometric scanning. Extended irradiation results in 
a build up of nicks on both strands of the plasmid which 
eventually results in its opening to the linear (lin) form, 
(Form III).
It is not necessary to enter into a lengthy 
description of the various transition metal photocleavers in 
this work. It is suffice to briefly discuss the 
ruthenium(II) polypyridyls which photosensitise DNA cleavage.
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Table 1.1 Summary of some of the metal complexes
investigated and reactions that have been used 
to cleave target sites along the strand.
Compound Binding Mode Cleavage
Mechanism
Site
[Rh(phen)3]3+ Intercalation/ 
Surface binding
photoredox B-DNA
[Co(phen)3]3+ Intercalation/ 
Surface binding
photoredox B-DNA
[Ru(phen)3 ]2+ Intercalation/ 
Surface binding
singlet oxygen guanine
A - [ C o (DIP)3]2+ Intercalation 
Surface binding
photoredox Z-DNA
[Ru(TMP)3 ]2+ Surface binding singlet oxygen A-DNA/
guanine
[R h (DIP)3]2+ Surface binding photoredox cruciforms
[R u (TAP)3]2+ Intercalation/ 
Surface binding
photoredox guanine
[Ru(bpy)3]2+ Surface binding singlet oxygen guanine
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2 + 2 +[Ru(bpy)^] and [Ru(phen)3 ] have been shown to
mediate the formation of singlet oxygen with the resultant
photocleavage of DNA. [71,95,96] The fact that both of these
complexes are capable of sensitising DNA photocleavage shows
that the mode of binding does not appear to be a factor in
determining whether these complexes sensitise this process,
2 +since [RuCphen)^] intercalates into DNA and 
2 +[Ru(bpy)^] electrostatically binds to DNA. In the 
2 +presence of Mg (20 mM), these complexes and 
2 +[Ru(TAP)^] were no longer able to sensitise the 
cleavage of pBR322 plasmid DNA. This salt concentration is 
more than sufficient to prevent intercalation of ruthenium 
complexes into DNA and may effect the release of the 
complexes from the strand. This observation indicates that 
binding is essential for cleavage. This is further 
substantiated by the fact that the neutral complex 
[Ru(phen)2 (C N )2 ], which does not bind to DNA, also does 
not sensitise its cleavage. [71]
2 +The complex [Ru(TMP)^] , which binds 
preferentially to A-DNA helices, also cleaves these helical 
forms. Furthermore, as observed in the binding process, 
enantiomeric selectivity similarly occurs with the cleavage 
process. The left-handed A  -[R u (TMP)^ ]2+, cleaves the 
A-DNA form with twice the efficiency of the right-handed A  
isomer. [85]
2 +[Ru(TAP)^] has been found to be the most 
effective as a photocleavage sensitiser. [71,74,97] For the 
other complexes mentioned, the sensitiser reacts with triplet
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oxygen present in the solution with the formation of singlet
oxygen which can attack the DNA. However, for the TAP
complex, since the complex is only inefficiently quenched by
oxygen and is therefore, expected to be a poor singlet oxygen
sensitiser, an alternative mechanism has been proposed. For
2 +this complex and also [R u (TAP)^ (bpy)] , both of which
are strongly oxidising and are capable of oxidising guanine 
(G), an electron transfer process has been suggested. 
Consideration of the excited state potentials shows that the 
following electron transfer reaction is thermodynamically 
favourable.
[Ru(bpy)n (TAP)3_n ]2+ + G -----------►
[Ru(bpy)n (TAP)J3_n ]+ + G #+
It is thought that the complexes [Ru(TAP)-
2 + 2 +(HAT^J and [ Ru ( HAT) ^  ] which are capable of
oxidising both guanine and adenosine, may also act as
photocleavage sensitisers through electron transfer
processes. In fact, this mechanism has recently been
confirmed by the detection of the monoreduced complex in
laser flash photolysis experiments in the presence of the
mononucleotides. [71,74]
2 +The effects of [R^TMP)^] and 
2 +[Ru(phen)3 ] on the photocleavage of transfer RNA (tRNA) 
have recently been reported and reveal that these complexes 
preferentially photocleave at the guanine residues. [98]
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Somewhat different patterns of cleavage were observed despite
the fact that both complexes sensitise photocleavage through
1 2 + the formation of singlet oxygen, ( C^). [Ru(TMP)^]
was found to photocleave a subset of those guanine residues
2 +cleaved by [Ru(phen)^] and with different relative
intensities. It was observed that some of the guanine
2 +residues are protected from [Ru(TMP)^] , because of its
molecular shape, (which governs its binding
characteristics). Therefore, given the uniqueness of the
sites cleaved, these probes may have application in the
assessment of the structural integrity of tRNAs.
A complex which provides a route to double
stranded cleavage through a metal-activated mechanism rather
than photoactivated cleavage has been described. [99,100]
2 +This complex is an analogue of the complex [RutDIP)^]
One of the three diphenylphenanthroline ligands are modified 
with two polyamine armlike segments that can themselves 
complex metal ions. See Figure 1.14. The concept is that 
the complex will bind to DNA and the two arms of the macro 
ligand will deliver complexed metal ions to each strand of 
the DNA helix for double stranded cleavage. The complex has 
been shown, in the presence of the redox active Cu(II) and 
the redox inactive Zn(II), though less efficiently for the 
latter, to efficiently effect the cleavage of double stranded 
DNA.
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The results suggest that the metal-activated 
cleavage by the [R u (DIP)^ (Macro)]n+ molecule occurs via 
nucleophilic attack at the phosphodiester backbone leading to 
hydrolysis of the anionic diester. As a result the 
possibility of using these types of molecule as artificial 
restriction enzymes has been proposed. [99,100]
1.4 Fluorescent probes in immunochemistry.
In addition to their use as probes of DNA structure, 
fluorescent molecules find application as probes in 
immunochemistry techniques. Immunoassays are based on an 
immunological reaction between the substance to be measured 
(antigen) and a specific antibody or antibodies. This 
interaction is reversible and non-covalent. In order to
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detect or quantify this reaction it is usual to label either 
the antigen or antibody with a probe of some sort, which may 
be a radioactive species, an enzyme or a fluorescent 
compound. [101]
Immunological methods for the qualitative and 
quantitative measurement of many types of molecules, 
including hormones, antibodies and drugs are employed because 
of their superior specificity and sensitivity. [102] 
Fluorescent agents are used in immunofluorescence (IF) and 
fluorescent immunoassay techniques (FIA, fluoroimmunoassay; 
IFMA, immunofluorometric assay), where the antigen or 
antibody is labelled with a fluorescent species.
Fluorescent methods are applied in immunology, 
mainly in fluorescence microscopy for studying various types 
of cells, tissues, bacteria, viruses, etc. In these cases, 
the sample under investigation is detected with an antibody 
which is labelled with a fluorescent species. This is a 
qualitative method of analysis, but a microscope that can 
quantitate fluorescence in an individual cell is available. 
However, with the recent advances in the use of fluorescence 
activated cell sorting (FACS), it is also possible to 
quantify the visual picture obtained under the fluorescence 
microscope. With this method also, dual labelling using two 
different fluorescent probes can be used to distinguish 
between different cell populations. [103]
Other quantitative fluorescent immunoassay 
techniques include fluorescent polarisation methods, 
fluorescence quenching methods, fluorescent enhancement
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methods and fluorescent excitation transfer methods.
The use of fluorescent probes to replace 
radioactive isotopes as labels is somewhat hindered because 
of the decreased sensitivity obtained with fluorescence, 
which is partially due to the samples own fluorescence, 
(autofluorescence). The intensity of this background has 
been overcome by the use of time-resolved fluorescence and 
labels with a long emission decay, including the lanthanide 
chelates and some ruthenium(II) polypyridyl complexes. 
[80,102,104]
Some of the other problems associated with 
fluorometric analysis include (a) light scattering due to the 
colloidal nature of the substances under investigation and 
(b) quenching of the fluorescence by oxygen, heavy atoms and 
concentration quenching due to the location of probes in 
close proximity to each other. [105]
The requirements for a suitable fluorescent probe 
in IF and fluorescent immunoassay techniques are outlined in 
Table 1.2.
1.4.1 Chemical modification of proteins.
Proteins contain several different chemical groups which can 
be used for the attachment of reporter molecules.
Conjugation usually involves binding to the amino 
side-chains, in particular the £ -amino group of lysines, 
the phenolic moiety of tyrosines, carboxyl groups of
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Table 1.2 Requirements for a good fluorescent probe.
(1) The fluorochrome should possess chemical groups which 
will form stable covalent bonds with protein molecules 
or be easily convertible to such a reactive form 
without destroying the fluorescent structure.
(2) It should be easy to separate the unbound fluorescent 
probe from the bound probe.
(3) The probe should possess a high quantum yield of 
fluorescence, ideally <P = 1 and this efficiency should 
not decrease upon conjugation.
(4) For IF procedures, the fluorescent colour should be 
distinguishable from that of the background.
(5) Conjugation of the probe to the protein molecule 
should not adversely affect the antibody-antigen 
binding process.
(6) It should be possible to conduct the conjugation 
reaction under mild conditions so that the 
conformation of the antibody or antigen is not 
disturbed.
(7) The probes should be photostable.
(8 ) The probe should exhibit a large Stokes shift so that
the scattered analysing light does not interfere with
the signal.
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glutamate and aspartate and the sulphydryl groups of 
cysteines. One feature common to all these approaches is the 
lack of specificity of the reactions, in that the label can 
not be directed to a particular site on the antibody or 
antigen. Also for immunoglobulins, the amino groups are 
located close to the antigenic binding site which may result 
in a decrease in the affinity of the antibody (Ig) for the 
antigen. [106] An alternative approach which generates more 
specificity in the labelling of immunoglobulins and other 
glycoproteins, is via modification of the carbohydrate 
moieties, particularly those which are covalently attached to 
asparagine. Also, the oligosaccharide moieties which are 
modified using this method, are not involved in the process 
of antigenic binding and are far removed from the site of 
binding. [106]
Some probes are themselves not fluorescent or only 
weakly fluorescent but become highly fluorescent upon 
conjugation. One such probe is 9-maleimidoacridine (Figure 
1.15), which couples with the protein and in doing so the 
conjugating group can no longer act as an intramolecular 
quenching species since its reaction with a nucleophile 
destroys its quenching ability. [107]
Figure 1.15 Reaction of 9-maleimidoacridine with protein
via the sulphydryl group on the protein. [107]
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Some intercalating dyes may also fall in this category and
2 +include the [Ru(bpy)^ (dppz)] complex described earlier.
[94]
Intercalating dyes which themselves are 
fluorescent include ethidium bromide and acridine orange and 
are used in immunofluorescence techniques for staining cells, 
to determine cell viability and measurement of DNA. [108]
Some probes require light for activation and are 
converted to the reactive species upon absorption of a photon 
of appropriate energy. The most common photoactivating 
functional group is the aromatic azide ion (R-N^). Upon 
photolysis azides are converted to nitrenes (R-N). Electron 
deficient nitrenes are extremely reactive and have broad 
reaction specificity. [108] They can potentially react with 
a variety of chemical bonds including NH, OH, CH and C=C via 
addition and insertion reactions. [109] Some of the azide 
fluorochromes are shown in Figure 1.16.
<^h,ch2 NH^  - o -
K
Lucifer Yellow AB 
Figure 1.16 Some photoactivatable fluorescent azide probes.
)i
Q ^ - N ^ o
K03S''' SOj
NH,
Azidopyrene
Other photoactivatable fluorochromes include the furan and 
o-nitrobenzyl compounds shown in Figure 1.17.
Figure 1.17 Two photoactivatable probes, (a) a furan
compound and (b) an o-nitrobenzyl compound.
[107]
Upon photolysis the furan under goes photoinduced 
rearrangement giving a highly fluorescent species. The 
o-nitrobenzyl derivative undergoes photofragmentation to give 
the fluorescent species. [107]
1.4.1.1 Conjugation reactions via modification of the 
amine groups of proteins.
Amine groups are common targets for modification in 
conjugation procedures. Fluorochromes which modify these 
groups include the isothiocyanates, succinimidyl esters,
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isocyanates and sulphonyl halides (chlorides). Examples of 
some of these types of fluororchrome are presented in Figure 
1.18 .
Isocyanates (N=C=0), yield ureas on reaction with 
amines but are unstable and are no longer commonly used as 
probes. Fluorescein isocyanate was first described by Coons 
et a l . . [110] The isothiocyanate analogue of this compound 
(FITC), was introduced by Riggs et al ., [111] and is probably 
the most commonly used fluorochrome for IF and fluorescent 
immunoassay procedures.
Fluorescein conjugates show an absorption maximum 
at 495 nm and have a strong fluorescence emission which is an 
apple-green colour. This colour is rarely encountered in 
mammalian tissues as autofluorescence and it also corresponds 
to a region of high retinal sensitivity, in the eye.
However, on the debit side, FITC has a small Stokes shift 
(about 25 nm), with the emission maximum occurring at about 
520 nm. Hence, light scattering causes considerable 
interference. Fluorescein is also subject to severe 
concentration quenching when several molecules are assembled 
in close proximity. [112] It is thought that this phenomenon 
is due to resonance energy transfer among the fluorophores 
caused by overlap of the fluorescence excitation and emission 
spectra. The advantage of the initial brilliant fluorescence 
is marred by rapid fading with continued exposure to exciting 
radiation. This has been attributed to oxidative and 
reductive photodegradation processes. [107] The fluorescence 
intensity of FITC conjugates varies appreciably with pH, with
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N'C^ S
FITC
Fluorescein
isothiocyanate
TMRITC 
Tetramethyl rhodamine 
isothiocyanate
S = c = N _ © ^ > =  Eu 3+
isothiocyanate phenyl-EDTA-Eu
H H
[f] -N < = S  +  NH2-[pj ------[f]—N-C-N — (pj
Carboxyfluorescein succinimidyl ester
f l - C - O y ]  +  NHj-fP] — [F]-C-NH-fP] 
0 0
Figure 1.18 Some fluorochromes that bind to protein
molecules via amino groups, together with the 
appropriate conjugation reaction.
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SO,CI
NM ej
o
SO,Cl
Texas Red DANS RB200SC
[F]-S02Cl +  NH2{P]   [F ]-S 02 N H '[P ]
Figure 1.18 Some fluorochromes that bind to protein
molecules via amino groups, together with the 
appropriate conjugation reaction.
a maximum around pH 8.0, however, this is not usually a 
problem since immunoreactions are normally conducted in 
buffered alkaline aqueous solution.
The principal alternatives to FITC are the 
rhodamines (tetramethylrhodamine isothiocyanate, TMRITC and 
rhodamine-B-isothiocyanate, XRITC) . Conjugates of these dyes 
exhibit an orange fluorescence at longer wavelengths than the 
FITC conjugates, but the fluorescence is not as intense. The 
rhodamines have lower pH sensitivity of both absorption and 
emission than fluoresceins, and are more stable to 
photobleaching (fading). Rhodamine conjugates are widely 
employed in dual fluorescent studies with FITC as the second 
fluorophore. [105]
The fluorescent lanthanide chelates form a 
relatively unique group of fluorophores because of their much
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extended fluorescence decay lifetimes. One of these chelates 
has been presented in Figure 1.18. The strong fluorescence 
exhibited by these chelates is due to the high absorption of 
the excitation radiation by the ligand and to the energy 
transfer from the triplet state of the ligand as a 
non-radiative transition to the central atom, which then 
produces a long wavelength, narrow emission typical of the 
rare earth metal. As far as their fluorescence is concerned, 
chelates of rare earth metals especially those of europium 
(Eu) are particularly suitable as probes. The prolonged 
fluorescence lifetime essentially stems from the delays 
incurred in the initial transfer processes. A second useful 
characteristic of the lanthanide chelates is their large 
Stokes shift. For example, Eu emits fluorescence in a narrow 
band around 613 nm; maximum excitation of the chelate occurs 
using incident light of a wavelength of 340 nm, implying a 
Stokes shift of about 270 nm. The combination of a large 
Stokes shift and an extended fluorescence decay time provides 
the basis for their use in time-resolved fluorometry. [113]
Succinimidyl esters are excellent reagents for 
amine modification since the amide products formed are very 
stable. [108] Both fluorescein and rhodamine succinimidyl 
esters are available.
The use of the esterified derivative of 
2 +[Ru(bpy)2 (COOHbpy)] , Figure 1.19, to conjugate bovine
serum albumin and anti-rabbit immunoglobulin has been 
described. [114], The retention of immunological activity 
after conjugation to the antibody was demonstrated by
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immunofluorescence. The complex has also been employed in a 
time-resolved fluorescence immunoassay. [104]
2+
Figure 1.19 Succinimidyl ester of the compound [Ru(bpy)2
2 +-(COOHbpy)] , where bpy = 2,21-bipyridyl and 
COOHbpy = 4,41-dicarboxylic acid-2, 2'- 
bipyridyl.
The succinimidyl esters of some bathophenanthro- 
line ruthenium (II) complexes (Figure 1.20), have been 
conjugated to oligonucleotides and the emission measured by 
time-resolved fluorescence techniques. Decay lifetimes of 
the order of (isec have been reported. [80] The complexes are 
thermodynamically very stable, they are chemically very inert 
and show strong and long lasting fluorescence after 
excitation by light pulses of short duration which allows 
their detection by time-resolved measurement methods.
Sulphonyl halides form extremely stable 
sulphonamides with amines. Texas Red (Figure 1.18), is the 
sulphonyl chloride derived from sulphorhodamine and exhibits 
orange / red fluorescence. The compound has a small Stokes
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shift with a X  max. of absorption of 595 nm and an emission 
maximum of 615 nm. In dual labelling techniques Texas Red 
provides more efficient spectral separation from FITC 
excitation than TMRITC can. [115]
Figure 1.20 Succinimidyl ester of a bathophenanthroline 
ruthenium(II) complex.
Other sulphonyl chlorides include Dansyl Chloride 
(DANS) and lissamine Rhodamine B 200 sulphonyl chloride 
(RB200SC). Spectra of the RB200SC conjugates are very 
similar to the XRITC conjugates but have higher chemical 
stability. Conjugates of RB200SC have two emissions, one in 
the yellow at 595 nm which is excited by any shorter 
wavelength and the second in the far red at 710 nm which is 
excited by shortwave radiation below 350 nm. The second 
longer wavelength fluorescence occurs after conjugation to 
proteins and is not exhibited by the free dye. [103]
Dansyl chloride is also used in immunological
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systems although its fluorescence is weaker. Its greatest 
drawback is that its excitation and emission wavelengths fall 
in the same region as those of serum, which leads to 
interference by the serum's own fluorescence. DANS 
conjugates have a green fluorescence but less brilliant than 
FITC and are more subject to photobleaching than FITC. [103] 
Structural isomers are available. The dye (isomer A),is 
valuable as a probe of amine terminus analysis of proteins 
and peptides. Isomer A has one of the largest Stokes shifts 
known ( A.max. ex. 340 nm and \  max. em. 578 nm) , and the 
other isomers B and C (Figure 1.21), have shorter Stokes 
shifts. Isomer B absorbs maximally at 373 nm and emits at 
470 nm, while isomer C absorbs maximally at 359 nm and emits 
at 435 nm. Isomer B and C have longer emission decay times 
than isomer A and are employed as protein markers in 
fluorescence polarisation studies. [108]
so,ci
(A)
Figure 1.21 Isomers of DANS,
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Dansyl chlorides have longer emission lifetimes (>14ns), than 
most of the fluorochromes described already, apart from the 
lanthanide chelates and the ruthenium (II)complexes.
The ruthenium polypyridyl sulphonyl chloride 
(Figure 1.22), has been prepared and conjugated to human IgG.
[104]
Figure 1.22 Bis(phenanthroline) Ru(II) (4,7-diphenyl- 
phenanthroline) sulphonyl chloride.
2 +The complex [Ru(bpy)2 ((CONCS)2bpy)] has also been
synthesised and has been conjugated to antibodies via lysine 
residues. [104]
Fluorochromes which bind to the amino groups of 
proteins principally bind to the e -amino terminal group of 
the lysine residues (Figure 1.23), or to the a.-amino 
terminal group on a protein.
Ijf 
h3n - ( c h 2)4- c - c o o -
Figure 1.23 Lysine at pH 6.0.
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1.4.1.2 Conjugation reactions via modification of the
sulphydryl groups of protein molecules.
The sulphydryl group of cysteine residues may also be 
modified, (Figure 1.24).
V
h s - c h 2- c -  c o o -
I 4 -
n h 3+
Figure 1.24 Cysteine.
The fluorochromes which target the sulphydryl 
groups of proteins include the maleimides and haloacetyls, 
principally the iodacetamides. Some maleimide and 
iodacetamide fluorochromes are presented in Figure 1.25.
Maleimides are useful reagents for thiol selective 
modification. They are probably among the most specific 
protein reagents, reacting under mild conditions and with the 
minimum of side reactions. Characteristic changes in the 
ultraviolet absorbance, associated with the reaction of 
maleimide derivatives with sulphydryl groups provide a 
convenient method for monitoring the conjugation reaction. 
[116,117]
Pyrene maleimide is essentially non-fluorescent 
until reacted with protein, when it exhibits quite long lived 
fluorescence. The fluorescence shows excimer formation with a
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new longer wavelength emission if two fluorophores are in 
close proximity. The absorbance X.max. occurs at 340 nm and 
emits at 392 nm and 375 n m . [108] Pyrene maleimides have
quite long emission lifetimes of about 100 ns which renders 
these probes as useful reagents in time-resolved fluorescence 
techniques.
In the absence of cysteine residues, haloacetyls 
may react with methionines, histidines or tyrosine residues 
on protein molecules. Iodacetamides are intrinsically 
unstable in light and especially in solution. However the 
tetramethylrhodamine iodacetamide is relatively photostable.
[108]
Other sulphydryl reagents include the 
phycobiliprotein conjugates such as the phycoerythrins, 
C-phycocyanins and allophycocyanin. The phycobiliproteins 
are proteins from the light collecting apparatus of algae. 
Their biological role as light collectors has led to maximal 
absorption and fluorescence without susceptibility to either 
internal or external fluorescence quenching. Their 
fluorescence yield is equivalent to about 30 molecules of 
fluorescein or 100 rhodamine molecules at comparable 
wavelengths. [108] These phycobiliprotein conjugates were 
introduced to provide an alternative fluorescent colour to 
fluorescein for use in single laser fluorescence activated 
analysis. Phycoerthryins exhibit orange fluorescence on 
excitation by light of similar wavelength to fluorescein. 
However, since the fluorescence spectrum of fluorescein 
extends into the red region, the use of phycoerythrin in
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Fluorescein maleimide
0I
I f ] -  n J  +  h s - [ p]
I
0
[ F ] - N ^
5
Tetramethylrhodamine 
5 (and 6 ) iodacetamide
N * 'OjS
o oi n
o c h ,c n h c h ,c h , n h c c h ,i
N a * ' 0 , S ^ i ^ ' S 0 , '  Na*
Cascade blue aminoethyl 
iodacetamide trisodium salt
U ^
[F ]-N h Cc H2I +  HS-[P j— [F]-N H C C H £-[P ]
Figure 1.25 Some maleimide and iodacetamide fluorochromes, 
together with the appropriate conjugation 
reaction.
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discriminatory double fluorescence analysis should be 
considered carefully.
Recently, attention has been drawn to a previously 
unrecognised hazard when R-phycoerythrin is employed in dual 
fluorescence analysis with fluorescein as the second probe. 
This arises due to energy transfer caused by spectral overlap 
of the absorbance curve of phycoerythrin and the emission 
curve of fluorescein, which may lead to an appreciable loss 
of the fluorescein signal in the presence of high intensity 
phycoerythrin staining. See Figure 1.26. Control tests in 
which phycoerythrin is omitted are essential in order to 
avoid misinterpretation of results particularly in the 
analysis of subpopulations by single fluorescence activated 
cell sorting. [107,118].
Figure 1.26 Absorption spectra of FITC and R-phycoerythrin 
demonstrating spectral overlap. [118]
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Phycoerythrins and other phycobiliprotein conjugates may be 
obtained as streptavidin conjugates, which may be linked to 
the protein via biotinylation of the protein. Streptavidin 
can bind four biotin ligands per mole with high affinity and 
low reversibility. By use of this system, increased 
sensitivity in immunostaining techniques is achieved. [108]
1.4.1.3 Aldehyde and ketone reactive probes.
Aldehydes and ketones are not common in proteins 
or nucleic acids. The deficiency of aldehydes can be 
advantageous for site selective modifications in that 
aldehydes can be introduced into certain biomolecules by 
periodate oxidation of glycols, including the terminal 
residue of RNA and carbohydrate sites such as sialic acids of 
immunoglobulins and glycoproteins, [106,108], Figure 1.27, 
shows the reactions involved.
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R - CHOH — CH,OH 
Vicinal Diol
NaiO*
O
R- CWHNH, 
H yd /azid e
R -  ch-nnh£-R' 
HYDRAZONE
R -  CHO 
Aldehyde
R-CH =N H-R' 
S ch iff B a s t
BH,CN‘
R -C H ,-1 N H -R '
R = antibody molecule? R ’ = reporter molecule.
Figure 1.27 Chemistry involved in the site-specific 
modification or conjugation of the 
oligosaccharide moieties of glycoproteins. 
[106]
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Some reagents which react with the aldehyde groups are shown 
in Figure 1.28.
N H CCH ^C H jC N H N H , I Ho o
5(((2-(carbohydrazino)methyl)thio) 
acetyl)amino fluorescein
SOjNHNH,
Texas red hydrazide
HCI
5(aminomethyl)fluorescein hydrochloride
[Fj-CH^H +  0 = C C & ~ [F ] -C * * K - [P ]
Figure 1.28 Some probes that react with aldehydes and 
ketones, together with the appropriate 
conjugation reaction involved.
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1.4.1.4 Carboxylic acid reactive probes.
The chemical reactivity of carboxylic acids in aqueous 
solution is very low and precludes the use of carboxylic 
reactive probes with biomolecules. However, some probes can 
modify carboxylic acids of synthetic polymers. So, prior to 
conjugation the carboxylic acid is usually derivatised by a 
water soluble carbodiimide followed by reaction with a 
hydrazine or amine. In some cases, the carbodiimide may have 
the fluorochrome within its structure (Figure 1.29) and then 
the fluorophore is specifically incorporated into the 
protein. [108]
0  NR
R-N-C-N-R ' +  P r o t e i n - C 0 0 H — Protein-  t-O -C
NHR'
N-cyclohexyl-N1(1-pyrenyl) N - (2-anthracenyl)-N
carbodiimide -cyclocarbodiimide
Figure 1.29 Carboxylic acid reactive probes, together with 
the appropriate conjugation reaction.
1.4.1.5 Diazonium compounds as labels for proteins.
Another labelling technique involves the use of diazonium 
compounds. When a suitable aromatic amino derivative of a 
fluorochrome is available, it may be diazotised and the 
resulting diazonium compound conjugated to a protein to give 
the azo-protein. The diazonium salts have been shown to 
couple to the phenolic moiety of tyrosine and to the 
imidazole group of histidine. [103]
This coupling method has been used to conjugate 
indium to bifunctional analogues of EDTA resulting in a 
radioactive probe. [119] The method was modified by Hemmila 
et al ., to couple europium-EDTA-diazophenyl to antibodies and 
was subsequently employed in time-resolved immunofluorometric 
assays. [120]
1.4.2 Fading effects in fluorescence microscopy.
One of the drawbacks of immunofluorescence is the fading of 
fluorescence during microscopy. FITC, RB200 and DANS are all 
subject to this phenomenon. It has been shown that FITC is 
susceptible to fading in the presence and absence of oxygen. 
[121] Later, studies showed that FITC was susceptible to 
fading in the presence of organic peroxides, hydroperoxides 
and oxyradicals. [122] Various reagents have been proposed 
to reduce this effect. [123] In 1981, the use of 
p-phenylenediamine was reported, however, the dye itself
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undergoes rapid photo-oxidation which may be retarded by the 
incorporation of a reductant which regenerates the diamine 
from its oxidised form. [107] DABCO (1,4,-diazobicyclo- 
octane) is extremely stable and is useful in the retardation 
of fluorescence bleaching. [123] Glutathione in the presence 
of glutathione peroxidase has also been found to be 
successful in inhibiting the oxidation processes which are 
involved in the photobleaching effects. [122]
1.4.3 Fluorescence immunoassay methods.
There are a number of immunoassay techniques (apart from 
microscopic methods), which employ fluorescent probes. These 
can be divided into fluoroimmunoassay (FIA), in which the 
antigen is fluorescently labelled and immunofluorimetric 
assay (IFMA) in which the antibody is labelled. These can be 
further divided into assays where (a) the unbound fluorescent 
probes and endogenous fluorochromes are separated from the 
bound fluorescent species and (b) separation of the unbound 
and endogenous fluorophores is not necessary.
In systems where separation is required, the 
antibody is bound to a suitable solid material such as 
plastic or glass beads, plastic test-tubes, Sephadex 
particles or magnetisable particles. The fluorescently 
labelled antigen binds to the antibody and unbound labelled 
antigen or other non-specific substances can be separated by 
rinsing or by centrifuging and washing steps. [102]
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Magnetisable particles which have the antibody-antigen 
fluorescent label complex attached are subjected to a brief 
magnetic field, while the supernatant containing the 
potentially interfering compounds may be aspirated to waste.
[105] After separation the fluorescence of the 
antibody-antigen complex may be directly measured.
The formation of an antigen-antibody complex can 
be studied by fluorescence methods without the necessity of 
separating the unbound labelled antigen from the bound 
labelled antigen. A number of techniques are available 
including fluorescence polarisation, fluorescence quenching, 
fluorescence enhancement and fluorescence excitation transfer 
immunoassays.
1.4.3.1 Fluorescence polarisation immunoassay.
In the fluorescence polarisation method, depicted 
schematically in Figure 1.30, a labelled sample is excited 
with polarised light and the degree of polarisation of the 
emission is measured. The extent of polarisation of the 
emitted light will depend on the extent of random Brownian 
motion of the molecules that occurs during their excited 
state lifetimes. The smaller the labelled antigen, the 
faster will be its random rotation. As the labelled antigen 
binds to the antibody, its rotation slows down and the degree 
of polarisation increases. The method requires a fluorescent 
probe with a relatively long emission lifetime so that 
rotation can be measured.
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The use of FITC-labelled rabbit anti-human placental lactogen 
for monitoring levels of human placental lactogen by 
fluorescence polarisation methods has been reported. [112]
P olarised
light
Free Label '
Polarised
light
Figure 1.30 Polarisation fluoroimmunoassay.
A fluorophore (F)r excited by plane polarised 
light, can emit polarised fluorescence.
However, the rapid movement of a small 
fluorescent-labelled antigen (Ag) reduces or 
eliminates the emission of plane polarised 
fluorescence. Following binding to the much 
larger antibody, movement is restricted, 
allowing for emission of plane polarised 
fluorescence. This can be used as a basis for a 
simple homogenous immunoassay. [101]
V %
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When the FITC-labelled antigen is bound by the large antibody 
molecule it undergoes an effective increase in size and a 
decrease in its rotational relaxational rate leading to an 
increase in polarisation.
1.4.3. 2 Enhancement and quenching fluoroimmunoassays.
Fluorophores in labelled antigens can give reduced (quenched) 
or increased (enhanced) fluorescence when bound by 
antibodies. Enhancement fluoroimmunoassays are not common 
but the method has been used for the thyroid hormone, 
thyroxine. The fluorescein labelled hormone has a low 
quantum efficiency which is thought to be caused by 
intramolecular quenching by the iodine in the molecule. The 
quantum efficiency increases four-fold when the fluorophore 
is bound by the antibody, presumably by inhibiting the 
quenching effect. The principle behind the assay is 
schematically illustrated in Figure 1.31. This effect has 
been used as the basis of an enhancement FIA for thyroxine in 
aqueous buffer samples. [105]
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0Free - impaired fluorescence Bound - enhanced fluorescence
Figure 1.31 Enhancement fluoroimmunoassay. A fluorophore 
when coupled to an antigen can show impaired 
fluorescence. The quenching effect of the 
antigen on the fluorophore can be removed by
binding to antibody. [101]
Quenching immunoassays are more common than enhancement 
assays. Quenching methods are used to measure the quenching 
of the fluorescence of the antigen-labelled probe when bound 
to the antibody. The fluorescence may decrease as the small 
molecule labelled hapten such as FITC-labelled gentamicin 
binds to the antibody because of the effect of a chemical 
quencher present in the antibody. Direct quenching methods
are used to assay small molecules only, such as haptens,
because large molecules, such as proteins, enable unimpaired 
emission from the fluorophore because of the distances 
between the sites of antibody binding and of label 
attachment. Indirect quenching methods are suitable for the 
assay of large molecules, such as proteins, because the 
presence of the antibodies in the bound fraction sterically
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hinders the binding of the label by the anti-fluorophore 
immunoglobulins. See Figure 1.32.
The indirect method which is also known as the 
fluorescence protection immunoassay, has made it possible to 
apply quenching principles to the measurement of large 
molecules. Indirect quenching employs a second antibody 
directed to the fluorophore. In this approach, sample, 
labelled antigen and anti-serum are incubated until 
equilibrium is reached when an excess of anti-fluorophore 
serum is added. This immediately binds to and quenches the 
fluorescence of any unbound labelled antigen, but because of 
steric hindrance by the first antibody, is unable to bind the 
fluorophore groups in the bound fraction, which continue to 
fluoresce. The method has been used for human albumin in 
serum, urine and cerebrospinal fluid and for human 
immunoglobulin G and placental lactogen. [105] The indirect 
method is not usually applicable to molecules with molecular 
weight < 20,000.
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Figure 1.32 Schematic diagram of quenching
fluoroimmunoassays. (a) direct quenching 
fluoroimmunoassay; most fluorophores when 
coupled to antigens show no reduction in 
fluorescence. However, in some cases, the 
binding of antibody may reduce or quench the 
fluorophore. (b) indirect quenching 
fluoroimmunoassay; the binding of a fluorophore 
by a specific anti-fluorophore antibody leads to 
quenching of the fluorescence. When the antigen 
fluorophore conjugate is bound by the primary 
antibody, steric hindrance may prevent the 
anti-fluorophore antibody from quenching the 
fluorescence. Increasing concentrations of 
antigen leads to a greater proportion of 
labelled antigen in the free fraction and hence 
to increased quenching. [101]
96
Antibodies that directly quench the fluorophore of a 
fluorescent labelled hapten are not common. An assay termed 
the alternative binding immunoassay allows indirect quenching 
principles to be applied to the assay of haptens and small 
molecules. See Figure 1.33. The principle of this 
immunoassay is that the labelled hapten can bind to only one 
antibody and if this is directed against the hapten, the 
fluorescence is unimpaired. Unlabelled hapten competes only 
for anti-hapten binding sites, so that its addition results 
in more of the label molecule becoming bound to anti­
fluorescein, with a decrease in its signal.
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A N T I-H A P T E N .
FL U O R E S C E IN  
H A P TE N
Fluorescence
Quenching
Figure 1.33 Alternative binding immunoassay. A complex of 
primary antibody and anti-fluorophore will bind 
an antigen-fluorophore conjugate at either end, 
yielding some fluorescence. With increasing 
concentrations of antigen, more conjugate will 
be bound at the fluorophore end, leading to some 
quenching. [101]
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1.4.3.3 Fluorescence excitation transfer immunoassay.
Fluorescent excitation transfer immunoassays exploit the 
phenomenon of non-radiative resonance energy transfer between 
a fluorophore (donor) and an acceptor chromophore. The 
efficiency of the process depends on the degree of overlap 
between the emission spectrum of the donor and the absorption 
spectrum of the acceptor. Fluorescein and rhodamine are the 
labels most used as the donor-acceptor pair and binding of 
fluorescein labelled antigen by rhodamine labelled antibody 
brings the two reagents within energy transfer range, with a 
consequent reduction in fluorescein fluorescence, up to 70% 
fluorescence quenching. This is really equivalent to a 
direct quenching immunoassay and has been used for the 
determination of haptens and proteins. [105] Other 
donor-acceptor pairs such as fluorescamine and fluorescein 
have been reported with better stability than the 
fluorescein-rhodamine conjugates. [124]
1.4.3.4 Release immunoassay.
Another immunoassay technique (release immunoassay or 
substrate labelled immunoassay), involves the use of a 
labelled antigen reagent which is non-fluorescent but 
releases a fluorophore when split by an enzyme. The enzyme 
uses the non-fluorescent reagent as a substrate and 
enzymically liberates a fluorescent species. These
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substrates include the umbelliferones. The antigen is 
usually labelled with a galactosyl-umbelliferone conjugate 
which is a substrate for a bacterial beta-galactosidase.
1105]
1.4.3.5 Time-resolved fluorescence immunoassay.
Background fluorescence is one of the main problems 
associated with the use of fluorescence immunoassays. This 
is one of the main reasons for limited sensitivity of the 
fluorescent labels and is associated with endogenous 
fluorophores and light scattering effects. In Table 1.3, the 
fluorescence decay time of some proteins and labels are 
listed.
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Table 1.3 Fluorescence decay time of some fluorophores 
and proteins.
Substance Fluorescence decay time (ns)
Non-specific background 10
FITC 4 . 5
Dansyl chloride 14
N-3-pyrene maleimide 100
Europium chelates 103-10
Human serum albumin 4.1
Haemoglobin 3.5
Cytochrome C 3.0
RB200SC 1.0
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Another problem mentioned already is the bleaching effect 
derived from continuous exposure of the fluorophore to high 
intensity light. Some of these problems can be solved by the 
use of pulsed light time resolved techniques. The basic 
concept behind this technique may be summarised as follows. 
When a fluorophore is excited by pulsed radiation, 
fluorescence is emitted following each pulse, with an 
intensity which decreases exponentially with time in a 
characteristic manner. An electronically gated detection 
system may be used to accumulate photons over any selected 
time interval immediately following extinction of the 
incident light source. Such a system may in principal be 
employed to identify the fluorescent signals emitted by 
fluorophores characterised by different decay times. The 
simplest situation for this technique exists when a sample 
contains two fluorophores, one of which displays a 
fluorescent decay time very much longer than the other. In 
this situation, it is possible to measure the signal 
originating from the fluorophore displaying the longer decay 
time by permitting the more rapidly decaying fluorescence to 
die away to an insignificant level before commencing photon 
measurement. Clearly, this technique may be exploited to 
reduce or effectively eliminate background fluorescence, if 
this is characterised by a much shorter lifetime than that of 
the fluorophore of interest. [113] The basic principal of 
the measurement is shown in Figure 1.34.
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VIn time-resolved measurements the sample is excited with a 
short light pulse (about 1 ns), measurement of the 
fluorescence is started after a certain time (delay time 
t ), has elapsed, during which time the short decay time 
background is reduced to almost zero. The fluorescence of a 
probe with a long lifetime is measured at certain intervals 
(t, counting time), starting from t .
Figure 1.34 Diagram of time-resolved fluorometric 
measurements.
Clearly, from Table 1.3, the method can not readily be 
exploited to distinguish between background fluorescence and 
that characterising many of the fluorophores such as FITC or 
Dansyl Chloride. Also, depending on the gating system, the 
use of the relatively long lived pyrene maleimide fluorophore
Excitation
Fluorescence with
■ t ^  , , i _
Delay Time Counting I ime
A t
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may not be feasible. However, the lanthanide chelates (euro­
pium and terbium) and ruthenium (II) polypyridyl complexes 
have fluorescence lifetimes which are much longer than that 
of conventional labels. Thus, the emission from these 
compounds can be distinguished from the background 
fluorescence with a short decay time by using a time resolved 
fluorimeter with appropriately selected delay, counting and 
cycle times.
A second useful parameter of the lanthanide and 
ruthenium polypyridyl compounds is that they both possess a 
large Stokes shift. For the europium chelates, maximum 
emission occurs at about 613 nm and maximum absorption at 
340 nm, so the Stokes shift is about 270 n m . The 
ruthenium(II) compounds of interest in this work absorb at 
around 450 nm and emit at about 600 nm, thus the Stokes shift 
is approximately 150 n m . The combination of the large Stokes 
shifts and the long emission decay times provides the basis 
for the application of these compounds in time-resolved 
techniques where high signal : noise ratios may be achieved.
The model for the fluorescence of a europium 
chelate consists of a series of four steps, (i) excitation of
the organic ligand, (ii) intersystem crossing from the
singlet excited state to the triplet excited state of the 
ligand, (iii) intramolecular energy transfer (energy is 
transferred from the triplet excited state of the ligand to
the resonance levels of the europium ion) and (iv) light
emission from the europium ion. [113]
The decay time and intensity of Eu fluorescence is
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very much dependent on the structure of the organic ligands 
which chelate europium. Different ^-diketones chelate 
europium ions. The chelates show typical emission maxima 
characteristic of europium, although the excitation maxima 
are dependent on the organic ligand. The fluorescence 
intensity depends largely on the ligand and solvent effects. 
Fluorinated ^-diketones have been found to give the highest 
fluorescence. [113]
In aqueous solutions, quenching due to loss of 
energy as heat from the excited complex to the surrounding 
water molecules occurs. Since immunoassays are carried out 
in aqueous buffered solutions, a measuring solution in which 
the europium ion would be protected from quenching by water 
molecules was developed. Triton X-100, a non-ionic detergent 
was found to dissolve the sparingly soluble -diketone in 
the micellar phase and excludes the quenching water 
molecules. Insulation from the solvent has been further 
optimised by the addition of a synergistic agent, 
trioctylphosphine oxide to the europium chelate solution.
[113] A schematic picture of the hypothetical micellar 
structure into which the fluorescent europium chelate 
consisting of the europium |3 -diketone and the 
trioctylphosphine oxide molecules is solubilised is shown in 
Figure 1.35.
In order to use the europium ion as a label in 
immunoassays, the ion has to be bound strongly to one of the 
immunoreactive components. Although europium could be 
measured with high sensitvity as a |3 -diketone chelate, the
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binding is not strong enough for the coupling of europium to 
antibodies. This may be circumvented by binding the antibody 
to the europium label in a more or less non-fluorescent form.
Figure 1.35 (a) A micelle consisting of Triton X-100
molecules with an association number of about 
140, in which a fluorescent europium chelate is 
solubilised, (b) A hypothesised form of the 
europium chelate, consisting of an europium ion, 
three 2-napthoyltrifluoroacetone and two tri(n- 
octyl) phosphine oxide molecules as solubilised 
in between Triton X-100 structures. [113]
This was achieved by the use of two EDTA derivatives, 
diazophenyl-EDTA-europium or isothiocyanatophenyl-EDTA- 
europium. [120,125] EDTA and other polycarboxyl acids bind 
strongly to europium. By variation of pH, the strength of
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binding to EDTA changes and at low pH, the europium is 
readily dissociated from the complex. This property is 
utilised when the pH change is caused by the addition of the 
enhancement solution containing j3-diketone, trioctyl­
phosphine oxide and Triton X-100 at pH 3.2. A highly 
fluorescent chelate solubilised in the micelle is formed.
Once the EDTA based complexes are bound to the europium label 
in a non-fluorescent form to the immunoreactive component, 
the europium may be dissociated from the immunoreactive 
component into the fluorescent enhancement solution and the 
fluorescence measured by time-resolved techniques. The 
presence of diazophenyl and isothiocyanatophenyl moieties 
allow the conjugation of the EDTA-Eu chelate to the protein 
or antibody. The diazophenyl moiety reacts with the tyrosine 
residues and the isothiocyanatophenyl moiety reacts with the 
lysine residues and free terminal amino groups on proteins. 
[120] A schematic representation of the immunoassay is 
depicted in Figure 1.36.
The europium chelate labels have been applied to 
immunometric assays of the hormones, hTSH, (thyroid 
stimulating hormone); hCG, (human chorionic gonadotropin) 
using labelled monoclonal antibodies. In both assays a high 
sensitivity coupled with a wide linear range and excellent 
precision was obtained. The labels have been employed in 
both competitive and in immunometric assays. The europium 
chelate labels have also been used to measure a number of 
viral antigens using different immunoassay procedures. [113]
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Figure 1.36 Principle for the europium release after the 
immunometric assay has been completed.
As a final step before fluorescence measurement, 
an enhancement solution is added. The europium 
ion dissociates from the labelled protein and 
forms a fluorescent chelate in solution. [113]
The synthesis of caged lanthanide complexes (cryptands / 
cryptates) in which the metal is surrounded by a "cage" of 
ligands such as those depicted in Figure 1.37, greatly 
improves their capacity and the cryptat described by Alpha et 
al ., [126] (b) in Figure 1.37, has the ability to convert
about 1% of the incident uv photons into emitted visible 
photons which is of interest in labelling of biological 
materials. [127]
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(a) (b)
Figure 1.37 Schematic representation of the [Eu 2.2.1]^+
3 +(a) and [Eu bpy.bpy.bpy.] cryptates.
2 .2.1 stands for 4,7,13,16,21-pentaoxo-l,10- 
diazabicyclo-[8 .8 .5]-tricosane and bpy.bpy.bpy. 
for 6 ,6 ' , 6 '1,6 ' ' 1 , 6 ' 1 1 1 , 6 ' ' '11-bis [nitrilotri 
(methylene)]tris(2 ,2 1-bipyridine). [126]
1.4.4 The use of ruthenium polypyridyl complexes as
labels for biomolecules.
It is appropriate to complete this section with a discussion 
on the use of ruthenium polypyridyl compounds in labelling 
procedures. Various ruthenium complexes have been prepared 
and coupled to albumins, antibodies and oligonucleotides.
The literature describes the use of [Ru(bpy)^ (COOH- 
bpy)]2+ [78,79,80,104,114,128], and the coupling procedure
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involves the esterification of the complex with 
N-hydroxysuccinimide, followed by coupling to the amino 
groups on the albumin or antibody or to the primary amino 
group at the 5' end of oligonucleotides. The coupling 
reaction has been previously given in Figure 1.18.
The use of [R u (bpy)2 (4,4'-dichloro-
2 +methylbpy)] has also been described, Figure 1.38, and has 
been conjugated to sheep and rabbit anti-mouse IgG. The 
complex reacts with a free amino group which attacks the 
chloromethyl group and displaces the chloride. [114]
c h 2ci
[F]-CH2C1 + NH2-[P] ---- ►  [F]-CH2NH-[P]
Figure 1.38 Structure of the complex [R u (bpy)2 (4 , 4 1 -
2 +dichloromethylbpy)] together with the 
conjugation reaction with amino groups of 
protein molecules.
The active ester of the dicarboxylic acid complex 
has been conjugated to bovine serum albumin, human IgG,
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rabbit anti-salmonella antibody and goat anti-rabbit 
immunoglobulin. Immunofluorescence studies were conducted 
using a direct method, where the rabbit anti-salmonella 
antibody was reacted directly with salmonella cells and 
bright red/orange emission was observed using a fluorescence 
optical microscope. [114]
A second indirect assay was conducted using the 
goat anti-rabbit IgG labelled with the succinimidyl ester 
derivative of [R u (bpy)^ (4,4'-COOHbpy) ] .  After 
incubation with the primary and secondary antibodies and 
after various washing steps to remove unbound material, 
bright red/orange emission was viewed under the microscope. 
These two assays demonstrated that immunological activity was 
retained after conjugation of the ruthenium complex to the 
antibodies. [114]
An esterified ruthenium(II) dicarboxylic acid 
complex conjugated to bovine serum albumin was detected using 
electrochemiluminescent techniques. Light intensity 
measurements were carried out by applying a potential of -2.0 
V (vs Ag wire) and detecting the emitted light with a 
Hamamatsu 928 photomultiplier followed by integration of the 
signal. Ruthenium concentrations of 1x10  ^ M were 
detected using this method.
The dichloromethy1 complex was conjugated to 
rabbit and sheep anti-IgG and retention of immunological 
reactivity was demonstrated by fluorometric analysis. The 
excitation wavelength used was 455 nm and emission was 
monitored at 623 nm. This experiment involved incubating a
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suspension of Legionella pneumophilia with a primary mouse 
monoclonal IgG antibody. A preparation of pooled 
rabbit/sheep anti-IgG antibody labelled with the ruthenium 
dichloromethyl complex was then added. After appropriate 
incubation and centrifugation steps, the Legionella 
pneumophilia cells were resuspended in buffer and transferred 
to a polystyrene cuvette for fluorimetric analysis at 
623 n m . Fluorescence was observed, demonstrating retention 
of immunological activity. [114]
Weber has described the use of some ruthenium
complexes in photoelectrochemical immunoassays which bind to
the amino groups on the analyte through a thiourea linkage
2 +using [R u (bpy)2(4,4'-isothiocyanato-2,21-bipyridine)] 
and also reports the use of the ester of 3-0-morphinyl ester 
of [R u (bpy)2(4,41COOHbpy)]2+ as a label for the 
determination of morphine. [128] In the photoelectrochemical 
immunoassay, the label transfers an electron to a quencher 
upon photoexcitation and the oxidised molecule is 
subsequently reduced with an electron from an electrode of 
the flow cell which is held at a suitable potential. This 
electron is measured as photocurrent. The amount of free 
labelled analyte is determined by the photocurrent signal.
The use of ruthenium bathophenanthroline complexes 
to label oligonucleotides has been described. The complexes 
have been linked to oligonucleotides via an amino group or 
via a phosphodiester linkage. The compounds of the type 
presented in Figure 1.39, which are bound to the
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synthetically prepared 5 1N^-modified fragments of DNA via 
the amino group, are firstly converted to the esterified 
derivative before coupling. [80]
Figure 1.39 Bathophenanthroline Ru (II) complexes which are 
converted to the hydroxysuccinimide ester before 
conjugation to oligonucleotides.
The coupling products exhibit the characteristic MLCT
absorption band of ruthenium polypyridyl complexes at about
450 nm and the maximum wavelength of emission is
approximately 616 nm, when measured in phosphate buffer
saline. The conjugates were measured by time-resolved
-14fluorescence and the detection limit was below 10 M.
The decay lifetimes were monitored in the presence of 
additives such as detergents, salts and reducing agents and 
longer lifetimes were observed. Increased lifetimes of the. 
order of up to 7.5 fisec were reported, compared to a lifetime 
of about 2.0 ^sec in the absence of any additive. [80]
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Ruthenium bathophenanthroline compounds have been used as 
non-radioactive labels for dideoxy DNA sequencing. [78] The 
ruthenium bathophenanthroline complex shown in Figure 1.39 
has been coupled to nucleotides directly in the course of 
their synthesis via a phosphodiester linkage. [79] This 
approach offers a number of advantages over the previous 
method for coupling the bathophenanthroline complexes to 
synthetic DNA fragments, including that functionalisation of 
the DNA with a primary amino group is not necessary, making 
the coupling procedure easier and more rapid to perform.
The use of hydroxysuccinimide esters, 
chloroformate, isothiocyanate and sulphonyl chloride 
derivatives of ruthenium polypyridyl complexes has been 
reported. [104] These complexes were conjugated to anti-TSH 
(thyroid stimulating hormone) and human IgG, and may be 
employed in time-resolved immunoassay techniques.
The use of ruthenium polypyridyl complexes has one 
major advantage over the use of the lanthanide EDTA 
chelates. In contrast to the lanthanide chelates where prior 
to fluorimetric analysis, the chelates must be destroyed and 
the lanthanide ion has to be embedded into liposomes in order 
to be detected. Fluorescence measurements may be carried out 
directly using the ruthenium(II) polypyridyl complexes.
This thesis describes the synthesis of various 
ruthenium polypyridyl complexes which were coupled covalently 
to albumins, antibodies and poly-L-lysine. Various binding 
methods have been employed to couple the reporter complex to 
the proteins: (a) via the £ -amino group of lysine residues
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using ruthenium complexes containing an isothiocyanate group 
and via the active ester of a dicarboxylic acid complex; (b) 
via the carbohydrate moieties of glycoproteins by reaction 
with a ruthenium polypyridyl amino complex after periodate 
oxidation of the carbohydrate moieties of the proteins and 
(c) via tyrosine and possibly histidine residues of proteins 
by reaction with the diazotised derivative of the amino 
ruthenium complex.
The effect of binding on the immunological 
activity, where relevant, the absorption and emission spectra 
and on the emission lifetimes of the conjugates is 
investigated.
The compounds have been characterised using 
various techniques including NMR, electrochemistry and 
absorption / emission spectroscopy. The emission decay 
lifetimes of the unbound complexes were also measured and are 
compared to those of the protein bound ruthenium complexes.
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CHAPTER 2
MATERIALS and METHODS
2.1 Synthesis.
2.1.1 Preparation of the complexes cis- [Ru(L-L)2 
(NH2p y )212+f [Ru(L-L)2 (NH2phen)]2+ and 
[Ru(L-L)2 (COOHbpy)]2+.
where L-L = 1,10-phenanthroline (phen) or 2,2'-bipyridine 
(bpy), NH2phen = 5-amino-l,10-phenanthroline, NH2py =
4-amino-pyridine and COOHbpy = 4,4'-dicarboxylic acid 
-2 ,2 '-bipyridine.
The complexes were prepared according to literature methods. 
[ 1 ]
2.1.1.1 [Ru(bpy)2 (NH2py)2 ](PF6 )2 .CH3COCH3 . (1)
Yield 680 mg (72%). Found C,41.66; H,3.62; N,11.76. 
Calculated C,41.72; H,3.58; N, 11.80%.
'*'H NMR; [(CD3)2CO]: 2 , 2 1-bipyridine ligand, 8.57-8.68
(H3/H3 '); 7.98-8.04, 8.22-8.28 (H4/H4 '); 7.43-7.48,
7.90-7.95 (H5/h5 '); 8.15-8.17, 9.24-9.26 (H6/H6 ').
2 34-amino-pyridine ligand, 7.89-7.92 (H ); 6.58-6.60 (H );
6.26 (NH2 ).
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Yield 700mg (75%). Found C,43.40; H, 3.04; N, 10.37. 
Calculated C, 43.36; H, 3.02; N, 10.57%.
NMR; [(CD3 )2CO]: 2,2'-bipyridine ligand, 8.80-8.86,
(H3 ); 8.12-8.28 (H4 ); 7.40-7.48, 7.59-7.68 (H5/H5 '; 
7.87-7.93, 8.12-8.20, (H6/H6 ').
2 35-amino-l,10-phenanthroline ligand, 7.96 (H ); 7.66 (H );
8.3 5 (H4 ); 7.31 (H6 ); 8.95 (H7 ); 7.88 (H8 ); 8.39 
(H9 ); 6.43 (NH2 ).
2.1.1.3 [Ru(phen)2 (NH2phen)](PFg )2. (3)
Yield 650 mg (69%). Found C, 45.16; H, 2.67; N, 10.28. 
Calculated C, 45.66; H, 2.63; N, 10.36%.
NMR; [(CD,)2CO]: 1,10-phenanthroline ligand,
7.84-7.88, 8.35-8.44 (H2/H9 ); 7.77-7.89 (H3/H8 );
8.76-8.82 (H4/H7 ); 8.42 (H5/H6 ).
25-amino-l,10-phenanthroline ligand, 7.92 (H ); 7.53 
(H3 ); 8.32 (H4 ); 7.31 (H6 ); 8.93 (H7 ); 7.75 (H8 );
8.3 6 (H9 ); 6.43 (NH2 ).
2.1.1.4 [Ru(bpy)2 (bdd)](PFg )2 . (4)
This complex was kindly donated by Joe Bolger, Dublin City
2.1.1.2 [Ru(bpy)2 (NH2phen)](PFg )2 . 1/2
CH3COCH3 . (2)
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University. The ligand bdd = 2,3-butanedionedihydrazone.
2.1.1.5 Preparation of the isothiocyanate derivatives of (1) 
to (4 ) .
The amino complex (0.2 mmol) in 10 ml distilled water was
stirred in the presence of an anion exchange resin (Amberlite
exchange resin Cl , which had been treated with 2 M NaOH,
washed thoroughly and then treated with 2 M HC1 and washed
thoroughly again) to exchange the PF^ anion for Cl
ions until the compound became soluble in the aqueous
solution. The solution was filtered, to remove the resin.
The dichloride compound was then reacted with thiophosgene,
0.01 mol in acetone (10 ml), which was added dropwise to the
aqueous solution over 30 m ins. During' this time the reaction
vessels were kept in an ice-bath, to inhibit the evaporation
of the thiophosgene.
After addition was complete, the reaction was
allowed to proceed at room temperature overnight in a covered
2 +vessel. The complex [R u (phen)^ (NCSphen)] which 
precipitated, was isolated by filtration and dried under 
vacuum. The other complexes remained in solution and were 
isolated by evaporation of the excess thiophosgene under 
reduced pressure, followed by precipitation using a saturated 
aqueous solution of NH^PFg. The compounds were dried 
under vacuum. All procedures were carried out with care due 
to the toxicity of thiophosgene. Gloves were worn and due to
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the volatility of the thiophosgene, each stage was carried out 
in a fume-hood.
2.1.1.6 Diazotisation of compounds (2) and (3).
These amino complexes were diazotised according to the method 
described by Sundberg et al. [2]
The amine complexes (0.1 mmol) were dissolved in 1:1 
1^0 : acetone (2 ml); 0.5 ml conc. HC1 was added and the
mixture cooled to 0°C in an ice bath. Cold 0.5 M NaNC^
(0.25 ml, 0.125 mmol) was added dropwise with stirring at 
0°C and the reaction allowed to proceed for 1 hour at 
0°C. Urea (3 mg, 0.05 mmol) was added to destroy excess
NaNC^ and the mixture was filtered. The filtrate was
neutralised by the addition of solid NaHCO^ to pH 7.5. The 
solution was made up to 5 ml with cold distilled £^0.
2.1.1.7 [R u (bpy)2 (COOHbpy)](PPg )2 .
The ligand 4,4'-dicarboxylic acid-2,21 bipyridine was prepared 
from 4 ,4'-dimethyl-2 ,2 1 bipyridine according to literature 
methods. [3]. Synthesis of the ruthenium complex (a) and its 
conversion to the active ester (b) were carried out according 
to Bard. [4]
(a) Sodium bicarbonate (6 mmol), [Ru(bpy)2CI2]• 2 ^ 0  
(1 mmol), and 4 ,4 '-dicarboxylic acid-2 ,2 'bipyridine (1.2 mmol)
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were heated at reflux in methanol (80 ml) / R^O (20 ml) for 
9 hours. The solution was then cooled in an ice bath, 
treated with 5 drops conc. and allowed to stand at
ice bath temperature for 1.5 hours. A precipitate formed 
which was separated by filtration and washed with methanol 
(10 ml).
The filtrate and wash solution were combined and
were treated with a saturated aqueous solution of
NH.PF,. The resulting solution was cooled in an ice bath 4 b
and the precipitate was collected. Yield 620 mg, (65%)
(b) Dicyclohexylcarbodiimide (DCC, 0.046g) and
N-hydroxysuccinimide (0.034g) were dissolved in 
dimethylformamide (DMF), 2 ml, with stirring and cooled in an 
ice bath. A solution of [R u (bpy)2(COOHbpy)](PF^ )^
(0.10g, 0.1 mmol) in 1 ml DMF was then added and the mixture
stirred for 5 hours, at ice bath temperature. Any 
precipitate which formed was removed by centrifugation. The
supernatant was retained for conjugation procedures.
2.1.2 Ligand preparation.
The following four ligands were obtained from and prepared by 
Ronald Hage, [5], according to literature methods.
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2.1.2.1 3-(pyridin-2-yl)-1H-1,2,4-triazole. (Hptr)
M.P.; 158-160°C. (lit.[6 ] 164-165°C.). 1HN.m.r.;
[(CD3) S0]f 14.62 (N-H), 8.70 (H6 ), 8.27 (H5 '), 8.09 
(H3), 7.98 (H4 ) and 7,51 (H5 ). 13C; [CDCl-j], 154.8
(C3 '), 151.8 (C5 '), 146.6 (C2 ), 137.8 (C4 ), 125.0 
(C^) and 121.9 (C3 ) p.p.m..
2 .1.2.2 4-Methy1-3-(pyridin-2-yl)-4H-1,2,4-triazole.
(4Mptr)
M.P.; 9 6-9 9°C. (lit.[7] 104-105°C.). 1HN.m.r.;
[(CD3)2SO], 8.66 (H6 ), 8.62 (H5 ), 8.11 (H3 ), 7.95 
(H4 ), 7.47 (H5 ) and 3.99 (CH3 ). 13C; [CDC13 ], 33.4
(CH3 ), 122.8 (C3 ), 124.2 (C5 ), 137.4 (C4 ), 147.2 
(C5 '), 147.5 (C2 ), 149.0 (C6 ) and 151.1 (C3 ') p.p.m..
2 .1. 2.3 3-Methy1-5-(pyridin-2-yl)-1H-1,2,4-triazole. 
(H3Mptr)
M.P.; 163-165°c .(lit.[8] 165-166°C ). 1H N.m.r.;
[(CD )2SO], 14.2 (N-H), 8.83 (H6 ), 8.02 (H3 ), 7.90 
(H4 ), 7.43 (H5 ) and 2.36 (CH3 ). 13C; (CDC13), 13.0
(CH3 ), 121.6 (C3 ), 124.3 (C5 ), 137.3 (C4 ), 147.5
(C2 ), 149.2 (C6 ), 156.5 (C3 ') and 158.5 (C5 ') p.p.m..
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2.1.2.4 l-Methyl-3-(pyridin-2-yl)-l,2,4-triazole.
(IMptr)
M.P.; 51-54°C.(lit.[9] 47-48°C.) 1HN.ra.r.; 
t(CD3)2SO], 8.66 (H6 ), 8.61 (H5), 8.16 (H3 ), 7.91 
(H4 ), 7.43 (H5 ) and 3.97 (CH3 ). 13C; (CDC13 ), 36.1
(CH3), 121.4 (C3 ), 123.8 (C5 ), 136.9 (C4 ), 145.8 
(C5 '), 149.5 (C6 ), 149.7 (C2) and 161.2 (C3 ')
p.p.m . .
2.1.3 Preparation of complexes of the type cis-[Ru(L-L)2
— (L-L1)]2+.
(L-L) = 4,4'-dimethyl-2-2 1 bipyridine, (dmbpy) or
1,10-phenanthroline, (phen). (L-L') = Hptr, H3Mptr, IMptr, 
or 4Mptr.
Hydrated ruthenium trichloride was obtained as a loan from 
Johnson Matthey and used without further purification. The 
complexes cis-[ Ru (dmbpy) 2C 12 2H2° anc  ^
cis-[Ru(phen)2C12 ].2H20 were prepared according to 
literature methods. [10,11]
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2.1.3.1 [Ru(dmbpy)2 (Hptr)](PFg)2 .H20. (1)
The complex cis-[ Ru ( dmbpy) 2 ^ 2  ' ^ H2° ^  was Seated
at reflux in water - ethanol (1 :1 ) in the presence of excess
pyridyl triazole ligand (1.2 mM) for four hours. In order to
ensure complete protonation of the bound ligand, 1-2 drops
conc. HCl were added. The solvent was removed by rotary
evaporation and the remaining residue was dissolved in 5 ml
water and added dropwise to an aqueous solution of
NH^PFg. The resulting precipitate was filtered and
purified by recrystallisation from acidic (HCl) mixtures of
acetone - water. Yield 730 mg (79%). Found C,40.28; H,3.64;
N,11.76. Calculated C,40.3; H,3.46; N ,12.13%.
Isomers were separated using semi-preparative HPLC (Section
2.2.5) and amounts up to 100 mg were isolated.
N.m.r.; [(CD^^CO] acidified with one drop conc.
5 'DC1. Isomer 1 : Pyridyltriazole ligand, 8.38 (H ), 8.26
(H3 ), 7.94 (H4 ), 7.30 (H5 ), 7.62 (H6 ).
4 , 4 1-dimethyl-2,2'-bipyridine ligand, 2.38-2.41 (CH^),
8.29-8.31 (H3 ), 7.08-7.22 (H5 ), 7.55-7.77 (H6 ).
5 1 3Isomer 2 : Pyridyltriazole ligand, 8.66 (H ), 8.22 (H ),
7.98 (H4 ), 7.32 (H5 ), 7.69 (H6 ). 4,4'-dimethyl-2,2'
-bipyridine ligand, 2.38-2.40 (CH^)* 8.27-8.32 (H3 ),
7.09-7.21 (H5 ), 7.52-7.64 (H6 ).
1H N.m.r.; [(CD3 )2CO] with one drop conc. NaOD.
5' 3Isomer 1 : Pyridyltriazole ligand, 7.47 (H ), 8.20 (H ),
7.91 (H4 ) , 7.19 (H5 ), 7.53 (H6 ).
4,41-dimethyl-2,21-bipyridine ligand, 2.45-2.55 (CH^)*
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8.37-8.41 (H3 ), 7.15-7.28 (H5 ), 7.57-7.73 (H6 ).
Isomer 2 : Pyridyltriazole ligand, 7.97 ( ) ,  7.98 (H3 ),
7.82 (H4 ), 7.12 (H5 ), 7.53 (H6 ). 4 #4 1-dimethyl-2,21 
-bipyridine ligand, 2.37-2.39 (CH^), 8.21-8.28 (H3 ), 
7.04-7.16 (H5 ), 7.36-7.60 (H6 ).
2.1.3.2 [Ru(dmbpy)2 (H3Mptr)](PFg )2 .2H20. (2)
This compound was prepared as for (1). Yield 633 mg (64%). 
Found C,39.41; H,3.58; N,11.55. Calculated C,40.21; H,3.77; 
N, 11.73% .
Isomers were separated as for (1) in mg quantities. "'"H 
N.m.r.; [(CD^^CO] acidified with one drop conc. DC1.
3Isomer 1 : Pyridyltriazole ligand, 1.62 (CH^), 8.16 (H ), 
7.89, (H4 ), 7.23 (H5 ), 7.83 (H6 ). 4 , 4 1-dimethyl-2,2-
bipyridine ligand, 2.37-2.42 (CH^), 8.27-8.31 (H3),
7.10-7.18 (H5 ), 7.49-7.63 (H6 ).
3Isomer 2 : Pyridyltriazole ligand, 2.44 (CH^), 8.14 (H ), 
7.97 (H4 ), 7.31 (H5), 7.55 (H6 ). 4 , 4 '-dimethyl-2,2'
-bipyridine ligand, 2.40-2.42 (CH^), 8.28-8.33 (H3 ),
7.10-7.24 (H5 ), 7.51-7.71 (H6 ).
1H N.m.r.,* [ (CD^) 2CO ] with one drop conc. NaOD.
Isomer 1 : Pyridyltriazole ligand, 1.37 (CH^), 8.00 (H3), 
7.78 (H4 ), 7.07 (H5 ), 7.43 (H6 ). 4,4 '-dimethyl-2,2'
-bipyridine ligand, 2.37-2.40 (CH^), 8.24-8.28 (H3 ),
7.09-7.18 (H5 ), 7.51-7.61 (H6 ).
3 4Isomer 2 : Pyridyltriazole ligand, 7.91 (H ), 7.81 (H ),
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7.09 (H5 ), 7.50 (H6 ). 4,41-dimethyl-2,21-bipyridine
ligand, 2.37-2.39 (CH3 ), 8.21-8.30 (H3 ), 7.09-7.19 
(H5 ), 7.44-7.57 (H6 ).
2.1.3.3 [Ru(dmbpy)2 (lMptr)](PFg)2 .2H20 . (3)
This compound was prepared as described for (1), without the 
addition of conc. HC1 whilst heating at reflux, since the 
complex does not undergo protonation / deprotonation 
processes. Yield 680 mg (69%). Found C,40.35; H, 3.63; N,
11.37. Calculated C, 40.21; H, 3.77; N, 11.73%
Isomers were separated as for 1. in mg quantities.
Isomer 1 : N.m.r., [(CD.^CO]: Pyridyltriazole
ligand, 8.69 (H5 '), 4.08 (CH3 ), 8.40 (H3 ), 8.16 (H4 ),
7.53 (H5 ), 7.89 (H6 ). 4,4'-dimethyl-2,21-bipyridine 
ligand, 2.55-2.58 (CH3 ), 8.62-8.69 (H3 ), 7.31-7.42 
(H5 ), 7.81-7.96 (H6 ).
Isomer 2 : N.m.r., [(CD3 )2CO]: Pyridyltriazole
ligand, 8.78 (H5 '), 3.44 (CH3 ), 8.45 (H3 ), 8.20 (H4 ),
7.54 (H~*), 7.89 (H^). 4,4'-dimethyl-2,2'-bipyridine 
ligand, 2.55-2.59 (CH3 ), 8.62-8.78 (H3 ), 7.40-7.45 
(H5 ), 7.75-8.02 (H6 ).
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2.1.3.4 [Ru(dmbpy)£ (4Mptr)](PFg)2• (4)
This compound was prepared as for (3). Yield 700 mg (76%). 
Found C, 41.48; H, 3.57; N # 11.91. Calculated C, 41.78; H, 
3.48; N, 12.19%
1H N.m.r., [(CD^^CO]; Pyridyltriazole ligand, 8.75 
(H5 '), 4.39 (CH3 ), 8.60 (H3 ), 8.20 (H4 ), 7.57 (H5),
8.09 (H^). 4,41-dimethyl-2,21-bipyridine ligand, 2.56-2.58
(CH3), 8.58-8.68 (H3 ), 7.31-7.43 (H5), 7.75-7-94 
(H6 ) .
2.1.3.5 [Ru(phen)2 (Hptr)](PFg)2• (5)
This compound was prepared as for (1). except that cis-
[Ru(phen)2Cl2 ].2H20 was used instead of cis-[Ru
(dmbpy)2C12].2H20. Yield 694 mg (77%). Found C, 41.74;
H, 2.80; N, 12.08. Calculated C, 41.56; H, 2.46; N, 12.51%.
Isomers were separated as for 1. in amounts up to 100 mg.
1H N.m.r., [(CD3 )2CO] with one drop conc. DC1.
5 1 3Isomer 1 : Pyridyltriazole ligand, 8.37 (H ), 8.34 (H ),
8.01 (H4 ), 7.24 (H5 ), 7.61 (H6 ). Phenanthroline 
ligand, 7.46-7.85 (H3 ), 7.96-8.36 (H2 ), 8.44-8.65 (H4 ),
8.15-8.20 (H5 ).
5' 3Isomer 2 : Pyridyltriazole ligand, 8.65 (H ), 8.31 (H ),
8.01 (H4 ), 7.26 (H5 ), 7.77 (H6 ). Phenanthroline ligand, 
7.93-8.38 (H2 ), 7.47-7.85 (H3 ), 8.45-8.65 (H4 ),
8.15-8.19 (H5 ).
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■*"H N.m.r., [(CD^-pCO] with one drop conc.NaOD.
Isomer 1 : Pyridyltriazole ligand, 7.43 ( ) ,  8.18 (H3 ), 
7.87 (H4 ), 7.06 (H5), 7.51 (H6 ). Phenanthroline ligand, 
7.95-8.38 (H2 ), 7.45-7.82 (H3 ), 8.42-8.60 (H4 ),
8.13-8.17 (H5 ).
5 1 3Isomer 2 ; Pyridyltriazole ligand, 7.95 (H ), 8.07 (H ), 
7.86 (H4 ), 7.05 ( ) ,  7.54 (H^). Phenanthroline ligand,
7.90-8.32 (H2 ), 7.43-7.81 (H3 ), 8.39-8.57 (H4 ),
8.11-8.16 (H5).
2.1.3.6 [Ru(phen)2(H3Mptr)](PF6 )2 .2H20. (6 )
This compound was prepared as for (5). Yield 760 mg (81%). 
Found C, 40.56; H, 3.01; N, 11.35. Calculated C, 40.54; H, 
2.96; N, 11.82%.
Isomers were separated as for (1) in mg quantities.
N.m.r., [CD3)2CO] with one drop conc. DCl.
Isomer 1 : Pyridyltriazole ligand, 1.37 (CH^), 8.25 (H3 ), 
7.93 (H4 ), 7.18 (H5 ), 7.53 (H^). Phenanthroline ligand, 
7.98-8.48 (H2 ), 7.44-7.84 (H3 ), 8.56-8.63 (H4 ),
8.14-8.20 (H5 ).
Isomer 2 : Pyridyltriazole ligand, 2.35 (CH^)/ 8.20 ( H^^ 
8.00 (H4 ), 7.24 (H5 ), 7.68 (H6 ). Phenanthroline ligand, 
7.92-8.45 (H2 ), 7.47-7.86 (H3 ), 8.45-8.65 (H4 ),
8.16-8.20 (H5 ).
1H N.m.r., [(CD3 )2CO] with one drop conc. NaOD.
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Isomer 1 ; Pyridyltriazole ligand, 1.10 (CH^), 8.10 (H3),
7.82 (H4 ), 7.01 (H'5), 7.42 ( )  . Phenanthroline ligand,
7.42-7.82 (H3), 8.39-8.58 (H4 ), 8.12-8.16 (H5 ).
Isomer 2; Pyridyltriazole ligand, 2.15 (CH^), 8.00 (H3 ), 
7.84 (H4 ), 7.02 (H5 ). 7.51 (H6 ). Phenanthroline ligand, 
7.89-8.30 (H2), 7.43-7.82 (H3 ), 8.38-8.57 (H4 ),
8.09-8.15 (H5).
2.1.3.7 [Ru(phen)2 (lMptr)](PFg )2. (7)
This compound was prepared as for (3) except that cis-[Ru 
(phen)2C 12 ].2H20 was used instead of cis- 
[Ru(dmbpy)2C12 ].2H20. Yield 715 mg (78%). Found C,
42.14; H, 2.80; N, 11.99. Calculated C, 42.15; H. 2.63; N, 
12.29%.
Isomers were separated as for (1) in mg quantities.
Isomer 1 : 1H N.m.r., [(CD3 )2CO]. Pyridyltriazole 
ligand, 8.64 (H5 '), 4.03 (CH3 ), 8.46 (H3 ), 8.17 (H4 ),
7.42 (H5 ), 7.87 (H6 ). Phenanthroline ligand, 8.24-8.70 
(H2), 7.66-8.04 (H3), 8.71-8.91 (H4 ), 8.37-8.41 (H5 ). 
Isomer 2 : 1H N.m.r., [(CD3 )2CO].- Pyridyltriazole 
ligand, 8.77 (H5 ' ^  3<25 (CH3 ), 8.58 (H3 ), 8.20 (H4 ),
7.43 (H5 ), 7.86 ( ) .  Phenanthroline ligand, 8.19-8.59 
(H2 ), 7.73-8.07 (H3), 8.66-8.93 (H4 ), 8.39-8.45 (H5 ).
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2.1.3*8 [Ru(phen)2 (4Mptr)](PF6 )2 (8)
This compound was prepared as for (7). Yield 698mg (77%). 
Found C, 42.19; H, 2.76; N, 12.09. Calculated C, 42.15; H, 
2.63; N, 12.29%.
1H N.m.r., [(CD3 )2CO]. Pyridyltriazole ligand, 8.69 
(H5 '), 4.39 (CH3 ), 8.64 (H3 ), 8.20 (H4 ), 7.46 (H5 ),
8.09 (H^). Phenanthroline ligand, 8.10-8.60 (H2 ), 
7.67-8.09 (H3), 8.67-8.85 (H4 ), 8.35-8.41 (H5 ).
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2.2 Instrumentation.
2.2.1 Absorption and emission measurements.
UV/vis spectra or set wavelength measurements were obtained 
using either a Shimadzu UV 24 instrument or a Hewlett Packard 
8452A Diode Array spectrometer. Absorption coefficients are 
accurate to 5%. Emission spectra were obtained on a 
Perkin-Elmer LS-5 luminescence spectrometer equipped with a 
red sensitive Hamamatsu R 928 photomultiplier tube. An 
emission slit width of 10 nm was used at room temperature and 
2.5/5 nm at 77 K and the results were not corrected for 
photomultiplier response.
2.2.2 pK and pK * measurements.
cl ci
Sample measurements were carried out in Britton-Robinson 
buffer (0.04 M boric acid, 0.04 M acetic acid and 0.04 M 
phosphoric acid). The pH of the solutions was adjusted using 
a 2 M NaOH solution. Luminescence titrations were carried 
out using an appropriate isosbestic point as the excitation 
wavelength. To facilitate dissolution of samples in aqueous 
solutions a minimal volume of acetone (<2 ml), was added. 
Measurements were carried out at room temperature.
Absorption and emission intensities were monitored 
as a function of pH. The pK values (from absorption
cl
titration data) and pH^ (from inflection point on the
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emission titration curve) values were determined using a 
program developed by Boris Fennema and Renyi Wang at DCU for 
a BBC microcomputer. The pK * (excited state pK ) values,
a . a.
were then determined using the equations given in Chapter 5.
2.2.3 Electrochemical measurements.
Cyclic voltammetry (CV) and differential pulse voltammetry 
(DPV) were carried out with an EG&G Par 174A polarographic 
analyser and an EG&G Par 175 universal programmer. A 
saturated calomel electrode was used as the reference 
electrode. Measurements were carried out in spectroscopic 
HPLC grade CH^CN dried over molecular sieves and with 
0.01 M TEAP (tetraethylammoniumperchlorate) or TBAP (tetra- 
butylammoniumperchlorate) as supporting electrolyte. A 
glassy carbon was used as the working electrode and a 
platinum electrode as the auxiliary electrode. The 
electrochemical cell was a conventional three compartment 
cell. The solutions were degassed with nitrogen for 
measurements conducted below 0.0 V. The scan rate was 100 
mV/s for the CV mode and 5 mV/s for the DPV mode. The pulse 
height in DPV measurements was 25 mV. Measurements were 
carried out at room temperature.
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2.2.4 High Performance Liquid Chromatography (HPLC).
A Waters 990 Photodiode array HPLC system was employed, in 
conjunction with a NEC APClll computer, a Waters pump model 
6000 or 501, a 20 |Lllitre injector loop and a fXPartisil SCX 
radial PAK cartridge. The mobile phases used were (a)
CH^CN : H20 (80 : 20) containing 0.08 M LiCl04 (about 
pH 6-7); (b) mobile phase (a) adjusted to pH 2-3 with 
HCIO^. The flow rate was 2.5 ml/min.
2.2.5 Semi-preparative HPLC.
An Applied Chromatography Services pump (model RR/066), de­
tector (model 750/11 uv/vis), a 1 ml injection loop and a 
Magnum 9 Partisil cation exchange column (10 mm/25 cm) was 
used. The mobile phase was CH^CN : H^O (80:20) 
containing 0.08 M LiClO^. The flow rate used ranged from 
4.0-6.0 ml/min.
2.2.6 Infra-red spectra.
Infra-red spectra were recorded on a Perkin-Elmer 983G 
Infrared Spectrometer using pressed KBr discs. This 
technique was used to check for the presence of the 
isothiocyanate group in the complexes which were subsequently 
used for conjugations to biomolecules. [12]
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2.2.7 NMR spectroscopy.
NMR spectra were recorded on a Jeol JNM-FX 200 NMR 
spectrometer. The measurements have been carried out in 
(CD^^CO. The peak positions are relative to TMS. For 
the COSY experiments 256 FID's of eight scans each, 
consisting of IK data points were accumulated. After digital 
filtering (sine bell squared), the FID was zero filled to 512 
W in the F^ dimension. Acquisition parameters were F^ =
+/- 500 Hz and = 0-001 sec; the cycle time was 1.5 s.
These measurements were carried out at Leiden 
University, The Netherlands.
2.2.8 Lifetime measurements.
The lifetimes of the complexes employed in conjugation 
procedures were measured using the time correlated single 
photon counting technique and were carried out at the 
University of Dublin, Trinity College, Dublin. These 
lifetimes were measured on an Edinburgh Instruments Fl 900 
fluorescence spectrophotometer. Instrumental conditions : ns 
flash lamp, N2 filled to 0.3 bar, electrode gap 1.5 mm, 
applied voltage 0.5 kV, frequency (pulse rate) 30,000 Hz.
The N2 emission line at 337 nm was used to excite the 
complexes. The measurements were carried out in 0.1 M 
carbonate buffer, pH 9.6, at 23°C. The analysis was 
performed with non-linear programs and the quality of the fit 
was assessed by the chi squared value (X^) close to unity and
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by regular distribution of the residuals along the time axis. 
[13,14]
The lifetimes of the pyridyltriazole complexes 
described in Chapter 5 were measured by Renyi Wang in Tulane 
University, New Orleans, USA. The long lifetime components 
were measured using a Laser Photoionics LN 1000 MegaPlus 
Nitrogen Laser (excitation wavelength 337 nm, pulse width 600 
picoseconds). The short lifetime components were measured 
using the time correlated single photon counting system 
employing a mode locked, cavity dumped Ar+ laser for 
excitation (doubled dye output at 295 nm).
The ruthenium pyridyltriazole complexes were 
measured at room temperature, in Britton-Robinson buffer and 
the pH was adjusted using either conc. NaOH or conc.
H2SO4 and were degassed prior to measurement.
2.2.9 Elemental analyses.
Elemental analyses on C,H and N were carried out at the 
Microanalytical Laboratory at University College Dublin, 
Dublin.
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2.3 Biological procedures.
2.3.1 Buffers.
The buffers used were (a) 0.1 M carbonate buffer, pH 9.6, 
prepared from 0.1 M sodium carbonate / 0.1 M sodium hydrogen 
carbonate in distilled water? (b) 0.1 M phosphate buffer, pH
7.4, prepared from 0.1 M sodium dihydrogen phosphate / 0.1 M 
disodium hydrogen phosphate in distilled water; (c) 0.1 M 
citrate buffer, pH 4.3, prepared from 0.1 M citric acid / 0.1 
M sodium citrate in distilled water and (d) 0.1 M acetate 
buffer, pH 5.5, prepared from 0.1 M glacial acetic acid /
0.1 M sodium acetate in distilled water.
2.3.2 Conjugation Procedures.
2 +2.3.2.1 Conjugation of [R u (L-L)2 (NH^phen)] to 
albumins.
This involves firstly the periodate oxidation of the albumin 
which is followed by conjugation to the amino complex. BSA 
(bovine serum albumin), HSA (human serum albumin) or OVA 
(ovalbumin), 10-25 mg, was dissolved in 0.1 M NaHCO^
(1-2 ml) and treated with 2.5 ml of 16 mmol NalO^ for two 
hours at 4°C in the dark. [15] The label solution was then 
added (50 molar excess) dropwise to the protein solution.
The ruthenium complex was dissolved in the minimum volume of
145
dimethylformamide (DMF) and 0.1 M carbonate buffer, pH 9.6, 
the total reaction volume was kept to a minimum. The 
conjugation reaction was allowed to proceed overnight at 
4°C, in the dark, with minimal agitation. Unbound 
ruthenium compound was then removed by extensive dialysis 
against 0.1 M carbonate buffer, pH 9.6, (at least 4 changes 
of buffer). The oxidation of the protein results in the 
formation of a Schiffs base which was then stabilised by the 
addition of 4 volumes of NaBH^ (5 mg/ml) and reacted for 
one hour at 4°C, in the dark. [15] Finally, the conjugate 
was dialysed against two changes of carbonate buffer.
2 +2.3.2.2 Conjugation of [Ru(bpy)2 (NH2phen)] to goat 
anti-mouse IgG.
The conjugation procedure is similar to that described in 
Section 2.3.2.1. 1-2 mg of pure goat anti-mouse IgG was used
per conjugation which was dissolved in 0.1 M acetate buffer, 
pH 5.5. The anti-IgG was oxidised using 1 ml of 10 mmol 
NaIC>4 . [16]
2.3.2.3 Conjugation of the active ester of [Ru(bpy)2~
2 +(COOHbpy)] to albumins and poly-L-lysine (PLL).
20 mg albumin / PLL was dissolved in 1-2 ml 0.1 M carbonate 
buffer, pH 9.6. The active ester solution (Section 2.1.1.7),
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was added dropwise in amounts which were equivalent to a 50 
molar excess of the ester to the albumin or PLL. The 
conjugation reaction was allowed to proceed overnight at 
4°C, in the dark, with minimal agitation. The conjugate 
was extensively dialysed against 0.1 M carbonate buffer, pH
9.6.
, 2 +2.3.2.4 Conjugation of [R u (L-L)2 (NCSphen)] and
2 +[R u (L-L)2(NCSpy)2 ] to albumins,
immunoglobulins and PLL.
Albumin / PLL (10-25 mg), pure goat anti-mouse IgG (1-2 mg), 
or 5 mg of the crude preparations of anti-mouse IgG and 
anti-BSA were dissolved in 1-2 ml 0.1 M carbonate buffer, pH
9.6. The ruthenium complex (50 molar excess) was dissolved 
in the minimum volume of DMF / 0.1 M carbonate buffer, pH 9.6 
(<2 ml) and added dropwise to the protein / PLL solution.
The conjugation reaction was allowed to proceed overnight at
4°C, in the dark, with minimal agitation. The resultant
solution was extensively dialysed against 0.1 M carbonate
buffer, pH 9.6, to remove unbound label.
The above describes the standard procedure used in
conjugations. In Section 4.2.3, Chapter 4, where BSA was
2 +labelled with [R u (bpy)^ (NCSphen)] and [Ru(bpy)2- 
2 +(NCSpy)] , conjugations were carried out at three 
different pHs and also using varying ratios of initial 
ruthenium : protein. The unbound label complex may also be
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removed by gel filtration chromatography using Sephadex G-25 
(bead size 50-150 |Xm, column size 1x25 cm3 ) and phosphate 
buffered saline (PBS), pH 7.4 as eluent. The flow rate was 
adjusted to 1-2 ml/min.
2.3.2.5 Conjugation of the diazotised complexes of
[Ru(bpy)2(NH2phen)]2 + and [Ru(phen)2 
2 +(NH2phen)] to albumins.
The diazotised material prepared according to Sundberg [2], 
and described in Section 2.1.3.6 , (50 molar excess) was added 
dropwise to solutions of BSA, OVA, HSA or PLL (10-25 mg) in 
carbonate buffer, pH 9.6, (1-2 ml), overnight at 4°C, in 
the dark, with minimal agitation. Unbound label was removed 
by extensive dialysis against 0.1 M carbonate buffer, pH 9.6.
2.3.3 Estimation of the conjugation ratio.
The amount of ruthenium complex present was determined by its 
absorption at A max. (approx 450 nm). The extinction 
coefficients of the unbound labels were previously measured 
in 0.1 M carbonate buffer, pH 9.6. No allowance was made for 
a change in the extinction coefficient upon binding to 
biomolecules. The protein concentration was determined using 
two methods described in Section 2.3.4. The conjugation 
ratio was estimated according to Nairn, [17] given by:
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moles F/moles P = x.A/Cp
where x = molecular weight of the protein / extinction 
coefficient of the label at X max.; A = absorbance of the 
label at X max.; Cp = protein concentration in mg/ml; F = 
fluorochrome and P = protein.
2.3.4 Determination of the protein concentration.
Two methods were used, the (a) Folin-Lowry method [18] and 
the (b) Bradford method [19]. A standard curve for each 
albumin, immunoglobulin and PLL (unconjugated) was prepared.
2.3.4.1 The Folin-Lowry method of protein determination.
Procedure:
Materials:
(1) Alkaline sodium carbonate solution (20 g/1 
Na2C03 in 0.1 M NaOH.
(2) Copper sulphate-sodium potassium tartrate 
solution (5 g/1 CuSO^. in 10 g/1 Na,K 
tartrate). Prepare fresh by mixing stock solutions.
(3) "Alkaline solution". Prepare on day of assay mixing, 50 
ml of (1 ) with 1 ml of (2 ).
(4) Folin-Ciocalteu reagent. Dilute the commercial reagent
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with an equal volume of water on the day of use. This 
is a solution of sodium tungstate and sodium molybdate 
in phosphoric and hydrochloric acid.
(5) Standard protein solution (for albumins and
immunoglobulins use 0.2 mg/ml; for PLL use 0.2 mg/ml).
Method:
Prepare a set of tubes at least in duplicate as follows:
Tube No. Protein Water Alkaline solution Folin-Ciocalteu
ml ml ml ml
1 ----  1.00 5.00 0.50
2 1.00 ----- 5.00 0 . 50
3 0.75 0.25 5 . 00 0 . 50
4 0.50 0.50 5 .00 0 .50
5 0.25 0.75 5.00 0.50
6 A suitable ----
dilution of 
unknown.
5 . 00 0 .50
After addition of "alkaline solution", allow the solution to 
stand at room temperature for 10 min. Add 0.5 ml of the 
diluted Folin-Ciocalteu reagent rapidly with immediate
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mixing. After 30 min, read the absorbance at 750 nm using
tube 1 as the blank. Prepare a standard curve and estimate
the protein concentration in the unknown sample.
2.3.4. 2 The Bradford method of protein determination.
Procedure:
Materials:
(1) Bradford reagent obtained from Bio-Rad as a 5x 
concentrate. Dilute 1 in 5 (200 ml dye plus 800 ml 
distilled water). Filter through Whatman No. 1 paper, 
store at room temperature for up to two weeks.
(2) Protein standard solutions in the range 0 to 140 ^ g/ml
in either PBS or 0.1 M carbonate buffer, pH 9.6. Use 0,
20, 35, 70, 100 and 140 jig/ml for the albumins. PLL 
requires a higher concentration range.
Method:
(1) Place 0.10ml of each sample or standard in a 
labelled test tube.
(2) Add 2.5ml of the diluted Bradford dye reagent.
(3) Vortex (avoid foaming) or mix by gentle inversion.
(4) Read absorbance at 595 nm after 5 and before 60 
minutes.
(5) Plot standard curve and estimate unknown.
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2.3.5 Enzyme-linked immunosorbent assay (ELISA).
This assay was conducted to determine whether the 
immunological activity of the immunoglobulins was retained 
after conjugation to the ruthenium complexes.
The wells of a 96 well Nunc maxisorb microtitre plate 
(obtained from Intermed Nunc, Denmark.) were coated overnight 
at 4°C with 100 M-l mouse IgG, 10 ^g/ml, for checking 
anti-IgG conjugates or BSA, 10 jxg/ml, for checking anti-BSA 
conjugates in phosphate buffered saline PBS, pH 7.4 . The 
plate was emptied by inversion and washed x3 with 
Tween-20/PBS (0.05% v/v) for 3 min. at room temperature. 
Blocking of free adsorption sites was achieved by the 
addition of 100 [ll lysine (1 mg/ml in Tween-20/PBS, 0.05% 
v/v) for 2 hours at 37°C. The plate was emptied and washed 
as before. Dilutions of samples and standards (positive 
controls) were prepared in PBS, (the samples used were the 
ruthenium labelled anti-IgG or anti-BSA conjugates and the 
standards were unconjugated anti-IgG or anti-BSA), 100 |xl of 
blank (PBS), sample or standard was added and incubated at 
37°C for 1 hour. The plates were emptied and washed as 
before. 100 JX1 of 1/750 dilution of rabbit anti-goat IgG 
(the ruthenium labelled anti-IgG and anti-BSA were raised in 
a goat) conjugated to horse radish peroxidase (HRP) was added 
to the wells and incubated for two hours at room 
temperature. The plates were emptied and washed. The HRP 
substrate was freshly prepared and consisted of 10 mg 
ortho-phenylenediamine (OPD) in 0.5 M Na 2 HPO^ and 0.1 M
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citric acid, pH 5.0. 5 jLt 1 H2°2 was to
substrate solution just prior to addition to the microtitre
plate. The plate was incubated for 30 min at room
temperature. 50 (.11 H2SO^ (20% v/v) was added to each
well to stop the reaction. The absorbance was read at 414 nm
using an ELISA reader, (Titertek twinreader plus). [15]
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CHAPTER 3
SYNTHESIS AND CHARACTERISATION OF RUTHENIUM 
POLYPYRIDYL AMINO AND ISOTHIOCYANATE COMPLEXES.
3.1 Introduction.
ruthenium polypyridyl amino and isothiocyanate compounds which
were used in conjugations to biomolecules are described. These
2 +compounds are [ R u (bpy)^ (NH2py )2 ] ,
[R u (bpy)2 (NCSpy ) 2 ] 2 + , [R u (bpy)2 (NH2phen)]2+,
[Ru(bpy)2(NCSphen)]2+, [R u (phen)2 (NH2phen) ] and
2 +[Ru(phen)2 (NCSphen)] . (See Figure 3.1 for ligand 
abbreviations).
The compounds have been characterised using HPLC, 
NMR, UV/vis spectroscopy, electrochemistry and emission 
spectroscopy.
3.2 Preparation of compounds of the type [Ru(L-L)2
(NH2py)2 )]2+ and [Ru(L-L)2 (NH2phen)]2+.
L-L = 2-2'bipyridyl(bpy) or 1,10-phenanthroline (phen);
Nl^py = 4-aminopyridine and Nf^phen = 5-amino-l,10-
phenanthroline . The compounds were prepared based on
literature methods [1]. Reaction of cis-[ Ru (bpy) 2C 1-? ] •
2 ^ 0  [2 ], with a 10-fold molar excess of NH2py yielded the
compound [R u (bpy)2 (NH2p y )2 ]2+ . Reaction of
cis-[Ru(L-L)2Cl2 ]■2H20 [3,4], with equimolar amounts of
2 +NH2phen yielded the compound [R u (L-L)^ (Nt^phen)]
The compounds were isolated as the divalent cations with 
PFg- as the counter ion.
In this chapter, the synthesis and characterisation of some
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For the compound [R u (bpy)2 (NH2p y )2 ](PFg)2 , two of
the NH2py ligands are coordinated to the ruthenium via the
nitrogen on the pyridine rings. For the complexes
[Ru(bpy)2 (NH2phen)](PFg)2 and [Ru (phen)2 (NH2~
phen)](PFg)2, only one NH2phen ligand is coordinated to
the ruthenium, via the N^ and positions of the
NH2phen ligand.
The isothiocyanate derivatives of these three
compounds were prepared by reaction with thiophosgene, (See
2 +Section 2.1.1.5, Chapter 2). The [R u (bpy)2 (NCSpy)2 ]
2+and [R u (bpy)2 (NCSphen)] compounds were isolated as the 
divalent cations with PF, as the counter ion.O
2 +[Ru(phen)2 (NCSphen)] was isolated as the dichloride 
salt.
2-2 1-bipyridyl 1 ,10-phenanthroline
(bpy) (phen)
NH, JNH, 
( # 1 ° )
4-aminopyridine 5-amino-l,10-phenanthroline
(NH2py) (NH2phen)
Figure 3.1 Structures and abbreviations of the bipyridyl,
iphenanthroline and pyridine ligands.
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3.3 High Performance Liquid Chromatography (HPLC).
The purity of the amino and isothiocyanate compounds was 
analysed using the HPLC method described in Section 2.2.4, 
Chapter 2. The retention time of each compound is listed in 
Table 3.1.
Table 3.1: Retention times for the ruthenium polypyridyl
amino and isothiocyanate compounds.
Compound Retention Time (min)
[Ru(bpy)2 (NH2py)2 ](pF g )2 2 .72
[Ru(bpy)2 (NCSpy)2 ](PFg )2 2 .34
[Ru(bpy)2 (NH2phen)](PFg)2 4.10
[Ru(bpy)2 (NCSphen)](PFg )2 3 .38
[Ru(phen)2 (NH2phen)](PF^ )2 3.14
[Ru(phen)2 (NCSphen)]C12 2 .52
Retention times of the compounds as listed above after 
separation in 80:20, CH^CNrH^O, with 0.08 M LiClO^ as 
mobile phase. The flow rate was 2.5 ml/min.
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The amino compounds were found to be pure by HPLC.
Figures 3.2 and 3.3 depict representative 
chromatograms and the associated absorption spectra of the 
amino and isothiocyanate compounds in this case 
[R u (bpy)2 (NH2phen)](PFg)2 and [R u (bpy)2 (NCS- 
phen)](PFg)2 . The HPLC analysis of the isothiocyanate 
compound after separation by HPLC clearly shows the presence 
of a second component (< 10%). The absorption spectrum of 
this second compound is similar to the amino compound and has 
been assumed to be the amino compound.
The isothiocyanate compounds were not 
recrystallised due to their instability in aqueous solution 
[5,6], and were used in the unrecrystallised form for 
characterisation and conjugation procedures.
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05
Figure 3.2 Chromatogram and the absorption spectrum of 
[Ru(bpy)2 (NH2phen)](PF6 )2 after 
separation in 80:20, CH^CNtl^O with 0.08 M 
L idO.. The flow rate was 2.5 ml/min.
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Figure 3.3 Chromatogram and the absorption spectra of (a)
[Ru(bpy)2 (NCSphen)](PFg )2 and (b) a second
component after separation in 80:20, CH^CN :
H„0 with 0.08 M LiClO.. The flow rate was 2 4
2.5 ml/min.
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3.4 Infra-red spectroscopy.
Infra-red spectra were examined in a purely qualitative 
manner to assess the success of the derivatisation reaction 
of the amino compound to the isothiocyanate compound. The 
presence of the isothiocyanate group was confirmed by the 
presence of an infra-red band at about 2050 cm"''' which is 
characteristic of isothiocyanate compounds [7]. The infra­
red spectra of the various compounds were compared to that of 
fluorescein isothiocyanate (FITC) where the absorption band 
due to the isothiocyanate group occurs at 2036 cm 
The infra-red spectra of [R u (bpy)2 (NH2~ 
phen)](PFg)2 and [Ru(bpy)2 (NCSphen)](PFg)2 which 
are typical of these compounds are presented in Figures 3.4 
and 3.5. Table 3.2 lists the frequency at which the 
absorption band due to the isothiocyanate moiety occurs for 
the various compounds.
Table 3.2 The infra-red stretching frequency of the NCS 
moiety in the isothiocyanate compounds.
Compound Frequency (cm-1) V
[Ru(bpy)2(NCSpy)2](PF6)2 2031
[Ru(bpy)2(NCSphen)](PF6)2 2056
[Ru(phen)2(NCSphen)]Cl2 2051
FITC 2036
The infra-red spectra were obtained using KBr discs.
16 2
Frequency (cm-1)
Figure 3.4 Infra-red spectrum of [Ru(bpy)2 (NH2
2-phen)](PFg) obtained as a KBr disc.
Frequency (cm'1)
Figure 3.5 Infra-red spectrum of [R u (bpy)2 (NCS­
phen) ](PF,), obtained as a KBr disc.
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3.5 Proton nuclear magnetic resonance spectroscopy.
The proton resonance signals obtained for the different 
compounds have been attributed to the different protons by 
comparison with literature data for similar compounds 
[8,9,10,11], and also by comparison with the 
bis(2,21-bipyridyl) ruthenium [12,13] and bis(1,10-phenan 
-throline) ruthenium compounds containing pyridyltriazole 
ligands (Chapter 5). 2D COSY techniques also facilitated in 
the assignment of the various resonances. The proton NMR 
spectra clearly confirm the expected cis geometry for all the 
compounds [8,14].
The main difference between the "'‘H NMR spectra
of the uncoordinated 2 ,2 1-bipyridyl and phenanthroline
ligands and the ruthenium coordinated ligands is that the 
6 6 1H /H protons of the pyridine rings of the bpy ligand
2 9and the H /H protons of the phen ligands experience a 
large upfield shift of about 1 ppm upon coordination to the 
ruthenium atom. This is because these protons are located 
just above a pyridine ring of an adjacent polypyridyl ligand 
and as such are located within the shielding cones of these 
ligands [15,16]. This diamagnetic anisotropic effect has 
previously been observed for the bis(2 ,2 1-bipyridyl) 
ruthenium compounds containing pyridyltriazole ligands 
[12,13]. In Figure 3.6, the 2D COSY NMR spectrum for 
[Ru(bpy)2 (NH2phen)](PF6 )2 is presented.
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Figure 3.6 2D COSY NMR spectrum of [Ru(bpy)2 (NH2“ 
phen)](PFg)2 measured in (CD3 )2CO.
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The NMR spectra of the isothiocyanate compounds were not 
assigned due to impurities of the amino compounds.
Table 3.3 lists the relevant NMR data for the coordinated 
NH2py and NH2phen ligands. The proton resonances of the 
coordinated bpy and phen ligands are given in Section 2.1.1, 
Chapter 2. The H NMR spectrum of [R u (bpy)2 (NH2~ 
py)2 ](PFg)2 is presented in Figure 3.7.
The proton resonance signals of the compound 
[Ru(bpy)2 (NH2p y )2 ](PFg)2 were assigned by
2+comparison with the NMR data on the [R u (bpy)2 (P y )2J 
compound [17].
For this compound one of the H 6/H6 1 protons of the 
bipyridine ligand lies trans to another bipyridine and 
experiences a downfield shift (at 9.25 ppm) and the other 
proton lies trans to the aminopyridine ligand and experiences 
an upfield shift (8.15 ppm). The proton which lies at lowest 
field is that due to the proton which is located trans to the 
bipyridine ligand.
The reason this proton resonates at much lower field
2 +compared to the H6/H6 1 protons of [Ru(bpy)^] is that 
the proton is not rigidly located above the plane of an 
aromatic ring. This has been confirmed by the crystal 
structure of [R u (bpy)2 (p y )2 ]2+, which shows that the 
pyridine is free to rotate around the Ru-N bond [17].
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Table 3.3 NMR resonances of the coordinated ligands.
[Ru(L-L)2(L 1)]2+ Chemical shift(&) 
L'
[Ru(bpy)2(NH^py)2 ]2 + H2 7.89-7.92; H3 6*58-6.60; NH2 6.26.
[R'j(bpy )2(NH2phen) ] 2 + H2 7.96; H3 7.66; H4 8.35; H6 7.31; 
H7 8.95; H8 7.88; H9 8.39; NH2 6.43.
[Ru(bpy)2(bpy)]2 + ^ H3 8.90; H4 8.12; H5 7.53; H6 7.71.
(Ru(phen)^ (Nf^phen)]2 + H2 7.92; H3 7.53; H4 8.32; H6 7.31; 
H7 8.93; H8 7.75; H9 8.36; NH2 6.43.
[Ru(phen)2(phen)]2+ H2/H9 8.09; H3/H8 7.60; H4/H7 8.57; 
H5/H6 8.16.
1 6 H NMR data for the amino compounds measured in d acetone.
(a) Ref. 18 measured in [CD-j^CO]; (b) Refs. 4 and 19, measured
in D20 .
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Figure 3.7 NMR spectrum of the compound [Rufbpy^
2+-(NH2py)2 l . The spectrum was measured 
in (CD^^CO.
Generally, for all the protons of the bipyridine, phenanthro­
line and aminophenanthroline ligands, a slight downfield 
shift is observed upon coordination to ruthenium, probably 
due to the decrease in electron density caused by the 
CJ-donation effect of the metal. This deshielding effect 
means that a lower value of the applied magnetic field is 
required to bring the protons to resonance.
For the H3/H31 protons of the bipyridine ligand 
this shift is quite significant (about 0.3 ppm) and is due to 
the steric crowding of these protons giving rise to strong 
Van der Waals interactions [16].
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3.6 Electronic spectra and redox properties.
The data obtained from electronic and electrochemical
measurements on the ruthenium polypyridyl compounds are
presented in Table 3.4. The intense absorption bands around
*450 nm have been assigned to d Jl - JT metal-to-ligand-charge
transfer bands [20]. The position of this band is determined
by a-donor and jt-acceptor properties of the ligands.
For all the compounds with the exception of 
2 +[Ru(bpy)2 (NH^py)2 J > the maximum wavelength of 
absorption occurs at about 450 nm. The X  max. of absorption 
for the aminopyridine compound occurs at 491 nm which 
indicates that this compound is a weaker jt-acceptor than the 
other compounds. As a result the metal d Jt orbitals are 
destabilised by the increase in the effective charge on the 
ruthenium.
Interestingly, upon conversion to the
isothiocyanate derivative the X. max. of absorption (and
emission) shifts to higher energy (Figures 3.8 and 3.9),
2 +higher even than the max. abs. for [R u (bpy)^ (P Y )2 ^
[ 2 1 ]
The absorption and emission spectra for some of 
the bis-bipyridyl and bis-phenanthroline compounds containing 
the NH2phen and NCSphen ligands are presented in Figures 
3.10-3.12.
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Table 3.4 Electronic and electrochemical data for the ruthenium
polypyridyl compounds with the aminophen/aminopy and 
isothiocyanate phen/isothiocyanate py ligands.
Compound Absorption Emission Redox properties
nm (logE) 303 K 77 K (V vs S C E . )
(a) nm (b ) (c)
[Ru(bpy)2 (N H 2p y )2 ]2+ 491(3.95) 648 623 1 . 00 -1.45, - 1.68
[R u (b p y )2(NCSpy2 ]2+ 440(4.02)(h) 638 605 1.15 -1.42 - 1.68
1.32
[Ru(bpy)2 (NH2p h e n )]2 + 457(4.15)(h >615 576 1 . 20 -1.37, -1.56, -1.82
1.34
[Ru(bpy)2 (NCSphen)]2+ 449(4.18)(h) 618 583 1.26 -1.38, -1.59, -1.86
[R u (b p y )3]2+ 452(4.11) 608 582 1.22 -1.36, -1.53, -1.80
[Ru(phen)2 (NH2p h e n ) ] 2 + 456(4.24)(h)600 570 1.18 -1.38, -1.53, -1.96
1.34
[Rutphen)2 (NCSphen)]2+ 445(4.16)(h) 613 576 1. 09 -1.36, -1.60, -1.93
1.28
[Ru(phen)3 ]2+ (e) 442(4.27) 604 568 1.27 -1.35
[R u (b p y )2 (p y )2 ]2+ 455(3.91) 606 1.30 -1.32, -1.56
[Ru(bpy)2 (phen)]2+ (g) 447(4.18) 610 1 . 26 -1.36
(a) Absorption spectra were measured in C H 3CN, (logs) was measured in 
CH3CN, M-lcm-1.
(b) Emission spectra were measured in C H 3CN at 303 K and in EtOH at 77 K. 
Emission slit at 303 K was 10 nm; at 77 K, 5 nm.
(c) Redox values obtained from differential pulse traces measured in 
C H 3CN/O.I M Tetrabutylammoniumperchlorate (T B A P ). Volts vs SCE.
(d) ref [18]. (e) ref [20]. (f) ref [21]. (g) ref [23].
(h) Extinction coefficients were measured in 0.1 M carbonate buffer, pH 9.6. 
Units are M-lcm-1.
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All compounds were found to emit at room temperature. A well 
defined vibrational progression was observed when emission 
spectra were measured at 77 K. For all compounds emission at 
low temperature is stronger than that at room temperature 
because thermal population of the deactivating d-d orbital is 
possible at room temperature resulting in a decrease in 
emission intensity, [23,24,25].
Figure 3.8 Absorption spectra of [Ru(bpy)2(NH2~
py)2 ]2+ 2xl0~5 M, (------ ) and
[Ru(bpy)2 (NCSpy)2 ]2+ 3xl0~5 M f (------)
in CH3CN.
171
Figure
Figure
W avelength  (nm)
3.9 Emission spectra of (a) [Ru(bpy)2 (NH2~ 
py)2 ]2+ and (b) [Ru(bpy)2 (NCSpy)2 ]2+ 
in EtOH at 303 K.
WAVELENGTH A (nm)
3.10 Absorption spectra of [Ru(bpy)2 (NH2~
phen)]2+, 1.5x10  ^ M (------) and
[Ru(bpy)2 (NCSphen)]^+ , 2x10 ^ M (---
c h 3 c n .
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) in
Figure
Figure
3.11 Emission spectrum of [Ru(bpy)2 (NH2~
1/1
<
CO
C£o
co
<
WAVELENGTH A (nm)
3.12 Absorption spectra of [Ru(phen)2(NH2-
phen)]2+r 1x10 ^ M (----— ) and [Ru(phen)2-
(NCSphen)]^+ , 2.5x10 ^ M (----- ) in
ch3cn.
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V vs S.C.E. V  vs S.C.E.
Figure 3.13 Cyclic voltammogram and differential pulse 
voltammogram of the oxidation of 
[Ru(bpy)2 (NH2py)2 ]2+ in 0.1 M 
t b a p /c h 3c n .
The first reduction potential for each compound is quite
2 + 2 +similar to those of [Rutbpy),] or [Ru(phen)^] as
appropriate. This indicates that most likely a bpy/phen
based reduction is observed. The first reduction potentials
are all at least as negative or more negative than that of
the tris compounds suggesting that the amino and
isothiocyanate ligands may be harder to reduce and are
therefore, weaker jt-acceptors than their bpy or phen
counterparts. The results suggest that the bpy or phen
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ligands may act as the emitting ligands and the amino and
isothiocyanate ligands are the spectator ligands. This is
corroborated to some degree by the trace presented in Figure
2 +3.14, of the reduction of [ Ru (phen ) 2 ( Nf^phen) ] . The
third reduction process occurs at about -1.96 V, the shape of 
this peak is somewhat different to those obtained for the 
first two reductions and may indicate that this third 
reduction is due to the reduction of the aminophenanthro- 
line ligand, which may not be as straight forward as the 
reduction of an unsubstituted bpy or phen ligand.
V  vs S.C.E.
Figure 3.14 Differential pulse voltammogram of the reduction 
of [Ru(phen)2 (NH2phen)]2+ in 0.1 M 
TBAP / CH3CN.
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The electrochemical results also indicate that the emission
and absorption processes most likely arise from the bpy or
phen ligands. This is demonstrated in Figure 3.15, which
shows a linear relationship exists between the energy of the
lowest MLCT band and A  E]_/2 (the difference between the
Ru111- Ru11 oxidation potential and the first reduction
potential of the complex Eox“E recj)' an<  ^ between A
and the emission energy. [25,26].
In an MLCT absorption process, an electron is
removed from the filled d metal orbital to an empty orbital
*of the ligand ( ji ) . Oxidation is also removal of an 
electron from the d-orbitals and by reduction, an electron is 
transferred to the lowest unoccupied molecular orbital of the 
complex. For these complexes the lowest unoccupied orbital
'kis the Ji orbital of bpy or phen. A similar explanation 
holds for the emission processes.
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A E 1/2 Volts
Figure 3.15
These are:
Plots of vs Absoption (a) and
Emission (b) energies for compounds 1-10. 
Emission spectra, absorption spectra and values 
for A E^y2 were obtained at room temperature
in CH3CN.
1 .
2 .
3.
4.
5.
6.
7.
8 . 
9. 
10
[R u (bpy)2(NH2py )2]
[R u (bpy)2 (NCSpy)2 ]
[R u (bpy)2 (NH2phen)] 
[R u (bpy)2(NCSphen)]
2 +
2+
2 +
2 +
[Ru(phen)2 (NH2phen)]2 +
[Ru(phen)2 (NCSphen)]2 +
[Ru(bpy)^1^+ . [Ref. 18] 
[Ru(phen)3 ]2+. [Ref. 20]
[Ru(bpy),(py)«] 2+ [Ref. 21]
2 +[RufbpyJjtphen)] . [Ref. 23]
All measurements were conducted at room temperature.
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3.7 Conclusion.
In this chapter, the characterisation and synthesis of a 
number of ruthenium polypyridyl amino and isothiocyanate 
compounds has been described. The compounds have been 
characterised using various techniques. HPLC is useful in 
determining the purity of the compounds. The amino compounds 
were all HPLC pure. The isothiocyanate compounds however, 
show some impurities by HPLC analysis. The NCS compounds 
were not recrystallised due to their instability in 
solution. The closeness of the retention times for the amino 
compounds and their isothiocyanate derivatives suggest that 
it may have been difficult to achieve pure isothiocyanate 
preparations anyway.
Infra-red spectra were used in a purely 
qualitative manner to assess the success of the 
derivatisation procedure, although these spectra may be used 
for the quantitative determination also. [27,28).
The various proton resonances of the amino 
compounds were assigned using NMR and 2D COSY NMR techniques. 
NMR spectra were taken of the isothiocyanate compounds but 
were too complex to analyse due to the presence of the amino 
impurities.
Generally the electronic and electrochemical data 
of the amino-phenanthroline and isothiocyanate - phenanthro­
line compounds are quite similar indicating that the 
properties do not change significantly upon conversion of the 
amino to the NCS derivatives, unlike those of the
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aminopyridine complex when Converted to the NCS derivative.
The fact that the first reduction potentials of
all the compounds are at least as negative or more negative
2 + 2 + than the [Ru (bpy)^ ] or [Ru(phen)3] analogues may
•kindicate that the lowest Jl orbital is located on the bpy
or phen ligands. The third reduction potential observed for
[Ru (bpy)2 (NH^phen)]2+ and [Ru (bpy)2 (NCSphen) ] is
more negative than the third reduction potential measured for 
2 +[Rulbpy)^] , which suggests that this potential is
probably located at the NCSphen/NH2phen ligand and that
these ligands are weaker jt-acceptors then bpy.
However, this is not possible to state
unambigously. For the compounds containing the NH2py
or NCSpy ligands, the first reduction potential is more
negative than the first reduction potential of 
2 +[Ru(bpy)3 ] indicating that the first reduction 
potential for these compounds is indeed bpy based.
The correlation between the absorption/emission 
energies and A  El/2 shows that the spectroscopic and 
electrochemical processes involve the same orbitals. Thus 
the bpy/phen ligands are most likely the emitting ligands 
whilst the NH2phen and NCSphen ligands and definitely 
NH2py and NCSpy act as the spectator ligands.
The questionable purity of the isothiocyanate 
compounds really renders it difficult to discuss the 
properties of these compounds in a definitive manner. 
Therefore throughout the previous discussion the possibility 
of amino impurities in the NCS preparations must be
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considered. The difficulties arising with impurities in the 
discussion of the characteristics of these compounds are not 
significant when these compounds are conjugated to biological 
molecules. The unbound molecules together with any 
impurities are removed by extensive dialysis leaving only a 
high molecular weight ruthenium bound biomolecule.
The emission lifetimes of some of the compounds 
were measured and are included in the chapter discussing the 
lifetimes of the various conjugates, Chapter 4.
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CHAPTER 4
THE CONJUGATION OF RUTHENIUM POLYPYRIDYL 
COMPLEXES TO BIOMOLECULES.
4.1 Introduction
In this chapter the conjugation of some ruthenium (II) 
polypyridyl complexes to albumins, immunoglobulins and 
poly-L-lysine is described. The complexes were bound at 
different sites on the biomolecules, using different binding 
methods.
Initial investigations were conducted on the
2 +conjugation of [ Ru ( bpy) 2 ( NCSphen ) ] and [Ru(bpy)2~
2 +(NCSpy^] to bovine serum albumin (BSA). The pH and 
initial fluorochrome to protein ratio (F/P), was varied and 
the effect of these parameters on the binding efficiency was 
examined. From these experiments the reaction pH and initial 
fluorochrome to protein ratio was selected and used in 
further studies using the NCS-type label molecules.
2 +Two other compounds [R u (phen)2 (NCSphen)] and 
2 +[Ru(bpy)2 (COOHbpy)] were then synthesised, and
conjugated to albumins, immunoglobulins and poly-L-lysine
2 +(PLL), together with the [R u (bpy)2 (NCSphen)] complex.
Those compounds containing the NCS moiety bind to the 
8 -amino groups of lysine residues directly via a thiourea 
linkage, the dicarboxylic acid compound upon conversion to 
the succinimidyl ester also binds to these £ -amino groups.
Methods for attaching a label to a protein 
molecule which involve modification of the amino acid side 
chains are not specific, in that the label molecule can not 
be directed to a particular site on the protein and this 
results in heterologous labelling. Where immunoglobulin
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(antibody) labelling is concerned, modification of the amino 
acid side chains may also lead to a decrease in the affinity 
of the antibody for the antigen, since these moieties are 
situated in or in close proximity to the antigen-binding 
site. [1 ]
In contrast to modification of the amino acid side 
chains, the carbohydrate moieties of immunoglobulins are not 
involved in the antigen binding site so that modification of 
these groups should not directly affect antigen binding. [1 ] 
So, in addition to modification of the amino acid side chains 
of proteins and antibodies, modification of the carbohydrate 
moieties of glycoproteins was also examined.
Immunoglobulins may be classed as glycoproteins 
with a carbohydrate content ranging from 4 to 18% depending 
on the immunoglobulin. In this work immunoglobulin G (IgG) 
and ovalbumin (OVA), were modified through periodate 
oxidation of the carbohydrate moiety (IgG has about 4% [1] 
and ovalbumin has about 1% carbohydrate [2]). This was 
followed by conjugation to an amino ruthenium complex, either 
[Ru ( bpy ) 2 ( NH^phen ) ] 2 + or [ Ru ( phen ) ^  ( NH2phen ) ] 2+ .
Periodate oxidation of BSA and human serum albumin (HSA), 
although not usually treated as glycoproteins, followed by 
conjugation to the ruthenium (II) amino compounds was also 
successful.
A third method of attaching a label molecule to a 
biomolecule was used. This involved diazotisation of the 
ruthenium (II) polypyridyl amino compounds by the method 
described by Sundberg et a l ..[3] Diazotised reporter
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molecules have been shown to bind via the tyrosine or 
histidine residues of a protein molecule. [4]
Where immunoglobulins were conjugated to ruthenium 
compounds, the retention of immunological activity after 
conjugation was monitored by employing an enzyme-linked 
immunosorbent assay (ELISA).
The effects of conjugation on the absorption and 
emission spectra of the ruthenium compounds and the effect of 
conjugation on the emission decay lifetimes of some of the 
free and biomolecule-bound ruthenium complexes was 
investigated.
4.2 Results and Discussion.
The visible region in the absorption spectrum of the
ruthenium complexes is unaffected by the absorbances due to
the protein molecules since these occur in the ultraviolet
3region. Therefore, any changes in the MLCT band reflects 
changes in the spectroscopic properties of the ruthenium 
complexes upon conjugaton to proteins.
The absorption and emission data on the unbound 
ruthenium complexes which have been used in these 
investigations are presented in Table 4.1.
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Table 4.1 Spectroscopic data for the ruthenium polypyridyl 
complexes which were used in conjugations 
involving biomolecules.
Compound Absorption Emission (303 K)
X, max, (nm) X. max. (nm)
(log £ )
[Ru(bpy)2 (NH2py)2 ]2+ 488 ( — — ) 645
[R u (bpy)2 (NCSpy)2 ]2+ 449 (4.,02) 631
[R u (bpy)2 (NH^phen)]2+ 454 (4..14) 609
[Ru(phen)2 (NH2phen)]2+ 452 (4..24) 604
[R u (bpy)2 (NCSphen)]2+ 453 (4..17) 610
[R u (phen)2 (NCSphen)]2+ 447 (4,.16) 608
[Ru(bpy)2 (COOHbpy)]2+ 460 (4,.19) 642
2 +[Ru(bpy)2 (esterbpy)] 458 639
The absorption and emission spectra were measured in 0.1 M 
carbonate buffer, pH 9.6, at room temperature. Extinction 
coefficients (log £ ) were measured in 0.1 M carbonate 
buffer, pH 9.6; units are M--*-cm~ l >
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4.2.1 Optimisation of conjugation conditions.
The conjugation procedure involved reacting BSA and a range of 
ruthenium label concentrations at three different pHs; (a) pH 
4.3 in 0.1 M citrate buffer, (b) pH 7.4 in 0.1 M phosphate 
buffer and (c) pH 9.6 in 0.1 M carbonate buffer. The initial 
label : protein ratios used were 5:1, 10:1, 20:1, 30:1, 50:1,
and 90:1. The ruthenium labels used were [R u (bpy)2 (NCS-
2 + 2 + py)2 J and [R u (bpy)2 (NCSphen)] and were dissolved
in the minimum volume of dimethylformamide (DMF). The
reaction was allowed to proceed for 18 hours, in the dark at
4°C, with minimal agitation. The free and BSA bound
ruthenium complexes were separated by gel-filtration
chromatography using Sephadex G-25 and phosphate buffered
saline (pH 7.4) as eluent. Using gel-filtration
chromatography, two coloured fractions are obtained. The first
fraction is the BSA-bound ruthenium complex (protein was
monitored qualitatively by using the Bradford reagent for
protein determination [5]). The second coloured fraction was
the unbound label and does not contain any protein. The
absorption and emission spectra of these fractions, for both
labels are shown in Figures 4.1 and 4.2.
From the absorption spectrum presented in Figure
4.1, it can be seen that the A. max. of absorption of the free
2 +unbound [R u (bpy)2 (NCSpy)2 ] species is about 485 n m .
However, a freshly prepared solution of the complex has a 
X max. of absorption at 449 nm. Also, the emission maximum 
of this gel filtration fraction is about 650 nm, whilst that
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Wavelength (nm)
Figure 4.1 Absorption (1) and emission (2) spectra of the
two fractions obtained after gel-filtration
2+chromatography of the [Ru(bpy)2(NCSpy)^ 1 
: BSA conjugate. Fraction (a) is the conjugate 
and fraction (b) is the unbound species.
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Figure 4.2 Absorption (1) and emission (2) spectra of the
two fractions obtained after gel-filtration
2+chromatography of the [Ru(bpy) (^NCSphen)]
: BSA conjugate. Fraction (a) is the conjugate 
and fraction (b) is the unbound species.
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of the fresh solution is 631 nm. Upon comparison with the
absorption and emission X  max. of [R u (bpy)^ (NH2- 
2 +py)2 ] , the absorption and emission data for this
complex are more similar to that of the unbound fraction than
that of the isothiocyanate analogue which suggests that the
unbound complex converts back to the amino complex. This
indicates the limited stability of the isothiocyanate
complexes in aqueous solution. It is easier to arrive at
this conclusion for the pyridine-containing complex, since
the absorption and emission data are quite different for each
complex. It is difficult to say whether the same occurs for
2 +the complex [R u (bpy)„(NCSphen)] , since the absorption
and emission data for both the isothiocyanate and amino
complex are quite similar. However, it may be observed that
upon conversion of the NH2phen complex to its NCS
derivative, an absorption band appears at about 320 nm, which
disappears upon conjugation and is probably related to the
reordering of the energy levels of the ligand orbitals. This
band is not present in the unbound fraction obtained after
gel filtration which could indicate that the unbound
2 +[Ru(bpy)2 (NCSphen)] also converts back to 
[Ru(bpy)2 (NH2phen)]2+.
The conjugation ratio was estimated according to 
Nairn. [4] This method is described in detail in Chapter 2. 
It was assumed that the extinction coefficient of the bound 
label complex is the same as that of the free complex.
Protein concentration was assayed using two methods, (a) the 
Bradford method [5] and (b) the Folin-Lowry method.[6 ]
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The results obtained at various pHs, using a range of initial 
fluorochrome : protein (F/P) ratios, are presented 
graphically in Figures 4.3 and 4.4.
Some discrepancies were noted between the F/P 
ratios estimated using the Bradford method and the 
Folin-Lowry method. However, at this stage these 
discrepancies were not thought to be significant since the 
method of determining F/P is really only an estimate. In 
later investigations, the Folin-Lowry method was employed as 
the more accurate method for protein determination in certain 
conjugation reactions. The reason why this assay was chosen 
over the Bradford assay will be discussed in Section 4.2.2.
The following discussion on the calculated F/P 
ratios deals with those ratios estimated by using the protein
concentration (C , mg/ml), determined by the Folin-LowryP
assay [6 ]. At maximum initial F/P ratios, approximately 12
2 +molecules of [Ru (bpy)2 (NCSpyr)2 ] and about 14
2 +molecules of [Ru (bpy)2 (NCSphen)] were bound per 
molecule of BSA, at pH 7.4 and pH 9.6, with a slightly higher 
F/P at pH 9.6. At pH 4.3, conjugation did not occur. At 
this pH, the first fraction obtained after gel-filtration 
chromatography which contained BSA, was uncoloured and 
absorptions arising from the ruthenium complexes were 
absent. This is significant because this indicates that the 
label molecules are probably reacting with the e -amino group 
of the lysine residues according to :
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Figure 4.3 Graph showing the fluorochrome / protein ratios 
(F/P), obtained at various initial F/P ratios,
at (1) pH 9.6, in 0.1 M carbonate b u f f e r , ®  ,
(2) pH 7.4, in 0.1 M phosphate buffer, Q  , and
(3) pH 4.3, in 0.1 M citrate buffer, . The
protein concentration was determined using (a)
the Bradford method [5] and (b) the Folin-Lowry
method [6]. The label is [Rufbpy^- 
2+(NCSpy^l and the protein is BSA.
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Figure 4.4 Graph showing the fluorochrome / protein ratios 
(F/P), obtained at various initial F/P ratios, 
at (1) pH 9.6, in 0.1 M carbonate buffer, | ,
(2) pH 7.4, in 0.1 M phosphate buffer, 0  , and
(3) pH 4.3, in 0.1 M citrate buffer, . The
protein concentration was determined using (a)
the Bradford method [5] and (b) the Folin-Lowry
method [6 ]. The label is [Ru(bpy)2~
2+(NCSphen)] and the protein is BSA.
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Protein-lysine-NH2 + [R u (bpy)2 (NCSpy)2 ]2+
or
[Ru(bpy)2(NCSphen)]2+
i f
2 +Protein-lysine-NH-C-[(NHpy)(NCSpy)Ru(bpy)_]n 1
S
or
2 +Protein-lysine-NH-C-[(NHphen)Ru(bpy)„]il A
S
The increase in F/P ratios as a function of pH is
most likely due to the greater deprotonation of the E-amino
group of the lysines at higher pH values, providing additional
sites for reaction with the isothiocyanate group. [7]
BSA has 57 lysine residues [8 ], and F/P ratios of
12 and 14 label molecules per molecule of BSA represents about
2 +21% labelling efficiency using [R u (bpy)^ (NCSpy)^ ] and
2 +25% labelling efficiency using [R u (bpy)^ (NCSphen)] ,
based on the total number of lysine residues. These labelling 
efficiencies indicate that there may only be limited access of 
the label to the lysine moieties, most likely due to the 
structural conformation of the albumin. Steric hindrance due 
to the size and shape of the label molecule, as well as the 
proximity of the lysine residues to each other also plays a 
role in determining how much label may be attached to the 
albumin. In fact, Canfi et a l . [9], have reported that there
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are only about 15 lysine residues available for reaction in 
albumins, (referring to BSA and HSA molecules rather than 
ovalbumin (OVA)), so the labelling efficiencies observed in 
these investigations could be estimated at 80% and 93%, 
instead of 21% and 25% for the NCSpy and NCSphen complexes 
bound to BSA respectively, based on the availability of 15 
lysine residues for binding.
It is unlikely that the label [Rufbpy^-
2 +(NCSpy)2 ] r could bind to two lysine residues since
these residues are for the most part well separated along the
albumin molecule. Thus, only one NCS group / label molecule
would be available for binding to the lysine residues. It
would be expected then, that similar F/P ratios to those of
2 +the [Ru (bpy)2(NCSphen)] conjugate would be obtained and
this is indeed observed.
For all further conjugations, the initial F/P 
ratio chosen was a 50 molar excess of label to protein, and 
reactions were conducted in 0.1 M carbonate buffer pH 9.6. 
Even though higher F/P ratios were attained when the initial 
F/P ratio was 90:1, it was found that increased dye 
concentrations required increased volumes of DMF for 
dissolution which could denature the protein and also that 
protein was lost by precipitation with increasing dye 
concentrations. This observation of increasing loss of 
protein due to precipitation with increasing F/P ratios has 
been reported previously for tetramethyl rhodamine 
isothiocyanate labelling of rabbit immunoglobulin. [10] 
However, the precipitate may be removed by centrifugation.
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4.2.2 Conjugation of [Ru(bpy)^ (NCSphen)] ,
2 +[Ru(phen)2 (NCSphen)] and the succinimidyl
2 +ester of [Ru(bpy)2 (COOHbpy)] to some
albumins and poly-L-lysine.
The synthesis and characterisation of the isothiocyanate 
complexes has already been described in Chapter 3.
Synthesis of the complex [R u (bpy)^(COOH-
2 +bpy)] (PF,)„ and its conversion to the succinimidylD Z
ester were carried out according to Bard. [11] The purity
of the dicarboxylic acid complex was checked by HPLC and the
chromatogram is shown in Figure 4.5. The absorption spectrum 
of the complex, together with that of the ester derivative 
are presented in Figure 4.6.
Using the optimised conditions described in 
Section 4.2.1, the complexes were bound to BSA, human serum 
albumin (HSA), Ovalbumin (OVA) and poly-L-lysine (PLL). In 
this study and in the remaining conjugation procedures, the 
unbound complexes were separated from the conjugates by 
extensive dialysis against 0.1 M carbonate buffer, pH 9.6.
The conjugation ratios were estimated and the 
absorption and emission spectra were measured. The results 
obtained are presented in Table 4.2.
2 +
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Figure 4.5 The HPLC chromatogram of [Rufbpy^-
2 +(COOHbpy)] . The mobile phase used was 80:20, 
CH3CN:H20 with 0.08 M LiClC>4 . The HPLC 
system used is described in Chapter 2, Section
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Figure 4.6 The absorption spectra of [Ru(bpy) (^COOH-
2bpy)] (------ ) and its active succinimidyl
ester derivative (------), measured in 0.1 M
carbonate buffer, pH 9.6.
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Table 4.2 Assessment of the extent of conjugation of [Ru(L-L)2~ 
(NCSphen)]2+ and the ester derivative of [Ru(L-L)2- 
(COOHbpy)]2+ to BSA, HSA, OVA, and PLL.
(1 ) (2) (3) (3)
Conjugate P / p  % labelling Abs. Em.
(a) (b) efficiency X max. X max.
BSA: [Ru(bpy)2 (NCSphen)]2+ 2 0 15 35 455 606
HSA: [Ru(bpy)2(NCSphen) ]2 + 2 0 13 35 454 608
OVA: [Ru(bpy)2(NCSphen)]2+ 9 9 44 454 607
PLL: [Ru(bpy)2(NCSphen)]2+ 2 2 15 2  (5 ) 454 608
BSA: [Ru(phen)2(NCSphen)]2 + 16 13 29 450 600
HSA: [Ru(phen)2(NCSphen)]2+ 13 1 0 2 2 450 600
OVA: [Ru(phen)2 (NCSphen)]2+ 6 8 33 449 601
PLL: [Ru(phen)2 (NCSphen)]2+ 31 1 1 4 (5) 451 604
BSA: [Ru(bpy)2(COOHbpy) ] 2 + 14 1 2 24 (4) 467 657
HSA: [Ru(bpy)2(COOHbpy)]2+ 15 1 0 26 {4) 467 657
OVA: [Ru(bpy)2(COOHbpy)]2+ 5 6 30 ( 4  } 465 655
PLL: [Ru(bpy)2(COOHbpy)]2+ 32 1 0 4 (4)(5) 465 660
(1). Fluorochrome to Protein (F/P) ratios were determined according 
to Nairn [4], using Cp (protein conc.in mg/ml) calculated 
using (a) the Folin-Lowry protein assay [6 ] and (b) the 
Bradford protein assay [5]. The assays were performed in 
duplicate.
(2). The % labelling efficiencies were calculated using the total 
number of lysine residues: BSA, 57; HSA, 58; and OVA, 18. The 
results were obtained using F/P ratios, derived using the 
Folin-Lowry assay to determine Cp.
(3). Absorption / Emission spectra were measured in 0.1 M carbonate 
buffer, pH 9.6, at room temperature; X. max. in nm.
(4). This compound was converted to the active ester before 
conjugation to the biomolecules.
(5) . See text.
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The labelling efficiencies have been calculated on the basis 
of the total number of lysine residues rather than on the 
number available, which as described already in Section 4.1 
increases the labelling efficiency significantly. As in 
Section 4.1, the protein concentration was assayed using both 
the Bradford and Folin-Lowry assays. Again the Bradford 
assay results in F/P conjugation ratios that are lower than 
those obtained using the Folin-Lowry assay, especially for 
the PLL conjugates.
This can be explained in terms of where the 
reagents actually bind on the protein molecule. The 
mechanism of dye-binding for the Bradford assay has been 
investigated. The dye used in this assay is Coomassie 
Brilliant Blue G. Slightly conflicting reports have been 
published, in one report it has been suggested that the dye 
binds to protein by electrostatic attractions of the 
sulphonic groups of the dye with protonated primary amino 
groups of proteins such as lysine and N-terminal groups.
[12] A second report suggests that interaction is primarily 
with the arginine residues rather than with primary amino 
groups, but lysine gives a slight response. [13] The results 
obtained in this work would suggest that the dye does indeed 
interact quite significantly with lysine residues.
Therefore, any possibility of dye binding through interaction 
with the lysine residues casts uncertainty on results 
obtained by this method, since both the Bradford reagent and 
the ruthenium complexes interact with the same groups on the 
protein or PLL molecule.
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The Folin-Lowry method combines the well known biuret
24-reaction where proteins react with Cu in an alkaline
2 +medium to produce Cu , with the detection of phenolic 
groups of tyrosine residues and to a lesser extent tryptophan 
residues, by the use of the Folin-Ciocalteu reagent, the main 
constituents of which are phosphotungstic and phosphomolybdic 
acids. The cupric ions form a coordination complex with the 
four nucleophilic -NH groups provided by the peptide bonds, 
of the protein or PLL molecule. A Cu-protein (or PLL) complex 
produced using a dilute version of the biuret reagent, causes 
the reduction of the phosphotungstic and phosphomolybdic 
acids to tungsten blue and molybdenum blue. Approximately 
75% of the reduction which occurs is due to the copper 
protein complex, while tyrosine (and to a lesser extent 
tryptophan) residues are responsible for the remainder. [14] 
In this method, therefore, the lysine residues are not 
involved in the protein binding process, so more accurate 
protein determinations, leading to more accurate estimates of 
conjugation ratios should be achieved.
For the reasons just outlined, the results are 
discussed based on F/P ratios derived using the Folin-Lowry 
method of protein determination. The conjugation ratios 
achieved for the PLL conjugates suggest that there is quite a 
substantial interaction between the Bradford reagent and the 
lysine groups which is in agreement with the observations 
reported by Fazekas de St. Groth et al .. [12] The 
differences between the Bradford and Folin-Lowry methods are 
not as significant for the albumins.
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Quite a noticeable difference in conjugation ratio is 
observed between the HSA or BSA conjugates and the OVA 
conjugates. This is expected since both BSA and HSA contain 
about 13% lysine with 57 and 58 lysine residues, respectively 
[8 ], while OVA contains only 6.3% lysine [15] or about 18 
lysine residues based on a molecular weight of 43,000 for 
OVA. The conjugation ratios for the OVA conjugates are 
approximately half those obtained for the BSA and HSA 
conjugates. However, the labelling efficiencies for the OVA 
conjugates are actually higher than for the HSA or BSA 
conjugates which may reflect differing degrees of 
accessibility of the labels for the lysine residues depending 
on the albumin. The fact that an initial F/P ratio of 50:1, 
which is in excess of the total number of lysines in 
ovalbumin, but is really only about 1:1 for HSA and BSA must 
also be considered.
Samuel et a l . [16]] in their assessment of the 
extent of conjugation of FITC to BSA and OVA, have reported 
for initial reaction F/P ratios of 5:1, that approximately 4 
molecules of FITC bound per molecule of BSA and 2 molecules 
of FITC per molecule of OVA, or 80% and 40% labelling 
efficiencies for the FITC/BSA and FITC/OVA conjugates, 
respectively. If the labelling efficiencies are calculated, 
based on total lysines rather than on the available lysines, 
this results in a significant underestimation of the 
labelling efficiency, then the labelling efficiencies are 7% 
and 12% for the FITC/BSA and FITC/OVA conjugates, 
respectively. In that report, as in the work presented here,
204
the molar extinction coefficient of the conjugated 
fluorochrome, in this case FITC, was assumed to be the same 
as unbound FITC.
As mentioned in Section 4.2.1, the conformational 
structure of the albumins, which are globular proteins with 
compact folded peptide chains, plays an important role in 
determining how many lysine residues are accessible to the 
ruthenium compounds.
The conjugation ratios are higher for the PLL 
conjugates than for the albumins. This is expected since 
there are nearly 750 lysine molecules in the poly-L-lysine 
molecule used in this work. The labelling efficiencies as 
defined in Table 4.2, are much lower but based on the initial 
F/P ratio of 50:1, the maximum labelling efficiency possible 
would be about 6%, (a possible 50 lysines out of a total of 
750 lysines), so the ratios obtained here (about 3-4%), are 
high given the initial amount of label added. The fact that 
6% labelling efficiencies were not achieved may reflect (a) a 
limited accessibility of the label to the polymer depending 
on the conformational structure at the pH used in this study 
or (b) limitations based on measurements used to calculate 
F/P or perhaps (c) steric hindrance due to the size of the 
ruthenium complex.
On average, about 28 molecules of ruthenium 
complex were conjugated to each PLL molecule. Based on an 
initial ratio of 50:1 (F/P), this represents about 56% 
labelling efficiency for ruthenium labelling. This concept 
of labelling efficiencies can be quite confusing, since there
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are a number of ways in which the labelling efficiencies can 
be interpreted. Labelling efficiencies can be determined 
based on (a) the amount of label complex that is added, (b) 
the total number of amino acid residues (in this case, 
lysine) that can react with the label complex and (c) the 
available number of amino acid residues with which the label 
molecule can react. The latter will be dependent on the 
accessibility of the label to the protein or polymer, the 
conformational structure of the protein or polymer, the pH at 
which conjugation occurs and on the structure of the label 
molecule itself.
For the three ruthenium complexes examined, the
F/P ratios are quite similar for a given albumin or PLL. The
succinimidyl ester complex may potentially react with two
lysine residues, depending on whether both carboxylic acid
groups were converted to ester moieties. However, it is
unlikely that the complex could bind two lysine residues for
2 +the same reason that the complex [Ru(bpy)2 (NCSpy)2 ] ,
probably does not bind two lysine residues, which is that the 
lysine residues are probably too well separated along the 
peptide chain.
The absorption spectra of the various unbound 
labels, together with the spectra of their albumin and PLL 
conjugates, are presented in Figures 4.7 - 4.9. The label 
and conjugate solutions were diluted in 0.1 M carbonate 
buffer, pH 9.6 , in order to present all the spectra on the 
same absorbance scale.
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Figure 4.7 Absorption spectra of (1) free [Ru(bpy)2
-(NCSphen)]^+ and bound to (2) PLL, (3) BSA,
(4) HSA and (5) OVA, measured in 0.1 M carbonate
buffer, pH 9.6. Ruthenium complex concentrations
_5are in the range 2-4 x 10 M.
207
300 W O  SOO
WAVELENGTH  A  (nm)
600
Figure 4.8 Absorption spectra of (1) free [Ru(phen)2
-(NCSphen)]^+ and bound to (2) OVA, (3) BSA,
(4) HSA and (5) PLL, measured in 0.1 M carbonate
buffer, pH 9.6. Ruthenium complex concentrations
_5are in the range 3-5 x 10 M.
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Figure 4.9 Absorption spectra of (1) the free succinimidyl
2+ester of [Ru(bpy)2 (COOHbpy)] and bound to 
(2) PLL, (3) BSA, (4) OVA and (5) HSA, measured 
in 0.1 M carbonate buffer, pH 9.6. Ruthenium 
complex concentrations are in the range 3-4 x 
10~5 M.
The absorption spectra of the bound [R u (bpy)^ (NCSphen)]
2 +and [Ru (phen)2(NCSphen)] are quite similar to their
2 +unbound spectra. For [Ru(bpy)2 (NCSphen)] conjugates,
the absorption intensity of the peak at X  max. appears to
have decreased slightly, with perhaps some broadening of the 
3 MLCT band to lower wavelength. The general shape of the
3MLCT band has changed. The same effects are observed for
2+ 3the [Ru(phen)2 (NCSphen)] conjugates. The MLCT bands
seem to experience a slight red shift of the order of 1-4 nm,
but it is difficult to confirm this since these shifts are so
small that some are within instrumental error.
Similar changes in the absorption spectrum of the
2 +succinimidyl ester of [R u (bpy)^ (COOHbpy)] upon binding
3to the albumins and PLL are observed. The MLCT band is 
quite clearly broadened and the X max. is red shifted by 
about 7-9 nm.
3These changes in the general shape of the MLCT 
band upon conjugation to the albumins and PLL are to be 
expected. Quite similar effects have been described for 
ruthenium polypyridyls which interact with DNA, the extent of 
which seems to depend on the type of binding (whether 
intercalative or electrostatic) [17].
For both [ Ru ( bpy) 2 (NCSphen ) ] 2+
2 4*[Ru(phen)2 (NCSphen)] conjugates, the emission Xmax. 
appear to be blue shifted slightly, about 2-4 nm for the bpy 
conjugates and about 4-8 nm for the phen conjugates. This is 
difficult to evaluate accurately, since these variations are
2 +
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probably within instrumental error. The emission X max. of
2 +the [Ru (bpy)2 (COOHbpy)] complexes which were esterified
before conjugations, have blue shifted considerably (about 20
nm), upon conjugation. However, this may not be as a
consequence of conjugation, since the literature reports two
different X  max. of emission at pH > 7, 638 nm and 659 nm
2 +for the complex [R u (bpy)^ (COOHbpy)] . Also depending on 
pH, the emission X  m a x . shifts from 638 nm to 670 nm at low 
pH. [18]
Generally, it is difficult to obtain much 
information from the slight changes occurring in the emission 
spectra of the complexes, when conjugated to the albumins and 
PLL. More information would be available from monitoring the 
changes in emission intensity which occur upon conjugation.
Indeed, this has been reported for ruthenium 
polypyridyl interactions with DNA, where the emission 
intensity and quantum yields were found to increase in the 
presence of DNA. These observations were substantiated from 
measurements of the emission decay lifetimes of the unbound 
and DNA bound ruthenium complexes. [17] The necessity of 
separating bound from unbound ruthenium complexes in this 
work renders it more difficult to monitor changes in emission 
intensity upon conjugation. In the DNA studies just 
mentioned, changes in the emission intensity from the 
ruthenium complexes have been monitored in the presence of 
DNA, and as with the absorption spectra measurements for 
these complexes, separation of any unbound from bound 
ruthenium is not required since the amount of DNA used is in
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excess of the amount of ruthenium complex, so that it is 
assumed that all of the added ruthenium complex becomes DNA 
bound.
The changes in the spectroscopic properties of the 
complexes described here may perhaps be indicative of the 
type, or indeed the site of binding which may make these 
complexes useful probes of protein structure especially in 
terms of their emission decay characteristics which will be 
discussed in Section 4.2.7.
The size and structural conformation of the 
biomolecule to which the ruthenium complex is bound does not 
appear to significantly affect the shape of the absorption or 
emission spectra. The actual binding mechanism leads to 
changes in the spectra but the size and conformational 
characteristics do not. The biomolecules studied in this 
work range in molecular weights of 43,000 (OVA), 67,000 (HSA) 
and 68,000 (BSA) to 109,000 for PLL, yet the absorption and 
emission spectra of a particular ruthenium complex bound to 
different biomolecules are all quite similar.
The structural conformation of the albumins and 
PLL are quite different. Albumins are globular proteins and 
exhibit (a) compact folding with little or no internal space 
for water molecules, (b) internal location of at least 50% of 
the hydrophobic R groups on the amino acid side chains and 
(c) external location of nearly all the hydrophilic R 
groups. The tertiary structure of globular proteins is 
stabilised by hydrophobic interactions between the non-polar 
R groups. [2]
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PLL can exist in an irregular random form at pH 7.0, or as 
an (X -helix at pH 12.0, depending on whether or not the 
E -amino groups of all the lysine residues are charged.
(See Figure 4.10.) At pH 7.0, these groups are charged and 
repel each other so strongly that the tendency for intrachain 
hydrogen bonding is overcome. At pH 12.0, the £ -amino 
groups are uncharged and the polymer adopts an a  -helical 
conformation. [2] At the pH used in these studies (pH 
9.6), it is expected that the polymer may exhibit a somewhat 
intermediatory conformation with quite a number of 
uncharged £ -amino groups.
pH
Figure 4.10 The effect of pH on the transition between the 
random conformation and the a  -helical forms of 
poly-L-lysine. [2]
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Any changes observed in the absorption and emission spectra 
of the ruthenium complexes upon binding to biomolecules are 
difficult to quantify, in terms of the investigations carried 
out in this work. However, differences between binding to 
albumins and PLL are demonstrated from the emission lifetime 
decay measurements. (Section 4.2.7) As already discussed, it 
would be easier to monitor changes in absorption or emission 
properties if the separation step to remove any unbound label 
molecule was not required, as with the DNA studies mentioned 
earlier. In future investigations, it would be interesting 
to monitor changes in the absorption and emission spectra 
(and intensities) upon conjugation by ensuring that the 
protein or polymer concentration is in excess of the 
ruthenium complex concentration, so that all of the ruthenium 
complex would be bound. This would mean that the separation 
step to remove unbound label would not be necessary, and 
changes in absorption or emission properties would be easier 
to follow.
2 +4.2.3 Conjugation of [Ru(bpy)2 (NH2phen)] and
2 +[Ru(phen)2 (NH2phen)] to BSA, HSA and OVA.
The conjugation procedure is detailed in the experimental 
chapter (Chapter 2), and essentially involves the periodate 
oxidation of the carbohydrate moieties of the proteins which 
results in the generation of aldehyde groups which can then 
be condensed specifically with the nucleophilic amine group
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of the ruthenium compounds. This reaction of an amine and an 
aldehyde results in the formation of a Schiff base which is 
stabilised by the addition of sodiumborohydride. The 
reaction sequence is shown below. Mild periodate oxidation 
results in the generation of aldehyde groups which can then 
be condensed specifically with a nucleophile such as an 
amine. [1 ]
protein-CH0H-CH2OH vicinal diol
NaI04
▼
protein-CHO aldehyde
[(NH2phen)Ru(L-L)2]2+ amine
where L-L = bpy or phen
i r
protein-CH=(+NHphen)Ru2+(L-L)2 Schiff base
NaBH4
\ r
protein-CH2-(NHphen)Ru2 + (L-L)2 conjugate
The conjugation ratios were again estimated using both the 
Bradford and Folin-Lowry assays to determine protein 
concentration. The results obtained are presented in Table 
4.3.
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Table 4.3 Assessment of the extent of conjugation of 
[Ru(L-L)2 (NH2phen)]2+ to OVA, BSA and HSA.
Conjugate F/P Absorption Emission
(a)(b) X  max. X max.
BSA:[R u (bpy)2(NH 2 phen)]2+ 4 4 454 609
HSA: [Ru(bpy) 2  (NH 2 phen) ] 24- 3 3 454 610
OVA: [Ru(bpy)2(NH 2 phen)]24 2 3 454 608
BSA:[Ru(phen)2 (NH 2 phen)]24 4 4 450 606
HSA:[Ru (phen)2 (NH 2 phen)]24 4 4 448 610
OVA:[Ru(phen)2(NH 2 phen)]24 2 3 449 609
(1). Fluorochrome to Protein (F/P) ratios were determined 
according to Nairn [4], using Cp (protein conc. in 
mg/ml) calculated from (a) the Folin-Lowry protein 
assay and (b) the Bradford protein assay. The assays 
were performed in duplicate.
(2). Absorption / Emission spectra were measured in 0.1 M 
carbonate buffer, pH 9.6, at room temperature, Xrnax. 
in nm.
The importance of considering which protein assay to use has 
already been highlighted in Section 4.2.2. In these 
investigations, the carbohydrate moieties have been 
modified. Since the carbohydrate moieties are not involved 
in the binding mechanism of either the Bradford reagent or 
the reagents employed in the Folin-Lowry assay, both assays 
may be used to determine the protein concentration. Good 
correlation between both assays was achieved.
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The proteins in this study have been treated as glyco­
proteins. Ovalbumin is a well recognised glycoprotein, with 
approximately 1% by weight of carbohydrate. The 
oligosaccharide groups of most glycoproteins are covalently 
attached to the R groups of specific amino acid residues in 
the polypeptide chain. In ovalbumin, as shown below and 
immunoglobulins, the oligosaccharide moiety is attached via a 
glycosylamine linkage between N-acetyl-D-glucosamine of the 
oligosaccharide to the amide nitrogen of an asparagine 
residue in the polypeptide chain. [2,19]
peptide chain
GlcNAc-►Man-^GlcNAc -►GlcNAc  >-Asn
(Man)4
Ovalbumin
GlcNAc = N-acetylglucosamine, Man = mannose, Asn = asparagine 
The oligosaccharide side chains are underlined.
Both BSA and HSA have been treated as glycoproteins although 
they are not usually regarded as such.
The much lower proportion of carbohydrate moieties 
compared to lysine residues on the protein molecules is 
clearly reflected in the conjugation ratios, with slightly 
higher ratios achieved for the higher molecular weight
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albumins.
This method of binding via the carbohydrate moieties is not 
of particularimportance in terms of albumins because the 
lysine residues can be readily conjugated to label 
molecules. Binding via the carbohydrate moieties on 
immunoglobulins is of more importance because not only does 
it generate specificity in the labelling but it may minimise 
the effect on the affinity of the antibody for the antigen, a 
decrease in which has often been ascribed to the modification 
of the amino acids in or in close proximity to the antigen 
binding site. This will be discussed in more detail in 
Section 4.2.5.
Modification of the carbohydrate moieties of 
albumins demonstrates the feasibility of the technique. 
Albumins are relatively inexpensive in comparison to 
immunoglobulins. This means that reasonable amounts of 
albumins (10-30 mg) were available per conjugation whilst for 
immunoglobulin conjugations only 1-2 mg per conjugation were 
available.
The absorption spectra of the free and bound 
[Ru(phen)2 (NH2 (phen)]2+ and [R u (bpy)2 (NH2phen)]2+ 
are presented in Figures 4.11 and 4.12.
The X  max. of absorption of the conjugated labels 
does not appear to have shifted appreciably. However, the 
changes in the shape of the absorption spectra are somewhat 
similar to those of the conjugates described earlier. The
3MLCT band becomes much less resolved and is broadened 
considerably upon conjugation. Again, the size of the
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Figure 4.11 Absorption spectra of (1) free [Ru(bpy)2
-(NH2phen)] and bound to (2) BSA, (3) OVA
and (4) HSA. The spectra were measured in 0.1 M
carbonate buffer, pH 9.6. Ruthenium complex
_5concentrations are in the range 2-5 x 10 M.
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Figure 4.12 Absorption spectra of (1) free [Ru(phen)2
-(NH2phen)]2+ and bound to (2) BSA, (3) HSA 
and (4) OVA. The spectra were measured in 0.1 M 
carbonate buffer, pH 9.6. Ruthenium complex 
concentrations are in the range 2-4 x 10  ^ M.
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protein does not seem to affect the shape of the spectra.
3The MLCT band for these conjugates appears broader and
3less well resolved than the MLCT band of the ruthenium 
isothiocyanate conjugates. This may be associated with the 
difference in binding sites, where one complex binds via the 
lysine residues and another via the carbohydrate moieties or, 
it may simply reflect differences between the labels.
As with the other conjugates, the emission X max. 
has not changed significantly upon binding to the albumins. 
The X max. may be slightly red shifted, whereas for the 
other conjugates described in Section 4.2.2, where the lysine 
residues are modified, the X max. was blue shifted 
slightly. However, nothing conclusive may be stated, since 
once again the shifts are within instrumental error.
4.2.4. Conjugation of diazotised [Ru(bpy)2~
(NH2phen)]2+ and [Ru(phen)2 (NH2phen)]2+ 
to BSA, HSA and OVA.
Preliminary experiments were carried out on conjugating 
diazotised ruthenium complexes to albumins, which under 
mildly alkaline conditions bind through the tyrosine residues 
of albumins. The amino complexes were diazotised according 
to the method described by Sundberg et a l . [3]. The 
diazotised material was not isolated and the protein was 
added to the diazotised material as soon as it was prepared. 
The conjugation reaction was allowed to proceed as normal, at
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During the diazotisation reaction of [RuCphen^- 
2+(N^phen)] , much of the complex precipitated out of 
solution. The conjugation was still attempted using this 
complex, but very little of the complex was found to bind to 
the albumins. The F/P ratio for all three albumins was <1.
More success was attained with the diazotisation 
2 +of [R u (bpy)2 (NH2phen)] . The complex remained in
solution and a 50:1 molar excess of this diazo solution was 
reacted with the albumins. After conjugation the unbound 
ruthenium complex was removed by dialysis against 0.1M 
carbonate buffer, pH 9.6. In this instance, the protein 
content was estimated by using the Bradford assay since the 
Folin-Lowry assay involves reaction with the tyrosine 
residues. The Folin-Ciocalteu reagent used in the assay 
reacts with the phenolic moieties of tyrosines, the same 
groups which are targeted by the diazo compound. The results 
are presented in Table 4.4.
4°C, in the dark, with minimal agitation.
222
Table 4.4 Assessment of the extent of conjugation of 
diazotised [Ru(L-L)2 (NH2phen)]2+ to BSA, 
HSA, and OVA.
Conjugate F/P % labelling Abs. Em .
ratio efficiency Xmax,. \ m a x .
(1 ) (2) (3) (3)
[Ru(bpy)2 (+N2phen)]2+ - 454 619
BSA: [Ru(bpy)2(+N2phen)]2+ 3 18 455 617
HSA: [Ru(bpy)2(+N2phen)]2+ 2 11 455 620
OVA: [Ru(bpy)2(+N2phen)]2+ 2 22 455 619
PLL: [Ru(bpy)2 (+N2phen)]2+ 1 455 622
[Ru(phen)2 (+N2phen)]2 + - 446 603
BSA: [Ru(phen)2(+N2phen)]2+ <1 <6 445 605
HSA: [Ru(phen)2(+N 2phen)]2+ <1 <6 445 605
OVA: [Ru(phen)2(+N2phen)]2+ <1 <11 445 604
PLL: [Ru(phen)2 (+N2phen)]2+ - 445 605
(1 ) Fluorochrome to Protein (F/P) ratios were determined
using the Bradford assay to determine protein conc . F/P
was calculated according to Nairn. [4]
(2 ) The % labelling efficiencies have been determined based
on the total number of tyrosines, BSA, 17; HSA, 18 7
and OVA, 9. [8,15]
(3) The absorption / emission spectra were measured in 0.1 M
carbonate buffer, pH 9.6 , at room temperature, X max. in
nm.
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The labelling efficiencies have been calculated on the basis 
of total tyrosines rather than available tyrosines so the 
labelling efficiencies could actually be higher.
In mildly alkaline conditions, diazonium salts are 
thought to react preferentially with phenols. Whilst in 
mildly acidic solution, the salts react preferentially with 
amines. [20] By using alkaline conditions in these 
experiments, it has been assumed that only tyrosine residues 
were modified. However, the diazonium salt was found to 
react with PLL (although not to any great extent), which does 
not have any tyrosines, suggesting that the diazonium complex 
does react with the lysine residues of the PLL molecule. 
Diazonium salts have previously been reported to couple with 
histidine and lysine residues [4,21], the efficiency of which 
presumably depends on the pH.
The choice of which assay to employ to determine 
the protein concentration should be considered. In these 
experiments, the total volume remaining after dialysis was 
noted for each conjugate and the protein content determined 
by dividing the total amount of protein used in mg by the 
total volume after dialysis. The results were very similar 
to those obtained using the Bradford assay. This simple 
method of monitoring protein concentration may be just as 
accurate as some of the other assays. Some protein is 
probably lost, through transfer and removal of the conjugate 
solution to and from the dialysis tubing, some protein could 
adhere to the reaction vessel and also to the dialysis tubing 
itself, but use of the Bradford and Folin-Lowry assays can
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also lead to an underestimate of the protein concentration.
Another method of measuring protein concentration 
is by measuring the absorption of the protein in the UV 
region. The ruthenium complexes also absorb about 280 nm, so 
this leads to difficulties in measuring the protein in the 
UV, especially if the extinction coefficient of the complex 
or indeed, the protein varies upon conjugation.
It is not necessary to discuss at length the 
advantages and disadvantages of the various methods of 
measuring protein concentration, since F/P ratios are only an 
estimate and not a precise quantity. However, the choice of 
method should be given some consideration, in order to 
minimise gross inaccuracies.
The coupling of diazonium salts represents just a 
preliminary investigation. Further tests will have to be 
conducted (a) to ensure the successful diazotisation of the
ruthenium complexes and (b) to determine which residues are
being targeted by the diazonium salts. This could be 
investigated by monitoring reactions with simple amino acids 
or poly amino acids in mildly alkaline and acidic solutions.
The absorption spectra of the diazotised ruthenium 
complex together with its conjugate to the albumins and PLL
are presented in Figure 4.13. As with other conjugates the
absorption band in the visible is subject to band-broadening 
effects. The 3MLCT band is also less well resolved than in 
the free diazonium salt.
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Figure 4.13 Absorption spectra of the free and bound
2+diazotised [R u (bpy)^ (Nf^phen)] . The
spectra were measured in 0.1 M carbonate buffer, 
pH 9.6. (1) free label; (2) bound to OVA; (3)
bound to BSA; (4) bound to HSA and (5) bound to 
PLL. Ruthenium complex concentrations are in the 
range 1-4 x 10  ^ M.
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The emission spectrum of the freshly prepared diazonium 
complexes were measured prior to conjugation in order to 
measure the wavelength of maximum emission of the unbound 
complex for comparison with the bound complexes. As may be 
seen from Table 4.4, the shifts in the X  max. are very 
small and are within instrumental error.
4.2.5 Conjugation of ruthenium complexes to
immunoglobulins.
Preliminary studies employed the use of crude preparations of
anti-BSA and anti-mouse IgG. These preparations were impure
in that they contained other proteins, which made the
estimation of the F/P ratios impossible. Also it is
difficult to specify initial molar F/P ratios as 50:1, since
the protein preparation is impure. But as a starting point
the initial ratios were prepared assuming that the
preparation was pure. The conjugation reaction was allowed
to proceed for 18 hours, at 4°C with minimal agitation in
0.1 M carbonate buffer, pH 9.6. The immunoglobulins were
2 +conjugated to [Ru(b py)2 (NCSphen)] and [Ru(phen)2~
(NCSphen)]2+^ thus modifying the lysine residues on these 
immunoglobulins. After conjugation, the unbound and bound 
ruthenium complexes were separated by gel-filtration 
chromatography on Sephadex G-25, using phosphate buffered 
saline, (PBS), pH 7.4 as eluent. The column volume was about 
10 times the volume of the reaction solution. Two coloured
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fractions were collected. The first fraction to elute is the 
high molecular weight conjugate and the second is the unbound 
label (or as discussed earlier the amino precursor complex).
Table 4.5 Spectroscopic data on the immunoglobulin
2+conjugates of [Ru(bpy)^ (NCSphen)] and
[Ru(phen)2 (NCSphen)]2+.
Conjugate Absorption 
X  max.
(nm)
Emission 
X. max.
(nm)
anti-mouse IgG : [Ru(bpy)2 (NCSphen)]2+ 451 606
anti-BSA : [R u (bpy)2 (NCSphen)]2+ 450 606
anti-mouse IgG : [R u (phen)2 (NCSphen)]2+ 448 598
anti-BSA : [R u (phen)^ (NCSphen)]2+ 445 599
The absorption / 
buffered saline,
emission spectra were 
pH 7.4.
measured in phosphate
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The absorption spectra presented in Figure 4.14 show the
spectra of the bound and unbound ruthenium complex
2 +([(Ru(bpy)2 (NCSphen)] which is conjugated to anti-BSA), 
fraction 1 and 2 from the gel filtration column 
respectively. The observed changes in the spectra are 
similar to those already described for other conjugates. It 
is not possible, using the absorption spectra, to distinguish 
between conjugates of albumins, PLL and immunoglobulins, once 
again indicating that it is the fact that the ruthenium 
complex binds to a biomolecule rather than the size of the 
biomolecule which dictates the observed changes in the 
spectra. As for the other conjugates only slight changes in 
the emission X  max, were observed.
Retention of immunological activity was 
demonstrated by ELISA (enzyme-linked immunosorbent assay) 
assays, as described in Chapter 2. For anti-BSA conjugates, 
the microtitre plate was initially coated with BSA, so that 
only the anti-BSA conjugates should bind. Similarly, for the 
anti-mouse IgG conjugates the microtitre plate was initially 
coated with mouse IgG. The specificity of the 
antigen-antibody reaction is such that any non-specific 
protein in the conjugate preparation should be removed by the 
various washing steps in the assay procedure. The positive 
result visualised when the antibody conjugated enzyme label 
reacts with the substrate resulting in a coloured product 
indicates that the immunological activity was retained.
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Figure 4.14 The absorption spectra of the unbound and
2 +anti-BSA bound [Ru(bpy)2 (NCSphen)] , after
gel filtration chromatography using Sephadex 
G-25 and phosphate buffered saline, pH 7.4, as 
eluent.
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Pure anti-IgG was labelled with [Ru(bpy)^ (NCSphen)] and
[Ru(bpy)2(NH2phen)]2+. [R u (bpy)2 (NCSphen)]2+ binds
to the anti-IgG molecule via the lysine residues and
2 +[Ru(bpy)2 (NH2phen)] binds via the carbohydrate
moieties. The methods used to conjugate the complexes to the 
anti-IgG molecule are given in Chapter 2. The anti-mouse IgG 
was reacted with a 50 molar excess of the appropriate 
ruthenium complex. Unbound complex was removed by extensive 
dialysis against 0.1 M carbonate buffer, pH 9.6. The 
conjugation ratios were estimated to be about 3, for 
conjugation via the lysine residues and about 1 for 
conjugation via the carbohydrate moieties. Protein was 
determined using the Folin-Lowry assay. Initial F/P ratios 
of 100:1 and 200:1 were also used, in an effort to increase 
the conjugation ratio for the conjugates bound via the lysine 
residues but the final conjugation ratios after dialysis were 
the same as those calculated for initial F/P ratios of 50:1.
ELISA assays were conducted on all the conjugates 
involving the pure anti-IgG and immunological activity was 
found to be retained in all cases.
An attempt was made to confirm retention of 
immunological activity using immunofluorescence microscopy. 
Solutions of [ Ru ( bpy ) 2 ( NCSphen ) ] 2"*’ conjugates of BSA were 
initially examined under the microscope and it was observed
that a solution of at least 10  ^ M [Rufbpy^- 
2 +(NCSphen)] was required in order to view red fluorescence
under the microscope. Therefore, after reaction of the
2 +Ru(bpy)2 (NCSphen)] : anti-IgG conjugate with isolated
2 +
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mouse spleen cells, with which the anti-IgG molecule should 
bind specifically, quite a large concentration of the 
ruthenium label would have to bind to the spleen cells in 
order to visualise the red fluorescence. Mouse spleen cells 
were incubated with the anti-IgG conjugate at various 
dilutions of the conjugate but after the appropriate 
incubation and washing steps, no red fluorescence was 
observed. In some respects this was not surprising, 
considering that quite a large concentration of the ruthenium 
complex was required to view fluorescence in the first place 
and after the various incubation and washing steps the 
solutions were totally colourless.
Bard [11], has described the use of the active 
ester of [Ru(bpy)2 (COOHbpy)] bound to rabbit 
anti-salmonlla antibody in immunofluorescence studies, but 
specific details on the conjugation ratio were not given.
The initial F/P ratio was in the order of 20:1.
Further studies were hindered due to the lack of 
sufficient quantities of anti-mouse IgG, but obviously 
further investigations are necessary. The fluorescence 
microscope was set up for the routine examination of FITC 
labelled preparations and the filters used in this system 
were also used to examine the ruthenium conjugates. Perhaps 
the use of filters should be investigated further, but since 
the red fluorescence of the BSA conjugates was observed using 
this system it was assumed that these filters were suitable 
for all the ruthenium complexes. The filters used in the 
Nikon fluorescence microscope were Nikon B filter blocks. The
232
excitation filter allows the sample to be excited in the 
range 450 - 490 nm, and the barrier filter operates at about 
520 nm, cutting excitation light not absorbed by the 
specimen which can obstruct fluorescence observation and 
transmits fluorescence of wavelength > 520 nm. The 
difficulties associated with using small quantities of 
anti-IgG for conjugation resulted in conjugates in which the 
IgG concentration was low and consequently, also low in 
ruthenium content. So unlike preparing conjugates of, for 
example BSA where the resultant conjugates were highly 
coloured, the conjugates of anti-IgG were not very coloured. 
In order to conduct in depth studies on conjugation to 
immunological molecules, a sufficient quantity of the 
anti-IgG is essential. Another aspect which should also be 
examined is the suitability of the use of mouse spleen cells 
in these immunofluorescence investigations. Other cell types 
may possess better binding sites for the immunoglobulin.
The conjugation ratios obtained for the ruthenium 
conjugates linked to the 6 -amino groups of lysine residues 
are quite similar to those usually reported for FITC 
preparations. Generally for immunological conjugation 1-4 
molecules of FITC per molecule of IgG is recommended for 
tissue staining procedures and higher ratios could lead to 
loss of immunological activity and also non-specific 
staining.
It has been reported -that there are approximately 
50 lysines available for reaction in IgGs [9], obviously 
labelling with this number would probably lead to
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inactivation of the biomolecule. Most of the literature 
suggests conjugation ratios much lower than this. In fact, 
most fluorochrome / protein ratios reported are less than 10 
molecules of fluorochrome per molecule of protein (where 
lysines are modified). Usual initial FITC / IgG ratios are 
of the order of about 20:1 and result in conjugation ratios 
of about 4:1, which may indicate that there is limited 
accessibility of the label to the protein. This would seem 
to be substantiated in these studies, since use of 100:1 and 
200:1 molar excesses of ruthenium complex to IgG did not lead 
to higher conjugation ratios.
Two small points are worth consideration; (a) any 
inaccuracies in protein estimation could lead to substantial 
errors in estimation of the conjugation ratios especially 
where anti-IgG conjugation is concerned, since the protein 
concentration is quite low initially and (b) at higher 
initial molar ratios such as those described, there is a 
greater chance of inactivation of the immunoglobulin because 
higher volumes of DMF were required to dissolve the ruthenium 
complexes and indeed, some precipitation was observed.
Periodate oxidation of the goat anti-mouse IgG and
2 +subsequent conjugation to [R u (bpy)^ (Nf^phen)] yielded 
an F/P ratio of about 1. The average carbohydrate content of 
IgGs is about 4% consisting of two oligosaccharide chains, so 
a low conjugation ratio is not surprising. The emission 
spectrum of this conjugate after extensive dialysis is 
presented in Figure 4.15 and shows that even at low 
conjugation ratios emission may still be detected, (assuming
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all the unbound label has been removed).
2+Figure 4.15 Emission spectrum of [Ru(b p y ( N C S p h e n )]
bound to anti-IgG (pure preparation), measured
in 0.1 M carbonate buffer, pH 9.6.
The commonly employed chemical reagents for immunoglobulin
conjugations include succinimidyl esters and isothiocyanates 
which react predominately with the e-amino groups of lysine 
residues. This method often leads to poor recovery of the 
antibody and significant loss of immunological activity.
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residues in or in close proximity to the antigen binding
site. Since the carbohydrate moieties of immunoglobulins are
not involved in the process of antigen binding and are most
often situated on the heavy chain in the Fc portion of the
molecule far removed from the antigen binding F , region,
cl D
modification of these carbohydrate moieties should not cause 
a loss of immunological activity, a phenomenon which is more 
common with monoclonal antibodies rather than with polyclonal 
preparations .
The oxidation of carbohydrates with sodium 
periodate is dependent on a number of variables including the 
concentration of oxidant, pH, temperature and time. [1]
Under the suitably mild conditions employed in these studies, 
the oxidation is made specific for the generation of 
aldehydes at the exocyclic C7 atom of the sialic acid 
residues. Sialic acids serve as the terminal residues of the 
oligosaccharide side chains of glycoproteins and are derived 
from glucosamine. Under harsher conditions the amino acids 
serine and threonine may be oxidised, if they occur as 
terminal residues, and this may lead to a reduction in the 
specificity of the site of modification. [1 ]
Inherent in the modification of carbohydrate 
moieties is the fact that F/P ratios achieved by modification 
of lysine residues may be higher than those achieved through 
modification of the carbohydrate sites. The sensitivity of 
the method of detecting a conjugated reporter molecule 
whether the reporter molecule is a fluorescent species, an
This has been suggested to be due to modification of lysine
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enzyme or a radioactive species etc. must be considered. 
Modification of carbohydrate moieties is quite a useful 
method when the loss of immunological activity is being 
avoided, but only a small number of reporter molecules can be 
covalently linked to the oligosaccharide moieties of an 
immunoglobulin, so the method of detecting the reporter 
molecules must be sensitive enough to detect the lower number 
of reporter molecules.
Nairn [4], reports that labelling of 
immunoglobulins with fluorochromes is not evenly distributed, 
some molecules are heavily labelled, others optimally and 
others not at all. This possibility must be taken into 
account when assessing the results from the ELISA assays.
The positive results obtained may originate from the binding 
of an unlabelled anti-IgG molecule to IgG coated on the 
microtitre plates rather than from binding of a ruthenium 
labelled anti-IgG molecule to IgG as depicted below.
]-IgG - goat-anti-mouse IgG - rabbit-anti-goat-Enz* 
instead of :
]-IgG - goat-mouse IgG-Ru* - rabbit-anti-goat-Enz*
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Immunofluorescence microscopy or fluorescent immunoassay 
methods would be more definitive in assessing the retention 
of immunological activity after labelling with the ruthenium 
fluorochromes, although non-specific staining must also be 
considered.
Based on the results obtained, it is probably 
reasonable to assume that if the anti-IgG molecule is not 
over labelled with reporter molecule, the immunological 
activity will be retained.
4.2.6 Conjugation of [Ru(bpy)2 (2,3-butanedione-
dihydrazone)](PFg)2 and its isothiocyanate 
derivative to BSA.
This section describes the use of [R u (bpy)^ (2,3-butane- 
dionedihydrazone)](PFg)2 and its isothiocyanate 
derivative in conjugation procedures. Although these 
complexes do not emit, presumably because of some 
deactivation process associated with the 2 ,3-butanedione- 
dihydrazone (bdd) ligand, it was hoped that emission from the 
conjugate would be observed. The idea to attempt this arose 
from a report regarding the complex [R u (bpy)2 (dppz)]2+/ 
where dppz = phenazine, (Figure 1.13, Chapter 1), which has 
been reported to be a "molecular" light switch for DNA. [22] 
The free complex does not emit in aqueous solution, but upon 
intercalation into DNA, emission is observed. It has been 
suggested that the unbound complex does not emit because the
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nitrogen atoms on the phenazine ring become protonated in the
excited state, thus leading to deactivation of the emission
process. However, it is unclear whether it is the electronic
characteristics of the DNA bases and their overlap with the
dppz ring, the accessibility of the dppz ring to protonation
or some mixture thereof, that is responsible for the emission
of the DNA bound complex. [22]
The complex [Ru(bpy)2 (2,3-butanedionedihydra-
zone)](PF,)~ was synthesised and obtained from Joe Bolger b A
at Dublin City University. The ligand 2,3-butanedione- 
dihydrazone is shown in Figure 4.16.
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Figure 4.16 Structure of 2,3-butanedionedihydrazone, (bdd).
The isothiocyanate derivative was prepared by reaction with 
thiophosgene as described in Chapter 2. The absorption 
spectra of the bdd complex and its isothiocyanate derivative 
are presented in Figure 4.17.
2 +For conjugation to [Ru(bpy)2 (bdd)] , BSA was
as usual, first oxidised with sodium periodate. The albumin 
was reacted with a 50 molar excess of the ruthenium complex
239
and conjugation was allowed to proceed in the usual manner. 
After the conjugation reaction was completed, the unbound 
label was removed by dialysis and the Schiff base was 
stabilised by reduction with sodium borohydride.
Wavelength (nm)
2 +Figure 4.17 Absorption spectra of (a) [Ru(bpy)2(bdd)]
and (b) [Ru(bpy)2(NCSbdd)]2+, in 0.1 M
carbonate buffer, pH 9.6. Ruthenium complex
-4concentrations in the range 7.5 x 10 to 1 x 
10" 5 M .
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The isothiocyanate derivative was reacted with BSA also and 
the unreacted label was removed by dialysis. The absorption 
spectra of the two conjugates are presented in Figure 4.18. 
The protein concentration was determined using the 
Folin-Lowry method. The absorption data pertaining to the 
bound and free complexes are presented in Table 4.6.
Figure 4.18 Absorption spectra of the complexes (a)
[R u (bpy)2 (bdd)]2+ (3 x 10-5 M) and (b)
[Ru(bpy)2(NCSbdd)]2+ (6 x 10" 5 M), 
conjugated to BSA, measured in 0.1 M carbonate 
buffer, pH 9.6.
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As expected the F/P ratio for the complex bound via the 
carbohydrate moiety is considerably lower than that for 
conjugation via the lysine residues. It seems probable that 
only one of the NCS groups (if the two NH2 groups were both 
converted to NCS groups), would bind per lysine molecule.
The F/P ratio for conjugation to the isothiocyanate is 
somewhat lower than those obtained for the other conjugates 
of BSA modified at the lysine residues. However, the 
structural nature of the ligand may prevent the complex from 
coming into close contact with the protein molecule, unlike 
the NCSphen or NCSpy ligands where the NCS moiety can quite 
easily come into close contact with the protein molecule.
As can be seen from the absorption spectra for 
both of the conjugated complexes, the 3MLCT band is red 
shifted and broadened considerably upon conjugation to BSA. 
Similar effects have already been described for the other 
BSA-bound ruthenium conjugates.
The use of these complexes as fluorescent probes 
is not possible since both the bound and free complexes do 
not emit, presumably the 2,3 butanedionedihydrazone ligand 
and its isothiocyantae derivative contribute to the 
deactivation of the emission process. However, conjugation 
of these complexes to BSA demonstrates the flexibility of 
using amino and isothiocyanate ruthenium polypyridyls for 
binding to proteins.
242
Table 4.6 Absorption data and F/P ratios achieved using 
the ruthenium complexes incorporating the bdd 
and NCSbdd ligands.
Complex / Conjugate Absorption F/P
\  max. (nm) ratio 
(1 ) (2 )
[Ru(bpy)2(NCSbdd)]2+ 425 (3.93)
[Rutbpy)2 (NCSbdd)]2+ . BSA 438
[ R u (bpy)2(bdd)]2+ 435 (4.12)
[Ru{bpy)2 (bdd)]2+ : BSA 445
(1) Absorption spectra were measured in 0.1 M carbonate
buffer pH 9.6. Extinction coefficients measured in 0.1
M carbonate buffer, pH 9.6, are in parentheses, units 
are M-l cm-1, log 8 .
(2) Protein conc. was measured using the Folin-Lowry
method. The F/P ratios were determined according to 
Nairn. [4]
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ruthenium complexes and their conjugates of BSA 
and PLL.
The emission lifetimes of selected BSA and PLL conjugates, 
together with the unbound complexes, were measured using the 
time correlated single photon counting technique (TCSPC).
The measurements were carried out in aerated, oxygenated and 
degassed solutions in 0.1 M carbonate buffer, pH 9.6, at 
23°C. Upon binding of BSA and PLL, the complexes display 
essentially double exponential decay behaviour, with a 
component which is substantially longer than the unbound and 
a second component which is short-lived with a lifetime about 
the same or shorter than the unbound complexes. This 
behaviour was exhibited in aerated, degassed and oxygenated 
solutions.
The results have been presented in Table 4.7. The
2emission decay lifetimes of [Ru(bpy)^l and 
2 +[Ru(phen)^] measured in aqueous solutions are also 
included. [23]
The lifetimes of the excited states of the protein 
bound ruthenium complexes were compared to those of the free 
complexes. The excited state decay of both 
[Ru(bpy)2 (NH 2 phen)]2+ and [R u (phen)2 (NH 2 phen ) ] 2  + 
can be fitted well by single exponential kinetics. (Figures 
4.19 and 4.20). The excited states of both complexes are 
efficiently quenched by oxygen.
4.2.7 Emission lifetime measurements of selected
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Figure 4.19 Emission decay profile of [RuCbpy^-
2 +(NH2Phen)] in an aerated solution of 0.1 M 
carbonate buffer, pH 9.6.
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Figure 4.20 Emission decay profile of [Ru(phen)2~
2 +(NH2phen)] in an aerated solution of 0.1 M 
carbonate buffer, pH 9.6.
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Lifetime measurements were also carried out with the 
[Ru(phen)2 (NCSphen)]2+ and [R u (bpy)^ (NCSphen)]2+ 
complexes but the fits were less good for single exponential 
kinetics, (possibly as a consequence of impurities or of the 
instability of these complexes). Interestingly, the measured 
lifetimes of the isothiocyanate derivatives are substantially
longer than those recorded for the corresponding [Rutbpy^-
2 + 2 +(NH2phen)] and [R u (phen)^ (NB^phen) and indeed
2 + 2 +for the [Ru(bpy)^] and [Ru(phen)^] complexes,
which may be indicative of an increase in the energy gap
between the emitting state and the metal centered
deactivating state.
As stated earlier, none of the lifetimes of the
excited states of the conjugates could be fitted to single
exponential kinetics. In some cases triple exponential
analysis gave better fits, but still indicated the dominance
of two exponential decays. Even in the case of poly-L-lysine
conjugates where only one type of amino acid is present,
double exponential analyses were required to obtain an
acceptable fit. Figures 4.21 and 4.22 show emission decay
2 +profiles for [R u (bpy)^ (NCSphen)] bound to PLL, fitted 
to a single exponential decay (Figure 4.21) and to a double 
exponential decay (Figure 4.22). Further investigations are 
ongoing to determine whether these decays (for both BSA and 
PLL conjugates) are truly double exponential or if triple 
exponential kinetics fit the experimental data better.
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Chi Sq= 326
Figure 4.21 Emission decay profile for [Rufbpy^-
2+(NCSphen)] conjugated to PLL fitted to 
single exponential decay kinetics, measured in 
an aerated solution of 0.1 M carbonate buffer, 
pH 9.6.
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Figure 4.22 Emission decay profile for [Rufbpy^-
2 +(NCSphen)] conjugated to PLL fitted to 
double exponential decay kinetics, measured in 
an aerated solution of 0.1 M carbonate buffer, 
pH 9.6.
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Table 4.7 Emission decay lifetimes for the bound and unbound 
complexes measured in 0. 1M carbonate buffer, pH 9.6.
Complex / Conjugate Lifetime(ns) 
Oxygenated Aerated Degassed
(1 ) (2 ) (3)
177 (1.05) 330 (1.18) 610(1.23)
299 [77] 320 [63] 376 [60]
808 [23] 931 [37] 1111 [40]
( 1 .1 0 ) (1.17) (1.16)
156 (1.30) 470 (1.18) 658(1.08)
253 [76] 305 [74] 280 [60]
761 [34] 1018 [26] 1206 [40]
( 1 .47) (1.28) (1.43)
178 (1.54) 425 (1.23) 780(1.12)
363 C880 460 C65D 525 C56D
810 C12D 909 C350 1092 C443
(1 .74) (1.34) (1 .1 1 )
186 [80] 256 [52] 178 [48]
431 [2 0 ] 593 [48] 550 [52]
(1 .25) (1.18) (1.30)
- - 616 [6 8 ] —
---- 1097 [32] 
(1 .2 0 )
— —
169(1.34) 640(1.20) 1201(1.76)
314 [73] 447 [57] 519 [59]
762 [27] 1210 [43] 1380 [41]
(1 .44 ) (1.15) (1.14)
147 [65] 237 [39] 278 [55]
384 [35] 601 [61] 880 [45]
(1 .37) (1.09) (1.75)
150 370 580
150 470 960
[ Ru ( bpy ) 2 ( NH2 phen )
[Ru(bpy)2(NH2phen)] / BSA
[Ru(phen)_(NH-phen)]^T 
[Ru(phen)2 (NH^phen)] / BSA
[ Ru ( bpy ) » ( NCSphen) ]^  + 
[Ru(bpy)2(NCSphen)] / BSA
[Ru(bpy)2(NCSphen)]
[Ru(bpy)2 (NCSphen)]
2 +
2 +
/ PLL
/anti-Ig
2 +[Ru(phen)„(NCSphen) ] 5  +
[Ru(phen)2 (NCSphen)] / BSA
[Ru(phen)2 (NCSphen)]2+ / PLL
[Ru(bpy)3 ]2t+ (5)
[Ru(phen)^] (5)
Samples were measured in (1) 0.1 M carbonate buffer pH 9.6,
which was oxygenated for 30 mins, then about 0.2 ml of sample
was added and further oxygenated for 15 mins; (2) aerated
solution of 0.1 M carbonate buffer, pH 9.6; (3) 0.1 M carbonate
buffer, pH 9.6 was degassed with argon for 30 mins, then about
0.2 ml sample was added and further degassed for 15 mins.
(4) A double exponential fit was also obtained, 915 ns [56] and
1530 ns [44], (1.38). (5) Ref. 23.
Figures in [ ] represents the proportion of each species.
Figure in ( ) are the chi. sq. values.
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The use of mixed ligand complexes might lead to complications
in analysing the double exponential behaviour of the
conjugates, since there is the possibility (although not very
likely, based on the electrochemical results), of two types
of ligand participating in the emission process. However, it
2 +has been shown for [Ru (bpy)^ (phen)] [24], and indeed
for the complexes investigated here, that these exhibit 
single exponential behaviour in the free form. For mixed 
ligand complex interactions with DNA, it has been assumed 
generally that only one type of ligand is involved in the 
emission process from the DNA bound complexes. This 
assumption has been carried through in this work.
Both of the recorded lifetimes of the BSA and 
anti-IgG conjugates are longer than those of the PLL 
conjugates suggesting that the PLL molecule may be more 
accessible to the oxygen quencher.
As a first approximation, it may be assumed that 
decays are double exponential, consisting of a long-lived 
bound species and short-lived unbound / quenched bound 
species. On closer examination of the short-lived component, 
it seems unlikely that this species is the unbound form, 
since the lifetime of the free form in degassed solution is 
much longer than the lifetime of the short-lived species in 
degassed conjugate solutions. Also, all unbound material 
should be removed after dialysis, which removes the unbound 
label. Therefore, this component could be the bound form, 
which appears to be considerably quenched even in the absence 
of oxygen. In the absence of oxygen, other deactivation
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mechanisms must also play a role otherwise no change in 
emission on binding would be observed in degassed solution. 
Bound excited complexes may be quenched by triplet-triplet 
annhilation (collision of two excited complexes) or by 
self-quenching (collision of excited and ground state).
Triplet-triplet annhilation has been proposed to
2 +cause quenching of DNA bound [RuCopy)^] r but in that 
case, high laser excitation intensities were employed [25], 
unlike in these studies where a low intensity lamp was used. 
So triplet-triplet annhilation most likely is not 
significant. Self-quenching is another possibility but this 
is not likely to be of much significance either since the 
lysine residues on the albumins are well separated from each 
other and for the PLL conjugates the Ru/PLL ratio is about 
1:30, implying that the ruthenium molecules may not come into 
contact with each other for this process to occur. However, 
it is difficult to dismiss these possibilities entirely and 
further detailed investigations are required.
This phenomenon of a long-lived component and a 
short-lived component also occurs for ruthenium polypyridyl 
interactions with DNA. The reason for the short-lived 
component has not really been elucidated. It is thought that 
this component may be due to an unbound or bound quenched 
species most probably the latter since in degassed solution 
as in this work the short-lived component was still 
considerably shorter in comparison to the free complex, where 
the emission decay lifetime is considerably longer in 
degassed solutions.
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It is worth pointing out that the long-lived species can be a 
composite of several decays from complexes bound to the same 
chemical site but at different locations along the albumin or 
PLL molecules.
In the absence of quenching, various factors may 
result in the enhancement of the emission lifetime, (a) 
protection from quenching in the sheltered environment of the 
protein molecule, (b) changes in the solvent environment,
(c) a decrease in the vibrational activity of the complex as 
it is held in a more rigid environment and (d) an increase in 
the energy gap between the emitting state and the metal 
centered deactivating state.
It seems likely that (b) and (c) do not play 
very significant roles in explaining why enhancement of the 
emission lifetimes of the ruthenium conjugates occurs here. 
The free and bound complexes have been measured in the same 
solvent so obviously it is not just the solvent which 
contributes to the enhancement of emission lifetime, although 
changes from solvent to solvent would be expected.
The decrease in vibrational activity of the 
complex would be expected to be of more relevance for 
intercalation of the ruthenium complexes into DNA. Here, the 
ruthenium complex is probably not held much more rigidly than 
it is in the free form, although this would depend to a 
certain degree on the conformation of the protein molecule 
and the extent to which the complex is surrounded by protein.
The two main factors governing the enhancement of 
the emission decay lifetimes are probably (a) and to a
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certain extent (d). From the results it can be seen that 
binding to the large protein and PLL molecules affords 
considerable protection from quenching effects. Also it has
been shown in preliminary studies on the interaction of
2 +[Ru(phen)^] with DNA, that enhancement of emission is 
partly due to a reduction in thermal deactivation. This 
requires an increase in the energy gap between the emitting 
state and the higher lying metal centered state which is 
responsible for thermal deactivation. [23] It is possible 
that similar effects for the conjugates discussed here could 
in part be responsible for the increased emission lifetimes.
Consideration of all the parameters involved in 
the interaction of ruthenium polypyridyls with protein 
molecules leads to the conclusion that the excited state 
decay behaviour of the conjugates could be quite 
complicated. It is unlikely that from these studies, a clear 
understanding of what is involved will be obtained, but these 
investigations will hopefully point the way towards 
unravelling the processes involved in the emission decays of 
the albumin / PLL bound ruthenium complexes.
The presence of two components (if not more) is 
consistent with the complexes occupying a number of different 
sites on the albumin / PLL molecules.
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The effect of triplet oxygen on quenching was estimated by 
calculating K^, the quenching rate constant using the 
Stern-Volmer equation:
1 / T = l / , o  + Kq tQ]
where x = quenched lifetime in aerated or oxygenated 
solutions, r o = unquenched lifetime in degassed solution,
= quenching rate constant and [Q] = concentration of 
quencher, in aerated solutions [C^] = 0.265 mM and in 
oxygenated solution [0^] = 1.33 mM. [23] The results have 
been tabulated in Table 4.8.
The oxygen quenching rate constants are markedly 
reduced for the long components of the BSA and PLL 
conjugates, which shows that the excited states of the bound 
complexes are protected from quenching by oxygen.
Substantial differences between the PLL and BSA 
conjugates may be observed, with both of the recorded 
lifetimes being longer for the BSA conjugates than for the 
PLL conjugates. This is reflected in the calculated 
quenching rate constants which are lower for the BSA 
conjugates than for the PLL conjugates indicating that the 
PLL molecule may be more accessible to oxygen than BSA. The 
values shown in Table 4.8 are only indicative as one 
representative emission decay profile was chosen to calculate 
Kg. No attempt has been made to quantify errors in this 
calculation since to do so would be misleading inferring 
accuracy in the measurements. Also, the levels of oxygen
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present in the aerated and oxygenated solutions used in this 
work were assumed to be the same as those reported in the 
literature, [23] and deviations from these values for the 
solutions used in this work would lead to inaccuracies in the 
calculated K values.q
The two recorded lifetimes of the [Rutbpy^- 
2 +(NCSphen)] / anti-IgG conjugates are longer than those of 
either the BSA or PLL conjugates to the same ruthenium 
complex. The lifetime of the long-lived species is just 
slightly longer than that of the long-lived species of 
[Ru(bpy)2 (NCSphen)]2+ / BSA, but the lifetime of the 
shorter component is significantly longer than that of the 
BSA conjugate indicating that perhaps this second bound 
component is not as susceptible to quenching and deactivation 
effects, as the short lived species of the BSA or 
particularly, the PLL conjugates appear to be.
The long lifetimes of the complexes bound via the 
carbohydrate moieties on the BSA molecule are quite similar 
to those measured for the complexes bound via the lysine 
residues. However, the shorter-lived component is 
significantly shorter than those of the complexes bound via 
the lysine residues. This requires further investigation 
because the actual linkage of each complex to the protein is 
quite similar, as depicted in Figure 4.23.
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Figure 4.8 The triplet oxygen quenching rates for the free and 
bound ruthenium complexes in aerated and oxygenated 
solutions.
Emitting species 10-9 Kq M-l sec-1
aerated oxygenated
[Ru(bpy)2(NH2phen)]2+ 5 . 3 3.0
[Ru(bpy)2 (NH2phen)]2+ / BSA 1.8 (s ) 0.5 (s )
0.7 (1 ) 0.3 (1 )
[Ru(phen)2(NH2phen)]2+ 2.3 3.6
[Ru(phen)2 (NH2phen)]2+ / BSA 4.2 (s) * 1.3 (s) *
1.0 (1 ) * 0.4 (1 ) *
[Ru(bpy)2(NCSphen)]2+ 4.0 3.3
[Ru(bpy)2 (NCSphen)]2+ / BSA 1.0 (s ) 0.6 (s)
0.7 (1 ) 0.2 (1 )
[Ru(bpy)2 (NCSphen)]2+ / plL 3.0 (s) ** 1.7 (s) *
1.2 (1 ) ** 0.7 (1 ) *
[R u (phen)2 (NCSphen)]2 + 2.8 3.8
[Ru(phen)2 (NCSphen)]2+ / BSA 1.2 (s ) 1.0 (S )
0.4 (1 ) 0.4 (1 )
[R u (phen)2 (NCSphen)]2+ / pll 2.4 (S ) 2.4 (s)
2 . 0 (1 ) 1.101 (1 )
Those figures denoted with asterisks indicate that triplet 
exponential fits were used to calculate Kq, for the appropriate 
degassed solution, because the double exponential lifetime fits 
were less than the aerated or oxygenated values. The third 
decaying component which is of the order of about 40 - 90 ns not 
has been taken into account. * 462 ns,1383 ns; ** 319 ns,724ns. 
(s) denotes short-lived species and (1 ) denotes long-lived 
species.
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LABEL-[NH-C-NH-]-lysine-PROTEIN 
S
H
LABEL-[NH-C-]-PROTEIN (b)
H
Figure 4.23 Linkage of protein to ruthenium (a) NCS 
complexes via lysine residues; (b) NH2 
complexes via carbohydrate moieties.
It seems unlikely that the presence of the C=S group in the 
linkage group from the ruthenium to albumin would account for 
the longer lifetime of the isothiocyanate complexes. A 
possible explanation which would be of relevance in 
immunoglobulin conjugates is that the carbohydrate moieties 
are located at a specific site on the protein molecule which 
may lead to self-quenching effects. Since, BSA and HSA are 
not generally treated as glycoproteins and references to this 
effect could not be found in the literature, it is difficult 
to speculate on the location of the carbohydrate moieties. 
However, it may be reasonable to assume that the carbohydrate 
moieties are attached to the albumin in a similar manner as 
they are attached to ovalbumin, which is via the aspargine 
residues. The asparagine residues are few in number and are
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well spaced out on the BSA molecule so self-quenching effects 
may not in fact be of relevance here. What may be 
significant is that asparagine is an uncharged polar amino 
acid whilst in contrast lysine is a non-polar amino acid. So 
the orientation of the asparagine residues on the albumin 
molecule may be significant.
The emission lifetime results and indeed Kq
values should be taken as being indicative rather than 
precise values. These measurements were preliminary 
investigations and changes in lifetime values were found 
depending on the starting channel of analysis from which the 
estimation of the fit was calculated. The stop channel was 
the same throughout but the start channel could be varied and 
depending on where this channel was chosen differences in 
lifetimes were observed. If the analysis was started at the 
lowest possible channel, the fits were less good, probably 
because of the inclusion of the lamp profile. However, when 
the analysis was started at the channel with the greatest 
number of counts or the next channel up, good fits were 
obtained. The results presented in this work are those 
obtained from fits where the analysis of the fit was started 
at the channel with the greatest number of counts.
Another factor which should be considered is the 
possibility of "pile up", which depends on the pulse rate of 
the flash lamp. The "pile up" effect may occur if the lamp 
in pulsing at a faster rate than that of the decay of the 
ruthenium complexes. This was not a problem in these
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measurements since the pulse rate of the flash lamp was set 
at a much slower rate than the decay of the sample.
The effect of purging protein solutions with 
either oxygen or argon could lead to denaturation of the 
protein molecules. This was circumvented (it is hoped) by 
purging the buffer before addition of the sample after which 
the solution was only purged for a further 15 mins.
Factors such as the number of counts to collect 
before analysing data and which the time-scale to use should 
also be considered. In general 5,000-10,000 photons were 
accumulated in the highest channel, before the measurement 
was finished. If the TAC (time to amplitude converter) scale 
is not set appropriately, the full decay profile may not be 
measured leading to errors in the calculated lifetimes.
Obviously, the effects of all these parameters on 
the calculated lifetime need to be taken into account. Also, 
it is of course preferable that the measurements should be 
made in at least duplicate if not in triplicate.
4.3 Conclusion
In this chapter, the conjugation of a number of ruthenium 
polypyridyl complexes to albumins, immunoglobulins and 
poly-L-lysine is described.
The complexes were bound at different sites on the 
biomolecules, via the lysine residues, the carbohydrate
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moieties, and via the tyrosine residues. This demonstrates 
the chemical flexibility available for using these complexes 
as reporter molecules. Conjugation via the lysine residues 
has generally remained the most widely used method of 
conjugating reporter molecules to proteins, mainly through 
the use of isothiocyanate moieties or succinimidyl ester 
moieties on the label molecule. This work has shown that 
these moieties may be introduced on ruthenium polypyridyl 
compounds.
The conjugation ratios were estimated and the 
importance of considering which protein assay to employ 
depending on where the reporter molecule binds, in order to 
determine the protein concentration was highlighted..
The effect of conjugation on the spectroscopic
properties of the complexes has been examined. The
absorption spectra were found to exhibit changes in the 
3MLCT band, with the absorption wavelength maximum 
experiencing slight red shifts together with general band 
broadening effects. These effects have also been found for 
ruthenium polypyridyls upon interaction with DNA, with an 
additional effect of hypochromicity of the band maximum. It 
is possible this also arises in this work but the nature of 
the conjugation procedure (i.e. the necessity of having to 
separate the unbound label)/ precludes the possibility of 
investigating this phenomenon.
The emission spectra were measured, however 
changes in the spectra upon conjugation are difficult to
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monitor since the emission band is broad and only slight 
changes in the emission X max. were observed. In addition, 
these changes are within instrumental error. For future 
studies it would be useful to monitor the changes in emission 
intensity upon conjugation.
The emission decay behaviour has also been 
studied. The unbound complexes were found to exhibit single 
exponential decay behaviour and the bound complexes exhibited 
what is essentially double exponential decay behaviour, 
however, a third decaying component may be present. From the 
double exponential decay fits, the first short-lived 
component was deemed to be a quenched bound species whilst 
the second much longer-lived species probably arises from a 
bound complex which is considerably protected from the 
effects of quenching molecules.
The effect of oxygen on quenching was examined.
It was found that the short-lived component was more 
efficiently quenched than the long-lived component which 
exhibited quite a long lifetime in the presence of oxygen and 
which suggests that this species is indeed protected from the 
effects of quenching molecules. It was also found that the 
two decay components of the PLL conjugates were more 
effectively quenched by oxygen than those of the BSA 
conjugates, which is perhaps related to the structural 
conformation of these molecules. It was also observed that 
for those complexes bound via the carbohydrate moieties, the 
short-loved component was significantly shorter than those of 
the conjugates bound via the lysine residues. It is
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difficult to explain this but the effect obviously requires 
further investigation.
Much of the work described in this chapter 
represents initial experiments into the use of these 
ruthenium complexes as reporter molecules in biological 
systems. The interaction of ruthenium polypyridyls with DNA 
has received extensive examination by various groups but the 
use of these complexes as labels for albumins and 
immunoglobulins has not been as extensively studied, 
particularly in terms of the effects of conjugation on the 
spectroscopic properties of the label molecules, but also 
regarding conjugation ratios and the significance of 
targeting different sites on the biomolecules. The 
literature describes the conjugation of ruthenium polypyridyl 
succinimidyl esters to albumins, immunoglobulins and 
nucleotides and the subsequent use of these conjugates in 
time-resolved measurements and in fluorescence microscopy and 
which have been described in a number of patents. [11,26]
These investigations will hopefully initiate 
detailed examination of the complexes in two main areas, (a) 
the study of these complexes in terms of their emission decay 
behaviour with the possibility of their application as probes 
of protein structure and (b) the use of these complexes in 
regard to their potential application as reporter molecules 
in time-resolved immunoassay techniques.
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CHAPTER 5
PREPARATION, CHARACTERISATION AND ACID-BASE 
PROPERTIES OF RUTHENIUM COMPOUNDS CONTAINING 
ASYMMETRIC PYRIDYLTRIAZOLE LIGANDS.
5.1 Introduction
In this chapter, the synthesis and properties of some
24-ruthenium (II) complexes ([Ru(phen)2 (L-L1)] or
2 +[Ru(dmbpy)2 (L-L1)] ), where L-L1 are various substituted 
3-(pyridin-2-yl)-1,2,4-triazole ligands are described. The 
2 ,2 '-bipyridyl (bpy) analogues have already been described. 
[1 ,2], and their properties are compared to those of the 
complexes investigated here. The complexes have been 
characterised using NMR, UV/Vis absorption spectroscopy, 
electrochemistry and emission spectroscopy.
For some of the complexes, geometrical isomers 
were obtained and have been separated using semi-preparative 
HPLC techniques. These were subsequently analysed using 
proton NMR spectroscopy.
The acid-base chemistry (both ground state and 
excited state) has been studied for those compounds where the 
3-(pyridin-2-yl)-1 ,2 ,4-triazole ligand may undergo 
protonation/deprotonation processes.
5.2 Preparation of complexes of the type
[ R u ( L - L ) 2 ( L - L ' ) ] 2 + .
Reaction of cis-[Ru(L-L)2CI2 ]•2H20 where L-L =
1 ,10-phenanthroline (phen) or 4,4'-dimethyl-2 ,2 '-bipyridyl 
(dmbpy) with equimolar amounts of ligand (L-L1), where (L-L') 
= Hptr, H3Mptr, 4Mptr or IMptr (See Figure 5.1 for
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structures, numbers, names and abbreviations of these
ligands), yielded complexes of the type [Ru(L-L)2~
2 +(L-L')] . The compounds were isolated as the divalent
cations with PFg~ as the counter ion. For the ligands
Hptr and H3Mptr, deprotonation occurs easily, therefore to
ensure protonation these complexes were recrystallised from
acidic acetone / H^O mixtures. The purity of the complexes
was analysed using the HPLC method described in Chapter 2 •
For three of the chelating ligands, Hptr, H3Mptr
and IMptr, different coordination modes are possible. For
2 1Hptr and IMptr coordination is possible through the N and
4' .N of the triazole ligand. For H3Mptr coordination is
1' 4 'possible through the N or N of the triazole ring.
Clearly only one coordination mode is possible for the ligand 
4Mptr.
The mode of coordination is anticipated to be
affected by the position of the methyl substituent present on
the triazole ring. Since the ligand Hptr does not have a
methyl substituent on the triazole ring, it is likely that
there is an equal possibility of coordination through either 
2' 4 1the N or N sites on the triazole ring.
On the other hand, the presence of a methyl
substituent on the triazole ring will cause steric hindrance
2 1 1 ' 4 1for coordination at the N / N and N sites on the
2 +triazole ring for the complexes [R u (L-L)2 (IMptr)] and
2 +[Ru (L-L)2 (H3Mptr)] respectively. Therefore it is
likely that coordination will be primarily through the N
2 +  1 ' site for [R u (L-L)2 (IMptr)] and through the N site
4 1
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2 +confirmed for [R u (bpy)^ (H3Mptr)] , the X-ray crystal
structure of which has been determined. [1 ]
2 +for [R u (L-L)2 (H3Mptr)] . This has already been
H
L
T r Q
2' N 1 N - ' g
H
H3Mptr
3-methy1-5-(pyridin-2-yl)
1 ,2 ,4-triazole
Hptr
3-(pyridin-2-y1)-
1 ,2 ,4-triazole
4'
H,C
5’
V
lM3ptr
1-methyl-3-(pyridin-2-yl)
1 ,2 ,4-triazole
4Mptr
4-methyl-3-(pyridin-2y l )
1,2, 4-triazole
Figure 5.1 Structures, names, numbering schemes and
abbreviations of the pyridyl-1,2,4-triazole 
ligands.
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5.2.1 HPLC analysis.
described were analysed using HPLC. The compounds
[R u (L-L)2 (Hptr)]2+ and [R u (L-L)2 (H3Mptr)]2 + are
easily deprotonated and were therefore studied in both a
neutral mobile phase (about pH 6-7) and in an acidic mobile
2 +phase (about pH 2-3). The compounds [ R u (L-L)2 (IMptr)]
2 +and [Ru(L-L)2 (4Mptr)] were separated using the neutral 
mobile phase.
The retention time of each complex is listed in 
Table 5.1. A change in retention time was observed when the 
Hptr and H3Mptr complexes were separated in both mobile 
phases. The UV/vis spectrum was obtained for each 
component. However the different pHs of the two mobile 
phases did not result in a shift of the wavelength of maximum 
absorption, which would be consistent with protonation / 
deprotonation processes occuring. This implies that the 
compounds remained protonated even in the neutral mobile 
phase where the pH is about 6-7. This may be due to the fact 
that the protonated forms were injected onto the HPLC column 
and possibly stay protonated because the pH of the mainly 
organic mobile phase may not be high enough to ensure 
deprotonation. This indicates that the changes in retention 
time observed in both mobile phases may be caused by a medium 
effect and not by protonation / deprotonation effects.
The purity and coordination modes of the ruthenium compounds
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5.2.1.1 [R u (L-L)2 (Hptr)]2+.
These compounds were separated using both mobile phases. Two 
peaks were obtained which are assigned as the two 
coordination isomers. The isomers were better separated 
using the neutral mobile phase (pH about 6-7) in 
approximately equal ratios, i.e. in this mobile phase there 
is better peak to peak resolution, (See Figure 5.2).
Figure 5.2 Chromatograms of the isomers of [Ru(dmbpy)2
(a) (b)
Ml-
Z□
I
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s
■
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o
a
<
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•  *  i *  15
R E T E N T IO N  TIME
(m in i
•  I 1# 15
RETENTION TIME 
( m i n i )
(Hptr)]2+ in (a) acetonitrile : water (80:20) 
with 0.08 M LiCl04 and (b) mobile phase (a) 
adjusted to pH 2-3 with HCIO^. Flow rate =
2.5 ml/min.
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Table 5.1 Retention times of the [Ru(L-L)2 (L-L1)]2+ 
compounds.
Compound Retention time (min)
mobile phase 
neutral acidic
[Ru(dmbpy)2 (Hptr)]2+ isomer 1 2.67 2.42
I isomer 2 4.15 3.14
[Ru(phen)2 (Hptr)]2+ isomer 1 4 . 00 3.42
I isomer 2 6 . 04 5.20
[Ru(dmbpy)2 (H3Mptr)]2+ isomer 1 2.28 2.74
I isomer 2 2.96 3.62
[Ru(phen)2 (H3Mptr)]2+ isomer 1 3.00 3.70
I isomer 2 4 .94 6.08
[Ru(dmbpy)2(IMptr)]2+ isomer 1 2 . 08 -
I isomer 2 2 .62 -
[Ru(phen)2 (IMptr)]2+ isomer 1 2.82 -
I isomer 2 4 .00 -
[Ru(dmbpy)2 (4Mptr)]2+ 3.14 -
[Ru(phen)2(4Mptr)]2+ 5.00 -
The compounds were separated in a neutral (pH about 6-7) 
mobile phase, acetonitrile : water (80:20) with 0.08 M 
LiClO^ and in an acidic mobile phase where the neutral 
mobile phase is adjusted to about pH 2-3 with HCIO^. Flow 
rate = 2.5 ml/min.
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These isomers were separated on the semi-preparative HPLC 
system using the neutral mobile phase, pH 6-7. After 
separation, the purity of the isomers was checked on the 
analytical column, (See Figure 5.3).
2 +The coordination isomers of [Ru(bpy)^ (Hptr)] 
have previously been separated using this method. [1]
wi
h
z3
U.
i
<«3*o
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——  r----- 1 — | ■
S I I  15
r e t e n t i o n  time
(mins) (m ins)
Figure 5.3 Chromatograms of the isomers of [Rufdmbpy^-
2+(Hptr)] after separation in a c e t o m t n l e  : 
water (80:20) with 0.08 M LiClC>4 . (a) isomer 1
(fraction 1). (b) isomer 2 (fraction 2). Flow 
rate = 2.5 ml/min.
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5. 2.1.2 [R u (L-L)2(H3Mptr)]2+.
Isomers of these compounds were found to be present after
HPLC analysis of the recrystallised products. Although this
is not unexpected, only one isomer was observed for the
bipyridyl analogues of these compounds. This may be due to
solubility factors or to the manner in which the compounds
were recrystallised. The ratios of the peaks were
approximately 10-20% for isomer 1 (peak 1) and about 80-90%
for isomer 2 (peak 2). From these peak ratios, peak 1 is
probably due to that isomer where coordination is through the 
4 1N site on the triazole ring which is sterically hindered 
because of the presence of the methyl substituent, (See 
Figure 5.4).
The degree of separation was slightly better in the 
acidic mobile phase. It is possible to achieve separation of 
the isomers on the semi-preparative HPLC system and isomers 
were obtained in mg quantities. Their purity was checked as 
before on the analytical column, (See Figure 5.5).
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Figure 5.4 Chromatograms of the isomers of [Ru(phen)2
2+(H3Mptr)] in (a) acetonitrile : water (80:20) 
with 0.08 M LiCl04 and (b) mobile phase (a) 
adjusted to pH 2-3. Flow rate = 2.5 ml/min.
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( m i n s )  ( m i n s )
Figure 5.5 Chromatograms of the isomers of [Ru(phen)2~
2+(H3Mptr)] after separation in acetonitrile : 
water (80:20) with 0.08 M LiClC>4 . (a) isomer 1 
(fraction 1), (b) isomer 2 (fraction 2). Flow 
rate = 2.5 ml/min.
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5.2.1.3 [R u (L-L))2(L-L1)]2 + , where L-L = dmbpy or
phen; L-L' = IMptr or 4Mptr.
These compounds were separated using the neutral mobile 
phase, (about pH 6-7). Two peaks were obtained for the 
compounds incorporating the IMptr ligand, (See Figure 5.6)
<oKO</>
CD<
J
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•  T  it
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(mins)
T~
15
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— r~ 11 i15
Figure 5.6
RETENTION TIME 
(mins)
Chromatograms of the isomers of (a) [Ru(dm-
bpy)2(lMptr)]2+ and (b) [Ru(phen)2~
(IMptr)]2+ in acetonitrile : water (80:20)
with 0.08 M LiClO.• Flow rate = 2.5 ml/min,4
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The ratios are reversed compared to the [RutL-L^- 
2 +(H3Mptr)] isomers with ratios of about 90-95% for peak
1 (isomer 1) and 5-10% for peak 2 (isomer 2). This suggests
that isomer 2 is the complex where coordination to the
2 'ruthenium is sterically hindered, i.e. through the N 
site on the triazole ring.
The isomers were separated and isolated in mg quantities
and purity was checked using the analytical HPLC column. It
proved difficult to obtain isomer 2 in pure form as can be
seen for example for the dmbpy and phen compounds in
Figures 5.7 and 5.8, however about 8 0% purity was
achieved. Isomer 1 was isolated in pure form. Only one
24-peak was observed for the [R u (L-L)^ (4Mptr)] . This
was anticipated since only one coordination mode is
possible, See Figure 5.9.,
5.2.1.4 Comment on HPLC results.
It is interesting to note that even at this early stage in 
the characterisation of the various ruthenium compounds 
synthesised, it is possible to tentatively assign the 
coordination mode based on HPLC data i.e. peak ratios.
This provides a good basis for further characterisation.
It can be seen that compounds with coordination through the
4 ' 1 1N site on the triazole ring elute first with N /
2 1N coordinating compounds eluting second.
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Figure 5.7 Chromatograms of the isomers of [Rufdmbpy^- 
2+(lMptr)] after separation in acetonitnle : 
water (80:20) with 0.08 M LiClC>4 . (a) isomer 
1 (fraction 1 ) and (b) isomer 2 (fraction 2). 
Flow rate = 2.5 ml/min.
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Figure 5.8 Chromatograms of the isomers of [Rufphen^-
2+(IMptr)] after separation in acetonitnle : 
water (80:20) with 0.08 M LiCl04 . (a) isomer 
1 (fraction 1) and (b) isomer 2 (fraction 2). 
Flow rate = 2.5 ml/min.
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Figure 5.9 2 +Chromatograms of (a) [Ru(dmbpy)2(4Mptr)]
2+and (b) [Ru(phen)2(4Mptr)] in acetonitrile 
: water (80:20) with 0.08 M LiClO^. Flow rate 
= 2 . 5  ml/min.
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5.3 NMR spectroscopic characterisation of complexes of 
the type [Ru(L-L)2 (L-L')]2+.
The presence of two phenanthroline or two dimethylbipyridyl
ligands and one pyridyltriazole renders it difficult to
identify the manner in which the triazole is coordinated
using UV/vis spectroscopic or electrochemical methods. ‘*'H
NMR techniques were used to unambigously assign the mode of
coordination for the pyridyltriazole ligands.
The '*'H NMR data confirm cis-geometry for all the
compounds. [3,4] By using 2D. COSY techniques and by
comparison with assignments made for other similar compounds,
[1 ], a complete assignment of the resonances was made.
2D COSY NMR spectra were obtained for the 
2 +[R u (L-L)2 (4Mptr)] complexes where coordination to
ruthenium via the triazole ring is only possible through the 
2 1N position. These spectra are presented in Figures 5.10 
and 5.11. The methyl / hydrogen resonances of the 
pyridyltriazole ring are quite distinguishable from those of 
the dmbpy and phen ligands. These spectra were very useful 
in assigning the pyridyltriazole resonances of the other 
complexes. By comparison with these spectra, the proton 
resonances of the other complexes were assigned.
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Figure 5.10 COSY NMR spectrum of [Ru(dmbpy)~ (4Mptr)]
measured in ( C D ^ ^ ^ 0,
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Figure 5.11 COSY NMR spectrum of[Ru(phen)2 (4Mptr)]2+ 
measured in (CD^^CO.
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The two possible modes of coordination of ruthenium to the 
Hptr ligand are shown in Figure 5.12.
I R
where R = H, ligand = Hptr; R = CH^, ligand = H3Mptr
Figure 5.12 Possible coordination modes for the two isomers 
of [Ru(L-L)2(L-L1)]2+ where L-L' = Hptr or 
H3Mptr.
For the purposes of this characterisation an analysis of the 
pyridyltriazole resonances is sufficient. The ^H NMR data 
for the coordinated complexes have been tabulated and are 
presented in Tables 5.2 - 5.4. For each pyridyltriazole 
ligand an upfield shift of the H^ proton of the pyridine 
ring ranging from 0.6 - 1.4 ppm, depending on the compound, 
resulted upon bidentate coordination to ruthenium. This 
shift may be explained by diamagnetic anisotrophic 
interaction of this proton with the ring currents of dmbpy 
and phen ligands. [2,5,6 ,7] The other protons have also been 
shifted somewhat because of the influence of the metal atom.
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Table 5.2 lH NMR data for the [Ru(dmbpy)2(L-L1)]n+ complexes.
Compound
[Ru(dmbpy)?(Hptr)]2 + 
Isomer 1 N 4 1 (a )
[Ru(dmbpy)?(Hptr)]2+ 
I s o m e r  2 N 2 ‘ (a)
[R u (d m b p y )7 (ptr ) ] + 
I s o m e r  1 N 4 ' (b )
[ R u ( d m b p y ) , (ptr ) ]+ 
I s o m e r  2 N 2 1 (b)
[Ru(dmbpy)_(H3Mptr)] 2 + 
I s o m e r  1 N 4 ' (a )
[ R u  (dmbpy.) _( H 3 M p t r ) ]2 + 
I s o m e r  2 Nl' (a)
[Ru(dmbpy).(3Mptr)]+ 
Isomer 1 N41 (b )
[Ru(dmbpy)2 (3Mptr)]+ 
I s o m e r  2 Nl' (b)
[Ru (dmbpy)_(IMptr)]2 + 
I s o m e r  1 N 4 1
[Ru(dmbpy).(IMptr)]2+ 
I s o m e r  2 N2'
[Ru(dmbpy)2 (4Mptr)]2+
CH3 H5 ' H3
- 8.38
(+0 .1 1)
8.26
(+0.17)
- 8.66
(+0.39)
8 . 22 
(+0.13)
_ 7.47 8.20
(-0.80) (+0 .11)
- 7 .97 
(-0.30)
7.98
(-0 .11)
1.62
(-0.74)
- 8.16
(+0.14)
2.44
(+0.08)
- 8.14
(+0 .1 2)
1. 37 
(-0.99)
- 8.00
(-0 .0 2)
2.35
(-0 .0 1)
- 8.20
(+0.18)
4.08 8.69 8.40
(+0.11)(+0.08) (+0.24)
3.44 8.78 8.45
(-0.53)(+0.17) (+0.29)
4.39 8.75 8.60
(+0.40)(+0.13) (+0.49)
H4 H5 H6
7.94 7.30 7.62
(-0.04) (-0.21) (-1.08)
7.98 7.32 7.69
(+0.00) (-0.19) (-1.01)
7.91 7.19 7.53
(-0.07) (-0.32) (-1.17)
7.82 7.12 7.53
(-0.16) (-0.39) (-1.17:
7.89 7.23 7.83
(-0 .0 1 ) (-0 .20) (-1.00
7 .97 7.31 7.55
(+0.07) (-0 .12) (-1.28)
7.78 7.07 7.43
(-0 .1 2) (-0.36) (-1.40)
8 . 00 7 .24 7.68
(+0 .1 0) (-0.19) (-1.15)
8.16 7.53 7.89
(+0.25) (+0 .1 0) (-0.77
8.20 7.54 7.89
(+0.29) (+0.11) (-0.77
8.20 7.57 8.09
(+0.25) (+0.10) (-0.57
Complexes denoted (a) or (b) were measured in D20 with a drop of either 
conc. DC1 or NaOD to ensure protonation or deprotonation respectively.
The other compounds were measured in (CD3 )2CO. Figures in parentheses 
are shifts compared to the free ligands measured in (CD3 )2SO, those to 
higher field being positive. Only resonances of the pyridyltriazole 
ligands are included. Resonance positions of the dmbpy ligands are given 
in Chapter 2.
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Table 5.3 1h NMR data for the [Ru(phen)2(L-L')]n+ complexes.
Compound CH3 H5 ’ H3 H4 H5 H6
[Ru(phen)2 (Hptr)J 2 + 
Isomer 1 N 4 1(a )
- 8
(+0
. 37 
.07)
8.34
(+0.25)
8 . 10 
(+0 .1 2 )
7 .24 
(-0.27)
7 .61 
-1.09)
[Ru(phen)?(Hptr)]2 + 
Isomer 2 N2 '(a )
- 8
(+0
.65
.38)
8.31
(+0 .22)
8 .01
(+0.03)
7 .26 
(-0.25)
7 .77 
-0.93)
[Ru(phen).(ptr)]+ 
Isomer 1 N4 1 (b )
- 7
(-0
.43
.84)
8.18
(+0.09)
7.87
(-0 .1 1 )
7.06
(-0.45)
7.51
-1.19)
[Ru(phen)~(ptr)J+ 
Isomer 2 N 2 1 (b)
- 7
(-0
.95
.32)
8.07
(-0 .02)
7.86 
(+0 .1 2)
7.05
(-0.46)
7.54
-1.16)
[Ru(phen)_(H3Mptr)]2 + 
Isomer 1 N 4 ' (a )
1.37
(-0 .99)
- 8.25
(+0.23)
7.93
(+0.03)
7.18
(-0.25)
7.53
-1.30)
[Ru(phen)_(H3Mptr)]2+ 
Isomer 2 Nl' (a)
2.35
(-0 .0 1)
- 8.20
(+0.18)
8.00 
(+0 .1 0 )
7 .24 
(-0.19)
7.68
-1.15)
[Ru(phen)_(3Mptr)]+ 
Isomer 1 N4 1 (b )
1.10
(-1 .26)
- 8.10
(+0.08)
7.82
(-0.08)
7.01
(-0.42)
7.42
-1.41)
[Ru(p h e n )_ (3 M p t r )]+ 
I s o m e r  2 N l 1 (b)
2.15
(-0 .21)
- 8.00
(-0 .0 2)
7.84
(-0.06)
7.02
(-0.41)
7.51
-1.32)
[Ru(p h e n ).(I M p t r )]2+ 
I s o m e r  1 N 4 '
4 . 03 
(+0 .
8.64 8.46 
06)(+0.03)(+0.30)
8 .17 
(+0.26)
7 .42 
(-0 .01)
7.87
(-0.79)
[Ru(p h e n ) (I M p t r )]2+ 3.25 8 .77 8.58 8 . 20 7.43 7.86
Isomer 2 N2' (-0.72)(+0.16)(+0.42) (+0.29) (+0.00) (-0.80)
[Ru(phen)_(4Mptr)]2+ 4.39 8.69 8.64 8.20 7.46 8.09
 ^ (+0.40)(+0.07)(+0.53) (+0.25) (-0.01) (-0.57)
Complexes denoted (a) or (b) were measured in D2O with either a drop of 
conc. DCl or NaOD to ensure protonation or deprotonation respectively.
The other complexes were measured in ( C D 3 )2 CO. Figures in parenthesis 
are shifts compared to free ligand measured in ( C D 3 )2 SO, those to 
higher field being positive. Only resonances for the pyridyltriazole 
ligand are included. The resonances of the phen ligands are given in 
Chapter 2.
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Table 5.4 lH NMR data on [Ru(bpy)2(L - L 1)]n+ complexes.
Compound CH 3 H5 ' H 3 H 4 H5 H6
[R u (b p y ).(H p t r )]2+ 8 .38 8 ,. 27 7 ,.96 7 .36 7 .,62
Isomer 1 N 4 '(a ) (+0 .1 1 ) (+0 .18) (-0 ,. 02 ) (-0 .15) (-1 ., 08 )
[Ru(bpy),(Hptr)]2+ _ 8 .65 8 . 23 8 , 00 7 .26 7 ,70
Isomer 2 N 2 1(a ) (+0 .38) (+0 .14) (+0 .0 2 ) (-0 .25) (-1 .,0 0 )
[Ru(bpy) (p t r )]+ 
Isomer 1 N 4 '(b )
- 7 .54 8 ,.08 1 A 5-7.9 7 .10 7 ,.52
(-0 .73) ( -0,.0 1 ) (-0 .1/ 2 ) (-0 .41) (-1 ,18)
[Ru(bpy) (ptr)]+ _ 7 .99 8 .05 7 . f3-8.0 7 .16 7 ,. 55
Isomer 2 N 2 '(b ) (-0 .28 ) (-0 .04) (-0 .2/ 0 ) (-0 . 28) (-1 .,15)
[R u( b p y ) (H3M p tr )]2+ 2 .40 — 8 ,.24 8 . 08 7 . 41 7 .63
(a ) (+0 .04 ) (+0 ., 2 2 ) (+0 ,.18) (-0 . 0 2 ) (-1 .0 0 )
[R u (b p y )~ (3Mptr)]+ 2 .20 _ 8 ,.02 7 ,.99 7 .23 7 .67
(b ) (- 0.16) (+0 .,0 0 ) (+0 ,.09) (:-o. 2 0 ) (-0 .96)
[R u (b p y ),(lMptr)]2+ 3 .97 8 .73 8 ,36 8 .10 7 .46 7 .58C (+0 .00)(+0 .1 2 )(+0 .24) (+0 ,.19) (+0 .03) (-1 .0 0 )
[Ru(bpy),(4Mptr)]2+ 4.35 8.74 8.59 8.13 7.57 8.05
^ (+0.36)(+0.12)(+0.48) (+0.18) (+0.10) (-0.61)
Complexes denoted (a) and (b) were measured in D 20 with a drop of either 
conc. DC1 or NaOD to ensure protonation or deprotonation respectively. 
The other complexes were measured in (CD3 )2CO. Figures in parentheses 
are shifts compared to the free ligands measured in (CD3 )2SO, those to 
higher field being positive. Only data on pyridyltriazole ligand 
resonances are included.
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For the ligands Hptr, H3Mptr and IMptr the resonance 
positions of the hydrogen / methyl substituent on the 
triazole ring are expected to be influenced by the co­
ordination mode of the ligand. If a nitrogen atom is 
coordinated to ruthenium, the neighbouring group will be 
affected not only by a change in electron density in the 
five-membered ring but also by the shielding cone of a dmbpy 
or phen ring, as has been demonstrated for the bpy analogues
[1], leading to upfield shifts of these resonances. These 
resonance positions are therefore indicative of the manner in
which the pyridyltriazole ligand is coordinated to the
4 'ruthenium and it is expected that for N coordination,
3 'the CH^ on the C position of the H3Mptr ligand and the
5 'H on the C position of the ligand IMptr and Hptr are 
shielded, resulting in a shift of these resonances to a 
higher field relative to the free ligand.
1 1In the case of coordination at N , the CH^ on
3 'the C position of the H3Mptr ligand will not be shielded
and will resonate at lower field. For the ligand IMptr,
2 ' . . .  coordination via N should result in a shift to higher
1 'field for the CH^ group on the N site of the triazole
5 1ring, while the H on the C position should result in a
shift to lower field. This effect has also been shown by
2 +Steel et a l . [8 ], for the complex [R u (bpy)^ (L-L1)]
where L-L' = 3,5-dimethy1-1-(pyridin-2-yl) pyrazole.
Relative to the free ligand, a shift upfield of -0.72 ppm
3 'was observed for the methyl moiety on the C position
2 'close to the coordinating N , while the methyl group on
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the C site was shifted downfield by +0.26 ppm.
For isomer 2 of [R u (L-L)^ (IMptr) ] ,  the
methyl resonance has been shifted upfield by -0.53 ppm and
-0.72 ppm for (L-L) = dmbpy and phen respectively, relative
to the free ligand. This suggests that in this case
2 'coordination to the ruthenium atom is through the N
position of the pyridyltriazole ring. For isomer 1, the
methyl resonance occurs at lower field for both the dmbpy and
phen compounds relative to the free ligand. The shift is
only 0.11 ppm and 0.06 ppm for the dmbpy and phen compounds
4 'respectively. This suggests coordination via the N on 
the pyridyltriazole ligand. It is difficult to 
unambigously assign the coordination mode based on the shifts
5 'of the H proton as only small shifts were observed.
5 1Nonetheless, the H resonances occurred at marginally
4 1higher field for the N coordinated compounds. The effect
is much smaller than for the methyl group because of the
smaller radius of the protons compared to the radius of the
methyl group.
The same effect on the methyl resonance is
2 +observed for the [R u (L-L)2 (H3Mptr)] compounds. For
isomer 1 (protonated), the methyl resonance has been shifted
upfield by -0.74 ppm for the dmbpy compound and by -0.99 ppm
for the phen compound. This indicates that coordination is 
4 1through the N position on the triazole ring. For isomer
2 (protonated), the methyl resonances occur at about the same
frequency as the free ligand. This is anticipated for
1 •coordination via the N position on the pyridyltriazole
5 1
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ligand.
These assignments are in agreement with those
proposed from HPLC data, which suggests that the main
2 +fraction for the [R u (L-L)^ (IMptr)] compounds is isomer
4 '1 where coordination through N is not sterically hindered
and the second smaller fraction (isomer 2 ) is that which
2 1would be sterically hindered (via N coordination). The
2 +reverse is true for the [R u (L-L)^ (H3Mptr)] compounds
where the main fraction (isomer 2 ) should be the isomer which
1 'is coordinated to the ruthenium atom via the N position
where steric hindrance would not be a problem. The smaller
fraction (isomer 1 ) would be subject to steric hindrance.
2 +Deprotonation of [R u (L-L)2 (H3Mptr)] causes
the methyl resonances of the protons on the pyridyltriazole
ligand to shift upfield for both isomers. The shift in the
resonance positions of the triazole protons can be explained
by the increased electron density in the triazole ring of the
pyridyltriazole ligand which probably also affects the
electron density in the pyridine ring of the ligand. [2,9]
It is rather more difficult to assign the 
2 +[Ru(L-L)2 (Hptr)] isomers. The shifts of the methyl
resonances where the methyl substituents are shielded, 
because of the presence of the shielding ring cones of dmbpy 
and phen are sufficiently different to those where shielding 
does not occur, to allow distinction between them. However,
5 'the shifts of the H protons for the protonated isomers of
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the [Ru(L-L)2 (Hptr)] compounds are similar. The NMR 
spectra of these compounds are difficult to interpret because
5 •the H proton resonance will also depend on the location
of the N-H proton. Upon deprotonation there is quite a large
5 'difference between the singlet (H ) resonances, 0.50 ppm
for [R u (dmbpy)2 (Ptr)]+ isomers and 0.52 ppm for the
[Ru(phen)2 (ptr)]+ isomers. This difference in ppm
should facilitate the assignment of the coordination mode.
See Figure 5.13, which shows the "^H NMR spectra for the two
2 +deprotonated isomers of [R u (dmbpy)^ (Hptr)] . From the
5 1data it can be seen that the H of isomer 1 is more
shielded than isomer 2. This suggests that isomer 1 is that
4 1isomer where coordination is through the N position of
5 'the pyridyltriazole ligand where the H proton would be 
affected to a greater extent by the dmbpy/phen shielding 
cone. [1 ]
2 +
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5.13 H NMR spectra of (a) isomer 1 and (b) isomer 
2 of [Ru(dmbpy)2(ptr)]+ . Spectra were 
measured in D20 with one drop of conc. NaOD to 
ensure deprotonation.
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5.4 Electronic spectra and Redox properties.
The electronic and the electrochemical properties of the
complexes are listed in Tables 5.5 - 5.6, together with the
data on their bipyridyl analogues, Table 5.7. [1] The
absorption bands of lowest energy (highest wavelength) can be
*assigned to d J l to jc MLCT bands. [10] The position of
this band is generally taken as a measure of the J l -acceptor
capacity of the ligand. If the ligand is a good Jl-acceptor,
the d J l orbitals are stabilised by the back donation of
electron density from the filled metal orbitals to the
unoccupied JT * orbitals of the ligand. The position of this
band may however, also be influenced by the ct-donor
properties of the ligand. [11]. The redox potentials
presented in Tables 5.5 and 5.6 have been determined by
differential pulse polaragraphy. The cyclic voltammetry
measurements indicate that all redox processes are
quasi-reversible with the difference in peak positions for
the oxidation waves in the range 60 - 150 mV. Figures 5.14
and 5.15 are representative diagrams of electrochemical
measurements, showing oxidation and reduction processes of
2 +the complex [R u (dmbpy)2 (4Mptr)]
Some of the compounds coordinated to the ligands 
H3Mptr and Hptr required the addition of a few drops of conc. 
HCl in order to measure the oxidation potential of the 
protonated species. The reduction potentials could not then 
be determined in these acidic solutions. For solutions where 
acid was not added, the electrochemically induced
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deprotonation process renders it difficult to determine the 
reduction potential accurately.
Figure 5.14 Cyclic voltammogram (a) and a differential pulse 
polarogram (b) showing the oxidation of 
[Ru(dmbpy)2(4Mptr)]2+ in 0.1 M TEAP / 
ch3cn.
295
Cu
rr
en
t
Voltage
6 - 1-8 - 2-0 - 2-2
(V)
Figure 5.15 Differential pulse polarogram showing the 
reduction of the complex [Ru(dmbpy)2- 
(4Mptr)]2+ in degassed 0.1 M TEAP / CH3CN.
Table 5.5 Electronic and electrochemical data for the [Ru(dmbpy)2 
-(L-L')]n+ complexes.
[Ru(dmbpy)2- Absorption Emission Redox Potentials
(L-L')]n+ X. max nm Xmax nm Ru Ligand based
where L-L' = (log £ )(d) 303 K 77 K V vs S.C.E.
(e)
Hptr isomer 1 450(4.00) (a 624 586 1.08 -1.59, -1.84
Hptr isomer 2 443(4.02) (a 621 (a 585 1.09
ptr- isomer 1 483(3.93) (b 667 <b 609 0.72 -1.75, -1.85
ptr- isomer 2 482(3.96) (b 674 (b 616 0.75 -1.63, -1.83
H3Mptr isomer 1 452 - (a 624 <a 590 1.06 -1.58, -1.81
H3Mptr isomer 2 440(4.14) (a 629 (a 583 1.09
3Mptr~ isomer 1 484 - (b 673 (b 623 0.71 -1.64, -1.88
3Mptr- isomer 2 480(4.02) (b 682 (b 
620 (C 
628 (C 
622 (C 
618
622 0.72 -1.60, -1.85
lMptr isomer 1 450(4.15) (c 582 1.08 -1.54, -1.75
IMptr
4Mptr
dmbpy
isomer 2 432(4.09)
448(4.21)
450
(c
(c
585
600
1.18 -1.49, -1.69
1.09 -1.53, -1.72, -2.02
1.10 -1.45
(a ). Protonated in solvent with one drop 6 M HCl.
(b). Deprotonated in solvent with one drop 6 M NaOH.
(c). Measured in CH3CN, protonated or deprotonated as
appropriate with HC1 or NaOH.
(d). Log E , units M-l cm-1.
(e). Spectra measured at 77 K in EtOH, protonated or deprotonated as 
appropriate with HCl or NaOH.
(f). Measured in CH3CN with 0.1 M NEt4C104 (TEAP), volts vs
S.C.E., N.H.E. = S.C.E. +0.2415V; protonated or deprotonated as 
appropriate with HCl or NaOH.
(g ). Ref. 10.
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Table 5.6 Electronic and electrochemical data for the [Ru(phen)2- 
(L-L')]n+ complexes.
[Ru(phen)2- Absorption Emission Redox Potentials
(L-L*)]n+ X max nm X max: nm Ru Ligand based
where L-L' = (log e )(d) 303 K 77 ] 
(e)
K V vs S.C.E.
Hptr isomer 1 445(4.22)(a) 611(a) 573 1.19 -1.51, -1.76, -2.03
Hptr isomer 2 416(4.15)(a) 607(a) 568 1.18 -
ptr-
ptr-
isomer
isomer
also 435 (sh)
1 478(4.08)(b)
2 475(3.99)(b)
(b)651
663<b’
603
600
0.84
0.86
-1.64, -1.89 
-1.51, -1.75
also 420
610U )
612U 1
H3Mptr isomer 1 449 - (a) 575 1.19 -
H3Mptr isomer 2 426 (4.21)(a) 
also 435 (sh)
568 1.20 - -
3Mptr- isomer 1 474 - {b) 651(b) 608 0.87 -1.57, -1.81
3Mptr- isomer 2 478(4.08)(b) 673(b) 608 0.71 -1.66, -1.90, -1.99
lMptr isomer 1 448(4 . 10 )(c) 594(c) 568 1.19 -1.42, -1.65, -1.84
IMptr isomer 2 434 - (c) 610(C)
600(C)
604
577 1.33 -1.40, -1.56, -1.75
4Mptr 
phen (?)
4 4 0 ( 4 . 23 )(c) 
442
576
568(
1.20h)1. 27
-1.46, -1.64 
-1.35
(a). Protonated in solvent with one drop 6 M HCl.
(b). Deprotonated in solvent with one <drop 6 M NaOH.
(c). Measured in CH3CN, protonated or <deprotonated as
appropriate with HC1 or NaOH.
(d). Log 6 , units M-l cm-1.
(e). Spectra measured at 77 K in EtOHr protonated or deprotonated as
appropriate with HC1 or NaOH.
(f). Measured in CH3CN with 0.1 M NEt4C104 (TEAP) , volts vs
S.C .E., N.H .E . = S.C.E. +0 .2415V; protonated or deprotonated as
appropriate with HC1 or NaOH.
(g). Ref . 1 0 .
(h). Ref . 1 2 .
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Table 5.7 Electronic and electrochemical data for the [Ru(bpy)2
(L-■L' )]n+ complexes1. H I
[Ru(bpy)2 Absorption Emission Redox Potentials
(L-L1)]n+ \  max nm X max nm Ru Ligand based
where L-L1 = (log e )^ 300 K 77 K 
(e)
V vs S.C. E.
Hptr isomer 1 452(4.05)(a) 616(a) 590 1.20 -1.47, -1.72
HPtr isomer 2 444(4 .11) 625(a) 575 1.10 -1.49, -1.73
ptr- isomer 1 488(3.97)(b) 670(b) 609 0.90 -1.51, -1.78
ptr- isomer 2 484(4.04)(b) 670(b) 608 0.83 -1.48, -1.74
H3Mptr 444(4.03)(a) 600(a) 587 1.20 -1.55, -1.81
H3Mptr 476(3.93) 660(a) 610 0.79 -1.50, -1.72
IMptr 452(4.03)(C)J V 600(C) 585 1.20 -1.42, -1.64
4Mptr 440(4.16) 600(C) 584 1.21 -1.42, -1.64
bpy (3) 452(4.11) 608 582 1.22 -1.36, -1.53
{a ) . Protonated in solvent with one drop 6 M HCl m
(b). Deprotonated in solvent with one drop 6 M NaOH.
(c). Measured in CH3CN, protonated or deprotonated as 
appropriate with HCl or NaOH.
(d). Log £ , units M-l cm-1.
(e). Spectra measured at 77 K in EtOH, protonated or deprotonated as 
appropriate with HCl or NaOH.
(f). Measured in CH3CN with 0.1 M NEt4Cl04 (TEAP), volts vs 
S.C.E., N.H.E. = S.C.E. +0.2415V; protonated or deprotonated as 
appropriate with HCl or NaOH.
(g). Ref. 10 .
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For the dications the position of the MLCT band occurs at
2 +about the same energy as their [Rutdmbpy)^] and
2 + 2 +[Ru(phen)^] analogues and indeed [Ru(bpy)^] . The
24-exception was isomer 2 of the [R u (L-L)„(IMptr)]
compounds where the MLCT band is found at higher energy,
which indicates that in this coordination mode, i.e. via 
2 'N on the pyridyltriazole ring, the ligand may act as a 
stronger Jt -acceptor. The oxidation potential of isomer 2 for
the IMptr coordinated compounds is higher than for the
2 + 2 + analogous [Rutphen)^] or [Rutdmbpy)^] compounds,
while the first reduction potential is still more negative
than for the tris compounds but slightly less negative than
for the other pyridyltriazole compounds. This higher
oxidation potential combined with the higher energy MLCT band
may indicate a decrease in the (7 -donor capacity of the
ligand. The effective charge on the ruthenium is decreased
which in turn stabilises the metal dJt orbitals.
2 +Deprotonation of the [Ru(L-L)^ (H3Mptr)] and 
2 +[Ru(L-L)2 (Hptr)] compounds causes profound changes in
their absorption, emission, (see Figures 5.16 - 5.18) and
electrochemical properties. Deprotonation leads to a shift
to lower energy for the MLCT band and a decrease in the
oxidation potential. These effects may be explained by the
increase in ct-donor properties due to the increase in
electron density in the triazole ring. These effects are
also reflected in the shift to lower energy of the emission
band upon deprotonation. Deprotonation tends to destabilise
*the metal d orbitals causing the d jt - Jt band to be
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shifted to lower energy. The reduction potentials also shift 
to a more negative value for the deprotonated compounds.
Figure 5.16 Emission spectra at low temperature (77 K), in 
ethanol of the protonated (1) and deprotonated
(2) forms of [Ru(phen)2(Hptr)]2+, isomer 1.
Wavelength (nm)
Figure 5.17 Absorption spectra in acetonitrile of (a) the
protonated form and (b) the deprotonated form of
2+isomer 1 of [Ru(dmbpy)2(H3Mptr)] . One drop
of 6 M HCl or 6 M NaOH was added to ensure 
either protonation or deprotonation.
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Wavelength (nm)
Figure 5.18 Absorption spectra in acetonitrile of (a) the
protonated form and (b) the deprotonated form of 
isomer 2 of [Rufdmbpy^tHSMptr) ]2+. One 
drop of 6 M HC1 or 6 M NaOH was added to ensure 
either protonation or deprotonation.
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to the first reduction potential of the appropriate
2 + 2 +[Ru(phen)^] and [RuCdmbpy)^] analogues. This
suggests that this reduction is dmbpy/ phen based and also
*indicates that the Jl levels for the pyridyltriazole 
ligands are at higher energy than those of bpy, dmbpy and 
phen and therefore, the pyridyltriazole ligands are harder to 
reduce. This implies that phen and dmbpy act as the emitting 
ligand whilst the pyridyltriazole ligands act as spectator 
ligands. In general, the reduction potentials become less 
negative with increasing Jl-acceptor abilities of these 
ligands. [2 ]
Spectrophotometric titrations have shown that the
2 +triazole N-H in isomer 2 for [R u (dmbpy)^ (Hptr)] and
2 +[Ru(phen)2 (Hptr)] is more acidic by about two orders of
magnitude than for isomer 1. This implies that the ligand
possesses better O  -donor properties when coordinated in this
2 1 1 1mode, i.e. via N / N position.
These results are in agreement with the NMR data
2 'discussed earlier where coordination through the N /
1 1N position on the triazole ring for isomer 2 and via the 
4 1N position on the triazole ring for isomer 1, was 
proposed for the Hptr / H3Mptr coordinated compounds.
3 1The substitution with a methyl group on the C 
position of the triazole ring (H3Mptr) appears to have had 
little effect on the electronic and electrochemical 
properties, with data being similar for both the Hptr and 
H3Mptr coordinated compounds (protonated and deprotonated).
The first reduction potential of each complex is very similar
304
The absorption spectra of the isomers of the deprotonated 
compounds are very similar, so it would be difficult to 
differentiate between isomers on the basis of their 
deprotonated spectra. However, the spectra of the protonated 
isomers are quite dissimilar which allows the distinction 
between them. See Figures 5.17 and 5.18 earlier.
The addition of a methyl substituent on either the
]_'N site of the triazole ring for isomer 2 of [Ru(L-L)2 
2+ 4 1-(IMptr)] or the N site of the triazole ring for
2 +[Ru(L-L)2(4Mptr)] results in spectra which are
comparable to the spectra for the protonated isomer 2 of the
Hptr and H3Mptr coordinated compounds. The spectrum of
2 +[Ru(L-L)2 (IMptr)] isomer 1 is similar to the protonated
2 +spectra of isomer 1 of [R u (L-L)^ (Hptr)] and
2 +[Ru(L-L)2 (H3Mptr)] . This would be expected since the
isomer 1 compounds are all thought to be bound to ruthenium 
4 'via the N position of the triazole ring and the isomer 2
1 ' 2 1compounds via the N / N position of the triazole ring.
All the compounds show emission at 77K and at room 
temperature. For all compounds, emission at low temperature 
is stronger than that at room temperature. A number of 
factors affect the intensity of emission including the energy 
difference between the deactivating anti-bonding d-d orbital
3and the emitting MLCT state. At room temperature this 
deactivating state may be thermally populated, thus leading 
to a decrease in the emission intensity. [11,12,13]
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literature, a linear relationship exists between the energy 
of the lowest MLCT band and A anc  ^ between A E]_/2
and the emission energy. [11,14] This relationship also 
holds for the compounds investigated here and indeed for 
their bisbipyridyl analogues, indicating that emission 
originates from the same 31* orbitals as observed for other 
ruthenium polypyridyl complexes. In Figure 5.19, the 
absorption and emission maxima converted to eV versus 
A ^1/ 2, the difference between the oxidation and 
reduction potential are plotted. Evidently, the emission / 
absorption maxima correlate well with the electrochemical 
measurements. The plots show that the electronic and 
electrochemical properties of the ruthenium bipyridyl, 
dimethylbipyridyl and phenthroline compounds are similar.
This can be explained by assuming that the same type of 
orbital plays a role in the absorption and emission processes 
as well as the oxidation and reduction processes of the 
compounds.
2 +For many [R u (bpy)2 (L2 )] compounds reported in the
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AEl/2 (V)
Figure 5.19 Plots of vs absorption and (b)
emission energies for compounds (1 ) to (20), as 
listed below.
2 +(1) [R u (dmbpy)2 (IMptr) , isomer 1; (2) [R u (dmbpy)
2+(IMptr)2 +> isomer 2; (3) [R u (dmbpy)2 (4Mptr)] ; (4)
2 +[Ru(dmbpy>2 (Hptr)] , isomer 1; (5) [Ru(dmbpy)2~
(ptr)]+ , isomer 1 ; (6 ) [R u (dmbpy)2 (p tr)]+ , isomer 2 ;
(7) [Ru(dmbpy)2 (H3Mptr)]2+, isomer 1; (8 ) [Ru(dmbpy)2
-(3Mptr)]+ , isomer 1; (9) [Ru(dmbpy)2 (3Mptr)]+ , isomer
2; (10) [Ru(dmbpy)3 ]2+ , Ref. 10; (11) [Ru(phen)2~
2+ +(Hptr)] , isomer 1; (12) [Ru(phen)2 (ptr)] f isomer 1;
(13) [Ru(phen)2 (ptr)]+f isomer 2; (14) [Ru(phen)2~
(3Mptr)]+ , isomer 1; (15) [Ru(phen)2 (3Mptr)]+ , isomer
2; (16) [Ru(phen)2 (IMptr)]2+, isomer 1; (17) [Ru-
(phen)2 (IMptr)]2+, isomer 2; (18) [Ru(phen)2~
(4Mptr)]2+; (19) [Ru(phen)3 ]2+, Ref. 10; (20) [Ru-
(bpy)3 ]2+* Ref. 10.
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5.5 Acid-Base chemistry
In this section the pH dependence of the ground state and of
2 +the excited state of [R u (L-L)^ (Hptr)] (isomers 1 and 2 )
2 +and [Ru(L-L)2 (H3Mptr)] (isomer 2) have been studied
using UV/vis and luminescence spectrophotometry. There were
insufficent quantities of isomer 1 of the [RutL-L^- 
2 +(H3Mptr)] compounds isolated to allow a pH titration to 
be carried out.
The acid-base chemistry of the free ligands has 
already been investigated and also that of the analogous 
bipyridyl compounds, [1,15], which readily allows comparison 
with the data obtained for the coordinated ligands.
5.5.1 Electronic spectra and ground state acid-base
properties.
The effect of pH on the UV/visible spectra of the ruthenium 
compounds was investigated. The cations exhibit pH 
dependence of the lower energy MLCT band. Figures 5.20 - 
5.25. All changes are fully reversible and independent of 
the direction of pH change. The spectroscopic data, pK
a .
and pK * (excited state pK ) values are presented in a a
Table 5.8. The observed behaviour can be explained by 
deprotonation of the pyridyltriazole ligands at higher pH 
yielding [R u (L-L)2 (p t r )]+ and [R u (L-L)2 (3Mptr)]+ and 
has been found for the corresponding bipyridyl compounds.[1 ].
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Table 5.8 Acid-base data for the pyridyltriazole coordinated complexes.
Compound isomer No. Abs.(a) 
X. max
acid base
Em.(a) 
K  max.
acid base
(b)pKa W  (t>)pHi pKa*
(1 ) (2 )(
[Ru(phen)2 (Hptr)]2+ 1 444 465 603 639 5.85 5.61 4 .03 3.81
[Ru(phen)2 (Hptr)]2+ 2 416 460 
(435,sh)
608 640 4.28 3.84 2.31 1.99
[Ru(dmbpy)2 (Hptr)]2+ 1 446 468 627 650 6.13 5. 93 4.78 4.99
[Ru(dmbpy)2 (Hptr)]2+ 2 438 466 632 654 4.40 3.40 2.16 2.34
[Ru(phen)2 (H3Mptr)]2+ 2 418 460 
(435,sh)
606 645 5.06 4.25 2.63 **
[Ru(dmbpy)2(H3Mptr)]2+ 2 438 466 616 660 5.23 5.13 2.97 -
[Ru(bpy)2(Hptr)]2+ 1 450 470 615 650 5.95 5.10 5.20 4 . 22
[Ru(bpy)2 (Hptr)]2+ 2 437 465 620 650 4.07 2.70 3.40 2.12
[Ru(bpy)2 (H3Mptr)]2+ 
Hptr (d)
H3Mptr
440 466 612 645 4.87
9 . 20 
9.80
4.20 4.30 4.44
(a) Absorption and emission spectra were measured at 303 K, in Britton- 
Robinson buffer, X  max in nm.
(b) Ground state pKa and pHi, obtained from the inflection points of 
the absorption and emission titration curves respectively, are 
correct to +/- 0 .1 .
(c) pKa*» the excited state values were obtained from Eqn. 5.2, [16],
for those values listed under (1); and from Eqn. 5.1, [17], for
those values listed under (2). See Section 5.5.2.
(d) Data obtained from References [1] and [15].
(e) Lifetimes T , measured in Britton-Robinson buffer at room temper­
ature, [Ru(phen)2 (Hptr)]+: isomer 1 , 8 ns, isomer 2 , 6 ns;
[Ru(phen)2 (ptr)]2+: isomer 1, 499 ns, isomer 2, 428 ns;
[Ru(dmbpy)2 (Hptr)]+: isomer 1, 11 ns, isomer 2, 7 ns;
[Ru(dmbpy)2 (ptr)]2+: isomer 1, 95 ns, isomer 2, 80 ns.
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[Ru(L-L)2 (Hptr)]2 + ,'v-
pK (acid)
H
[Ru(L-L)2 (p tr)]
The shift to higher wavelength (lower energy) upon 
deprotonation is consistent with a destabilisation of the 
metal d orbitals because of increased sigma donor capacities 
of the triazole ring. As the 71 * levels of dmbpy or phen are 
not altered significantly when the triazole ligand is 
deprotonated, this leads to a small difference between the 
filled d orbitals and the empty Jt * orbitals of dmbpy / 
phen. The pK values presented in Table 5.8 (obtained from
cl
the inflection point of an absorption vs pH plot), show that 
the ligands act as stronger acids when coordinated to the 
Ru(phen)2 / Rufdmbpy^ moiety which can be attributed to 
electron donation from the pyridyltriazole ligand to the 
central metal ion. The pK values are higher for the
cl
H3Mptr coordinated compounds which is expected from the 
electron donating properties of the methyl group. This has 
also been found for [(NH^)^Ru(HMe2p z ) ] ,  (HMe2Pz)
= 3 ,5-dimethyl-pyrazole) where the pK^ was found to be 
higher than the pKg of [(NH^)^Ru(Hpz)]^+ . [18]
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is more acidic than the free ligand. This effect of
increased acidity has been found for a number of compounds
including recently, R u Copy^ compounds of 3-(2-hydroxy-
phenyl)-5-(pyridin-2-yl)-1,2,4 triazole and 3,3-dimethyl-
5 , 5 1-bis-1,2,4 triazole. [19,20], and may be attributed to
electron donation from the ligand to the central metal atom.
The only compound for which acidity has been decreased is
3 +[Ru(NH^) (pyz)] , (pyz = pyrazine), which may be
attributed to back donation of electron density from the 
filled metal based t_ orbitals to the unoccupied jt *2g
orbitals of the ligand. [21 ].
The results obtained for the compounds discussed 
here are very similar to the data obtained for the bpy 
analogues. The pK values of the two isomers of the3.
2 +[Ru(L-L)2 (Hptr)] compounds are quite different, the
pK^ of isomer 2 is about 2 orders of magnitude lower than
for isomer 1. This suggests that the coordinating nitrogen
for isomer 2 is a better O-donor than for isomer 1. This
2 'indicates that coordination for isomer 2 occurs via the N 
position of the triazole ring since the presence of a 
nitrogen adjacent to the coordinating nitrogen is considered 
a better a  -donor. This supports the NMR evidence discussed 
earlier.
The pK of isomer 2 of [R u (L-L)- (H3Mptr)]2+cl ^
is slightly higher as would be expected due to the presence 
of the electron donating methyl group on the triazole ring, 
which yields a higher electron density on the triazole ring,
For most compounds the coordinated ligand in the ground state
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but is comparable to the pK^ of isomer 2 of [RutL-L^- 
2 +(Hptr)] which suggests that coordination is through the
1 IN position of the triazole ring. No evidence for further 
protonation was found at very low pH, which suggests that 
there is a reduction in the basicity of the coordinated 
ligand. It should be noted that protonation is hindered by 
coordination of the ligand to the ruthenium ion. Protonation 
of the free ligand probably occurs at the pyridine ring since 
pyridine is more acidic than 1,2,4 triazole.
There was insufficient sample available in order 
to conduct a pH titration curve on isomer 1 of the H3Mptr 
coordinated complexes, but the pK values of the isomer 2cl
compounds were comparable to those for isomer 2 of the Hptr 
coordinated complexes, allowing for a slight increase due to 
the methyl group. It seems likely that the pK of isomer 1cL
of the H3Mptr coordinated complexes would also be comparable 
to those of isomer 1 of the Hptr coordinated complexes.
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Figure 5.20 pH dependence of the absorption spectrum of 
[Ru(phen)2(Hptr)]2+, isomer 1, (1)— (31): pH 
= 1.53, 2.50, 3.07, 3.51, 3.73, 4.06, 4.17, 
4.28, 4.39, 4.50, 4.62, 4.75, 4.90, 5.05, 5.22,
5.37, 5.55, 5.73, 5.88, 6.02, 6.22, 6.43, 6.62,
6.85, 7.08, 7.53, 8.01, 9.02, 10.01, 11.02 and
Figure 5.21 pH dependence of the absorption spectrum of 
[Ru(phen)2(Hptr)]2+, isomer 2, (1)— (25): pH 
= 1.00, 1.50, 2.01, 2.53, 3.03, 3.55, 3.77, 
3.92, 4.14, 4.28, 4.42, 4.60, 4.80, 4.92, 5.07, 
5.24, 5.58, 5.73, 6.03, 6.40, 6.85, 7.01, 8.12, 
10.06 and 11.10.
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Figure 5.22 pH dependence of the absorption spectrum of
[Ru(dmbpy)2(Hptr)]2+, isomer 1, (1)— (33)s pH 
= 1.00, 2.00, 3.05, 3.45, 3.74, 4.02, 4.25,
4.43, 4.61, 4.73, •h00«■«* OJo•in 5.19, 5.30, 5.56
5.75, 5.83, 6.00, 6.18, 6.34, 6.50, 6.62, 6.82
7.01, 7.32, 7.55, 7.86, 8.05, 8.48, 9.05, 9.56
10.02 and 11.00.
Figure 5.23 pH dependence of the absorption spectrum of 
[Ru(dmbpy)2(Hptr)]2+, isomer 2, (1)— (29): pH 
= 1.46, 2.04, 2.53, 3.04, 3.39, 3.62, 3.91, 
4.14, 4.27, 4.38, 4.53, 4.68, 4.83, 4.97, 5.12,
5.31, 5.49, 5.76, 6.01, 6.02, 6.44, 6.66, 7.07,
7.52, 7.99, 9.01, 10.03, 11.01 and 12.01.
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pH
Figure 5.24 pH dependence of the absorption spectrum of 
[Ru(dmbpy)2(H3Mptr)]2 , isomer 2, (1)— (37)s 
pH = 1.53, 2.05, 2.54, 3.01, 3.33, 3.62, 3.83, 
4.01, 4.22, 4.37, 4.47, 4.58, 4.69, 4.79, 4.92,
5.00, 5.07, 5.16, 5.28, 5.35, 5.47, 5.63, 5.79,
5.90, 6.05, 6.15, 6.25, 6.41, 6.64, 6.84, 7.07,
7.48, 8.12, 9.02, 10.06, 11.03 and 12.02.
PH
Figure 5.25 pH dependence of the absorption spectrum of 
[Ru(phen)2(H3Mptr)]2+, isomer 2, (1)— (29)s 
pH = 0.83, 2.01, 2.51, 2.71, 2.93, 3.16, 3.31, 
3.53, 3.75, 3.91, 4.14, 4.33, 4.50, 4.74, 4.93,
5.14, 5.30, 5.51, 5.74, 6.04, 6.25, 6.57, 6.79,
7.05, 7.51, 8.02, 9.04, 10.02 and 12.00.
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5.5.2 Emission spectra and excited state properties.
The effect of pH on the emission properties of the complexes
was also investigated. The emission spectrum as a function
2 +of pH of [Ru(dmbpy)2 (Hptr)] , isomer 1, is presented in
Figure 5.26. This spectrum is typical of these compounds, 
with the emission intensity increasing with increasing pH and 
the X max. of emission shifting to lower energy upon 
deprotonation.
Wavelength (nm)
Figure 5.26 pH dependence of the emission spectrum of
[Ru(dmbpy)2(Hptr)]2+, isomer 1, (l)-(29): pH 
= 0.99, 1.21, 1.57, 1.74, 2.00, 2.24, 2.44, 
2.62, 2.81, 3.02, 3.23, 3.43, 3.63, 3.83, 4.02,
4.27, 4.51, 4.73, 5.04, 5.27, 5.50, 5.73, 6.55,
7.01, 7.50, 8.06, 9.02, 9.97 and 11.07.
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The inflection point in an emission intensity (pH^) versus 
pH plot gives an excited state pK * which is called the
3.
"apparent pK *" value (given as pH. in Table 5.8),3. 1
because these values need to be corrected for the different 
lifetimes of the protonated and deprotonated complexes, 
according to equation 5.1, [17].
pKa * = pHi + log (X  a / X b) Eqn. 5.1.
where X  and T  , are the excited state lifetimes ofa b
the protonated and deprotonated compounds respectively, and 
pH^ is the inflection point of the emission intensity 
versus pH curve.
The excited state pK * values may also be determined
cl
using the Forster cycle as in equation 5.2, [16].
pKa* = pKa + 0 .625 (Vfa - V a ) / T Eqn. 5.2
where V and v , are the energies of the (0-0)a b
transition from the ground state to the excited state 
involved in the deprotonation equilibrium, for the protonated 
and deprotonated forms respectively, obtained using the 
X  max. emission values measured at 77 K, and pK is thea
ground state pKa value.
From the results, it may be seen that the
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coordinated Hptr and H3Mptr ligands are more acidic in the 
excited state than in the ground state, (with quite good 
coorelation between the two methods used for calculating 
pK *). This shows that the pyridyltriazoles act as
cl
spectator ligands and do not actively take part in the
emission processes. The lifetime values given at the end of
Table 5.8, indicates that the emission is strongly
deactivated at low pH. This may be caused by population of
3the d-d level lying above the MLCT state, which may become 
accessible upon protonation of the complexes.
This increased acidity in the excited state has 
also been found for the bpy analogues and also other 
ruthenium compounds including [Ru (bpy)2 (3-(2-hydroxy- 
phenyl)-5-(pyridin-2-yl)-H-l,2,4 triazole and [Ru(bpy)2~ 
(3,3'- dimethyl-5,5'-bis-1,2,4 triazole. [19,20],
4,7-dihydroxy-l,10-phenanthroline, 4,4'dicarboxy-2 ,2 1 - 
bipyridine and 2,2'-benzimidazole. [22,23,24,25] The shift 
to lower energy of the emission X. max. upon deprotonation is 
consistent with the stronger O-donation properties of the 
deprotonated pyridyltriazole ligand.
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5.6 Conclusion
A series of pyridyltriazole compounds of the type [Ru(L-L)2 
-(L-L1)]n+ have been synthesised and characterised. (L-L) =
dmbpy or phen and (L-L') = IMptr, 4Mptr, H3Mptr or Hptr.
For all of the L-L' ligands, with the exception of
1 1 2' 4 'the 4Mptr, coordination through the N / N and N
on the triazole ring is possible. The use of semi-prepara- 
tive HPLC techniques permitted the separation of these 
coordination isomers and analytical HPLC was used to 
determine their purity. New isomers were isolated for the 
coordinated H3Mptr and IMptr complexes, which had not been 
previously isolated for the bpy analogues. The ratios 
obtained for these isomers (about 80-90% for one and about 
10-20% for the second), substantiate in themselves the 
coordination mode since the isomer in the lowest yield would 
be expected to be that isomer where coordination would be 
hindered sterically.
From the ^H NMR data on these compounds the 
coordination mode of the ligands to the Ru(dmbpy)2 and 
Ru(phen)2 moieties was proposed. The very clear NMR shifts 
of the methyl groups of the [R u (dmbpy)2 (L-L1)]n+ 
complexes facilitated in this regard. The coordination modes 
suggested by NMR data were further substantiated by data on 
the acid / base chemistry of the compounds incorporating the 
Hptr and H3Mptr ligands where protonation / deprotonation 
processes may occur. On the basis of the electronic and 
electrochemical results for these compounds, it was not
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no substantial differences were found. However, it was
proposed on the basis of NMR and acid / base properties that
for isomer 1 of the Hptr and H3Mptr coordinated compounds,
4 'coordination occurs via the N position on the triazole
ring. The results for isomer 2 of the IMptr coordinated
4 1compound also suggest coordination via the N position on
the triazole ring. The data obtained for the other isomer 2
2 1compounds implies that coordination occurs through the N 
site on the triazole ring.
Only one coordination mode is possible for the
2 + 2 '[Ru(L-L)2 (4Mptr)] compounds which is via the N
position on the triazole ring, due to the presence of a
4 ' . .methyl group on the N position.
The X-ray studies of [R u (bpy)^ (3Mptr)]+ have 
1 1substantiated the N coordination mode of the 3Mptr ligand 
for the bpy compound. Although in this case, coordination 
isomers were not observed or isolated, this site would be the 
site where coordination would not be sterically hindered and 
which for the dmbpy / phen compounds would represent the main 
fraction.
An attempt was made to determine the structure of 
isomer 2 of [R u (dmbpy)^ (Hptr)](PF^)^ (ClO^). f^O
[26] The R value obtained (which is a measure of how good 
the expected result compares with the calculated result) was 
too high to be able to distinguish between a carbon or 
nitrogen atom and therefore, to differentiate between 
isomers. There were some indications to suggest that
possible to differentiate between the coordination isomers as
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coordination to the ruthenium atom occurred through the N 
site on the triazole ring but nothing conclusive. The
calculated Ru-N distances and N-Ru-N angles were found to be
3-t­in good agreement with the structure of [Ru(bpy)]
[27,28]. An ORTEP diagram of the cation is presented in
Figure 5.27. [29]
2 1
Figure 5.27 ORTEP diagram [29], of the [RuCdmbpy^-
2+(Hptr)] cation. Atoms are represented by
ellipsoids showing a 10% probability of their
thermal replacement. Hydrogen atoms, water
molecules and the disordered PF ~ and CIO.o 4
groups have been omitted for clarity.
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Deprotonation was found to have a profound effect on the 
electronic and electrochemical properties of the [Ru(L-L)2 
-(Hptr)]2+ and [R u (L-L)2 (H3Mptr)]2+ compounds. The 
data shows that upon deprotonation the ligands are better 
CT-donors / weaker jt-acceptors due to destabilisation of 
the metal d orbitals.
All the compounds investigated were found to emit 
at both room temperature and at 77 K, with emission intensity 
increasing with increasing pH for the compounds where 
protonation / deprotonation processes may occur i.e. the Hptr 
and H3Mptr coordinated compounds.
The acid-base properties show that the ligands act as 
stronger acids in the excited state indicating that the 
pyridyltriazole ligands do not participate in the emission 
processes. The observed emission for all the compounds is 
dmbpy / phen based.
In general, the properties of the complexes
studied in this work are very similar to those of the
analogous bpy complexes. However certain differences are
evident for the dmbpy complexes in relation to their
electrochemical behaviour. The oxidation potentials for the
dmbpy complexes are somewhat lower than those of the phen or
bpy complexes, indicating that the metal ion has more
electron density, which is caused by strong (J -donating or
weak JI-accepting ligands. Also the more negative reduction
potentials for the dmbpy complexes shows that these complexes
★
are weaker jt-acceptors, have higher lying ji orbitals 
and consequently are harder to reduce.
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The pK values determined for the H3Mptr coordinatedSi
complexes are generally higher than for the Hptr coordinated 
complexes. This is caused by the electron donating methyl 
group which yields a higher electron density on the triazole 
ring. For the H3Mptr and Hptr coordinated bis dmbpy 
complexes, the pK values are higher than for the phen or
cl
bpy analogues, again showing the additional donating effect 
of the methyl groups present on the dmbpy ligands.
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CHAPTER 6
FINAL REMARKS
6 . 1 Final remarks.
This thesis deals primarily with the synthesis and 
characterisation of ruthenium (II) polypyridyl complexes 
containing amino and isothiocyanate phenanthroline and 
pyridine ligands and the application of these complexes as 
fluorescent probes in biological systems. The secondary 
concern was the characterisation of a series of bis-(l,10 
-phenanthroline) and bis-(4,41-dimethyl-2 ,2 1-bipyridyl) 
ruthenium (II) complexes containing various pyridyltriazole 
ligands and completes the study which was initially conducted 
on the bis-(2 ,2 1-bipyridyl) analogues.
Chapter 1 begins with a general introduction on 
the properties of ruthenium polypyridyl complexes relevant to 
this thesis. The main subject matter of this chapter deals 
firstly with, the interactions of ruthenium polypyridyls with 
DNA and secondly, the use of fluorescent probes in 
immunochemistry. The interactions of ruthenium polypyridyl 
complexes with DNA are reviewed. This area has been the 
subject of active investigation over the past few years and 
concerns both electrostatic and intercalative interactions 
with DNA. The literature describes the use of ruthenium 
complexes as probes of DNA helicity which is possible by 
virtue of their chirality, where both left- and right-handed 
enantiomers are observed. By a judicious choice of ligand, 
the complexes may be made specific for different helical 
forms of DNA.
The spectroscopic properties of DNA bound
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ruthenium polypyridyl complexes and the effects on the 
physical properties of DNA are described. The strong visible 
absorption band which is distinct from the absorption due to 
DNA, together with the stronger luminescence and increased 
excited state lifetimes of the DNA bound complexes, provide a 
spectroscopic tool for monitoring the binding process.
DNA thermal denaturation measurements can be used 
to distinguish between those complexes which bind 
intercalatively and those which bind electrostatically.
Also, intercalation causes DNA to unwind and lengthen. This 
effect may be examined using electrophoretic mobility assays. 
In addition, intercalation stabilises the DNA helix by 
substantial structural overlap between the base pairs of the 
DNA molecule and the intercalated ligand. This effect may be 
monitored using fluorescence depolarisation and anisotrophic 
techniques, which indicate if intercalation occurs, that 
polarisation of emitted light is retained.
The use of ruthenium polypyridyl complexes as 
sensitisers for the photocleavage of DNA is briefly examined.
The second part of Chapter 1 reviews the use of 
fluorescent probes in immunochemistry. Conjugation reactions 
involving the modification of various chemical groups on the 
protein molecules are described and examples of various types 
of fluorescent probes are given.
The use of fluorescent probes in fluorescence 
microscopy and in immunoassay procedures is also discussed 
and includes the use of time-resolved fluorometric analysis.
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This technique is applicable for' the use of lanthanide 
chelates and ruthenium polypyridyl complexes as fluorescent 
probes. This is due to a combination of long emission 
lifetimes and large Stokes shifts. The use of ruthenium 
complexes in this manner has an advantage over the use of 
lanthanide chelates because fluorescence measurements may be 
carried out directly. With lanthanide chelates, prior to 
analysis, the chelate must be destroyed and the lanthanide 
ion must be embedded into liposomes in order to be detected.
The use of ruthenium complexes as fluorescent 
probes for biomolecules is reviewed. Various ruthenium (II) 
complexes have been conjugated to antibodies and albumins.
The conjugation reaction has involved mostly, the 
modification of the £ -amino groups of lysine residues of 
protein molecules. This has been the subject of a number of 
patents. The use also, of ruthenium (II) bathophenanthroline 
complexes to label oligonucleotides has been described.
Chapter 2 deals with the experimental details and 
includes sections on (a) the synthesis of the complexes 
described in this work, (b) the instrumentation used to 
elucidate the various properties of the complexes and (c) the 
biological procedures, including details of the various 
conjugation reactions used and methods for determining 
protein concentration.
Chapter 3 describes the synthesis and 
characterisation of ruthenium (II) bis-(1,10-phenanthroline) 
and bis-(2 ,2 1-bipyridyl) complexes containing amino and 
isothiocyanate phenanthroline and pyridine ligands. These
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complexes were characterised using HPLC, UV/vis spectroscopy, 
electrochemistry, NMR, IR, and emission spectroscopy. HPLC 
was used to determine the purity of the various complexes. 
Infra-red spectra were used in a purely qualitative manner, 
to assess the success of the derivatisation reaction of the 
amino complex to its isothiocyanate derivative.
The proton resonance signals measured were 
assigned by comparison with literature data for similar 
compounds and also by comparison with the NMR spectra 
obtained for the pyridyltriazole complexes discussed in 
Chapter 5.
Electronic spectra and electrochemical 
measurements indicate that most likely, the 2 ,2 1-bipyridyl 
and 1 ,10-phenanthroline ligands are the emitting ligands and 
the amino and isothiocyanate phenanthroline and pyridine 
ligands act as the spectator ligands.
The complexes described in this chapter were 
subsequently conjugated to biological materials and this is 
dealt with in Chapter 4.
In Chapter 4, the conjugation of a number of 
ruthenium (II) polypyridyl complexes to albumins, 
immunoglobulins and poly-L-lysine is described. The 
complexes were bound at different sites on the biomolecules, 
via the lysine residues, the carbohydrate moieties and via 
the tyrosine residues, demonstrating the chemical flexibility 
available for using these complexes as reporter molecules.
The effect of conjugation on the spectroscopic 
properties of the complexes was examined. The absorption
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spectra were found to exhibit changes in the MLCT band with 
the absorption wavelength maximum experiencing slight red 
shifts together with general band broadening effects. The 
emission decay behaviour was also investigated. The unbound 
complexes were found to exhibit single exponential decay 
behaviour and the bound complexes exhibited essentially 
double exponential behaviour. From the double exponential 
decay fits, the first short-lived species was suggested to be 
a quenched bound species whilst the second species probably 
arises from a bound species which is considerably protected 
from the effects of quenching molecules.
Much of the work described in Chapter 4, 
represents initial experiments into the use of ruthenium 
complexes as reporter molecules in biological systems. These 
investigations show that there are two possible areas of 
research which may be pursued. One area is the study of 
these complexes in terms of their emission decay behaviour, 
with the possibility of their use as probes of protein 
structure. The second area concerns the use of ruthenium
(II) polypyridyl complexes in time-resolved immunoassay 
methods.
With regard to the emission decay behaviour of the 
albumin and poly-L-lysine conjugates examined in this thesis, 
these were high molecular weight conjugates with high F/P 
ratios. Future studies could involve variation of the F/P 
ratio and size or structural conformation of the biomolecule. 
It would be interesting and appropriate to investigate the 
use of much lower molecular weight conjugates, which could
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include the use of amino acids such as lysine or other amino 
acids which may be covalently bound to the ruthenium 
polypyridyl complexes and working up to quite large 
polypeptides consisting of the same or different amino acids. 
For lysine and poly-L-lysine conjugates (a range of various 
molecular weight poly-L-lysines are available), the effect of 
pH on the conformational structure of the poly-L-lysine 
molecule could lead to interesting effects in the emission 
decay behaviour.
Only preliminary measurements were made on the 
emission decay behaviour of antibody bound ruthenium 
complexes, so this needs further investigation.
The use of ruthenium labelled immunoglobulins as 
fluorescent probes was examined briefly. However, the 
retention of immunological activity after conjugation was 
demonstrated.
The fact that about a 10-^M concentration of a 
ruthenium (II) polypyridyl complex is required to be bound to 
a biological molecule before emission is observed under the 
fluorescence microscope may indicate that these complexes may 
not be suitable in fluorescence microscopy techniques. 
However, the successful use of a ruthenium (II) polypyridyl 
complex in fluorescence microscopy procedures has been 
described in a patent, so, obviously further investigations 
are necessary.
The use of ruthenium polypyridyl complexes in 
time-resolved techniques has been described and hopefully the 
complexes described in this work will also find application 
in this way.
332
a number of bis-(1,10-phenanthroline) (phen), and
bis-(4,41-dimethyl- 2,21-bipyridyl) (dmbpy), ruthenium (II)
complexes containing a series of pyridyltriazole ligands are
1 1 2 1detailed. The ruthenium ion may bind via the N / N or 
4 'N of the triazole ring. The most favourable coordination
mode being dependent on the position of a substituent on the
triazole ring. Coordination isomers were obtained and
separated by semi-preparative HPLC methods." The
electrochemical results suggest that the phen and dmbpy
ligands are the emitting ligands and that the pyridyltriazole
ligands are the spectator ligands.
The acid-base chemistry of those complexes which
can undergo protonation / deprotonation reactions was
investigated and the results substantiated the coordination
modes proposed using NMR data for the complexes. The ground
state pK^ values show that there is a strong CT-donating
effect from the triazole ring to the ruthenium ion. Also,
*the excited state pK& values are lower than the ground 
state pK values which indicates that the pyridyltriazole 
ligands do not participate in the emission process. As 
mentioned already, this study completes investigations which 
were initially conducted on the 2 ,2 1-bipyridyl analogues.
Finally, in Chapter 5, the synthesis and characterisation of
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